[
  {
    "question_number": "Q99",
    "question_text": "A young female has a Kayser\u2013Fleischer ring on slit lamp exam and presents with parkinsonism and dystonia, what is the treatment?",
    "options": "{\"A\": \"D-Penicillamine\", \"B\": \"Trihexyphenidyl\", \"C\": \"Zinc acetate\", \"D\": \"Levodopa\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic signs (Kayser-Fleischer ring) and symptoms (parkinsonism, dystonia) of Wilson's disease and asks for its treatment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q26",
    "question_text": "What is the recommended treatment for cervical dystonia?",
    "options": "{\"A\": \"Botox\", \"B\": \"Clonazepam\", \"C\": \"Levodopa\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the standard first-line treatment (Botulinum toxin injection) for cervical dystonia, a common focal dystonia.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q94",
    "question_text": "How can the diagnosis of idiopathic Parkinson's disease be confirmed?",
    "options": "{\"A\": \"Clinical evaluation\", \"B\": \"Levodopa challenge test\", \"C\": \"Pathology\", \"D\": \"Radiology\"}",
    "correct_answer": "C",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about the definitive method (neuropathological examination) for confirming a diagnosis of Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q6",
    "question_text": "In the same scenario of paroxysmal kinesigenic dyskinesia, what is the most appropriate management option?",
    "options": "{\"A\": \"Baclofen\", \"B\": \"Levodopa\", \"C\": \"Phenytoin\", \"D\": \"Tetrabenazine\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assumes a prior scenario describing Paroxysmal Kinesigenic Dyskinesia (PKD) and asks for its treatment (often Carbamazepine or Phenytoin).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q66",
    "question_text": "What is the treatment for hemifacial spasm?",
    "options": "{\"A\": \"Botox\", \"B\": \"Carbamazepine\", \"C\": \"Physical therapy\", \"D\": \"Surgical decompression\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the standard treatment (Botulinum toxin injection) for hemifacial spasm.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q34",
    "question_text": "In a scenario involving essential tremor and asthma treatment, which medication is commonly used?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Gabapentin\", \"D\": \"Topiramate\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses the treatment of essential tremor, considering a comorbidity (asthma) that influences medication choice. (Duplicate of Q223 part 2 2021).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q4",
    "question_text": "A patient diagnosed with Parkinson's disease 6 years ago presents with dyskinesia and is currently on levodopa. What is the next step in management?",
    "options": "{\"A\": \"Decrease levodopa dose\", \"B\": \"Amantadine\", \"C\": \"Levodopa and entacapone\", \"D\": \"Pramipexole\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on managing a common motor complication (levodopa-induced dyskinesia) in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q116",
    "question_text": "A 70-year-old man with Parkinson\u2019s disease has become progressively more demented over the past year. For the past 2 months, he has been having more frequent hallucinations, which makes him more agitated and violent. He is on Levodopa/Carbidopa and Rivastigmine. What is the appropriate treatment?",
    "options": "{\"A\": \"Quetiapine\", \"B\": \"Risperidone\", \"C\": \"Memantine\", \"D\": \"Clozapine\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the management of non-motor symptoms (psychosis, agitation) in the context of Parkinson's disease dementia.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q191",
    "question_text": "A 46-year-old female patient presented with jerky movements that improved with wine. Her father has the same symptoms. What is the diagnosis?",
    "options": "{\"A\": \"Myoclonus dystonia\", \"B\": \"Essential tremor\", \"C\": \"Huntington\\u2019s disease\", \"D\": \"Wilson\\u2019s disease\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes features highly suggestive of Myoclonus-Dystonia syndrome (jerky movements/myoclonus, alcohol responsiveness, family history).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q79",
    "question_text": "Best to explain orthostatic tremor:",
    "options": "{\"A\": \"Improves with walking\", \"B\": \"Present only at rest\", \"C\": \"Worsens with voluntary movement\", \"D\": \"Associated with rigidity\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of a specific clinical characteristic (improvement with walking, though unsteadiness on standing is key) of orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q222",
    "question_text": "In Progressive Supranuclear Palsy (PSP), which symptom will improve with treatment?",
    "options": "{\"A\": \"Rigidity\", \"B\": \"Bradykinesia\", \"C\": \"Postural instability\", \"D\": \"Vertical gaze palsy\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the limited symptomatic response to treatment (e.g., levodopa) in Progressive Supranuclear Palsy (PSP), focusing on motor features.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q245",
    "question_text": "A young girl with PKAN presents with dystonia and an MRI showing central hyperintensity. What is the diagnosis?",
    "options": "{\"A\": \"PKAN\", \"B\": \"Wilson's disease\", \"C\": \"Huntington's disease\", \"D\": \"Dystonia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic clinical (dystonia) and imaging ('eye-of-the-tiger' sign) features of Pantothenate Kinase-Associated Neurodegeneration (PKAN), a type of NBIA presenting with movement disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q99",
    "question_text": "A patient with Parkinson's Disease for 7 years on Sinemet has started to wean off the medication. What is the most likely reason for this?",
    "options": "{\"A\": \"Disease progression\", \"B\": \"Medication failure\", \"C\": \"Development of motor fluctuations\", \"D\": \"Side effects of Sinemet\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the concept of waning drug efficacy ('wearing off' or need for dose adjustment) due to disease progression in long-standing Parkinson's disease. \"Wean off\" likely misinterpreted \"wearing off\".",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q46",
    "question_text": "In a patient with Parkinsonism symptoms not responding to Sinemet, which condition is characterized by dystonia and abnormal movements?",
    "options": "{\"A\": \"Corticobasal degeneration (CBD)\", \"B\": \"Lewy body dementia (LBD)\", \"C\": \"Progressive supranuclear palsy (PSP)\", \"D\": \"Multiple system atrophy (MSA)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on differentiating atypical parkinsonian syndromes based on clinical features (poor levodopa response, dystonia, suggesting CBD).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q226",
    "question_text": "A patient on pramipexole for Parkinson's disease developed hallucinations. What should be done?",
    "options": "{\"A\": \"Stop pramipexole\", \"B\": \"Increase pramipexole dosage\", \"C\": \"Add an antidepressant\", \"D\": \"Refer for cognitive therapy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the management of medication side effects (hallucinations from dopamine agonist) in a Parkinson's disease patient.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q374",
    "question_text": "In a typical scenario of left hemifacial spasm, what is the recommended treatment?",
    "options": "{\"A\": \"Botox\", \"B\": \"Oral corticosteroids\", \"C\": \"Antiepileptic drugs\", \"D\": \"Physical therapy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the standard treatment (Botulinum toxin injection) for hemifacial spasm. (Duplicate of Q66).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q25",
    "question_text": "In a case of an elderly patient with symptoms suggestive of Multiple System Atrophy (MSA), which of the following is the most common presenting symptom?",
    "options": "{\"A\": \"Impairment of down gaze\", \"B\": \"Autonomic insufficiency\", \"C\": \"Cognitive impairment of amnestic type\", \"D\": \"Pyramidal signs\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the typical initial clinical manifestation (autonomic dysfunction) of Multiple System Atrophy (MSA).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q127",
    "question_text": "A patient exhibits on-off palatal movements accompanied by click sounds, which resolve with sleep. What is the likely condition?",
    "options": "{\"A\": \"Essential palatal myoclonus\", \"B\": \"Tardive dyskinesia\", \"C\": \"Myasthenia gravis\", \"D\": \"Wilson\\u2019s disease\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes clinical features characteristic of essential palatal myoclonus (resolves with sleep).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q507",
    "question_text": "A female with abnormal movements in the form of arching back had an EEG that was normal during the event. What is the most likely diagnosis?",
    "options": "{\"A\": \"Psychogenic movement disorder\", \"B\": \"Temporal Lobe Epilepsy (TLE)\", \"C\": \"Herpes Simplex Virus (HSV) encephalitis\", \"D\": \"Dystonia\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Scenario with unusual movements and normal ictal EEG suggests a non-epileptic, likely psychogenic, movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q131",
    "question_text": "Who is more likely to benefit from dopamine agonists compared to levodopa?",
    "options": "{\"A\": \"Patients with juvenile Parkinsonism\", \"B\": \"Elderly patients with Parkinson's disease\", \"C\": \"Patients with advanced Parkinson's disease\", \"D\": \"Patients with essential tremor\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Discusses treatment strategies in Parkinsonism, specifically the preferential use of dopamine agonists in younger patients to delay levodopa-related motor complications.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q201",
    "question_text": "A patient presents with typical orthostatic tremor. What is the treatment?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Levodopa\", \"C\": \"Propranolol\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the first-line pharmacological treatment (Clonazepam) for orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q35",
    "question_text": "An elderly patient presented with peak dose dyskinesia that is bothering him and affecting his daily living activities. He is a known case of Parkinson's disease and is maintained on levodopa/carbidopa four times a day. He is doing well otherwise but has a recurrence of the Parkinsonian features just 30 minutes before the next dose. Which of the following is the appropriate management?",
    "options": "{\"A\": \"Add Selegiline\", \"B\": \"Add Amantadine\", \"C\": \"Switch to levodopa/carbidopa/entacapone\", \"D\": \"Increase the frequency of levodopa/carbidopa dosing\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Complex scenario requiring management of both peak-dose dyskinesia and wearing-off in Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q89",
    "question_text": "A patient presents with hand stiffness, usually during writing. Her father had the same symptoms. What is the diagnosis? (case of DYT 11)",
    "options": "{\"A\": \"Myoclonus dystonia syndrome\", \"B\": \"Writer\\u2019s cramp\", \"C\": \"Parkinson\\u2019s disease\", \"D\": \"Essential tremor\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes features suggestive of a task-specific dystonia (writer's cramp) with a family history, likely pointing to an inherited dystonia like Myoclonus-Dystonia (DYT11).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q18",
    "question_text": "A 72-year-old woman is brought to the clinic by her family due to trouble walking. She reports feeling unsteady when she stands to walk and is scared of falling, but she can walk normally afterward. What is the most likely diagnosis?",
    "options": "{\"A\": \"Ataxic syndrome\", \"B\": \"Orthostatic Tremor\", \"C\": \"Parkinsonian gait\", \"D\": \"Peripheral neuropathy\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Classic description of the subjective unsteadiness upon standing characteristic of orthostatic tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q135",
    "question_text": "In a clear scenario of essential palatal myoclonus, what is the recommended investigation?",
    "options": "{\"A\": \"MRI of the brain\", \"B\": \"EEG\", \"C\": \"Electromyography (EMG) of the palatal muscles\", \"D\": \"Blood tests for metabolic causes\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the appropriate workup (MRI brain) for palatal myoclonus to exclude a structural (symptomatic) cause, even if essential type is suspected.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q185",
    "question_text": "In a case of spontaneous generalized chorea, which of the following options describes the phenomenology of the condition?",
    "options": "{\"A\": \"Tics\", \"B\": \"Task-specific dystonia\", \"C\": \"Chorea\", \"D\": \"Myoclonus\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the basic definition and recognition of chorea as a specific movement phenomenology.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q248",
    "question_text": "A case of essential tremor in a young law student with bronchial asthma is presented. What is the most appropriate treatment?",
    "options": "{\"A\": \"Primidone\", \"B\": \"Propranolol\", \"C\": \"Topiramate\", \"D\": \"Clonazepam\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses treatment selection for essential tremor considering comorbidity (asthma), favoring Primidone over Propranolol. (Duplicate concept Q223, Q34).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q229",
    "question_text": "In a scenario of hemifacial spasm, what is the recommended treatment?",
    "options": "{\"A\": \"Botox\", \"B\": \"Oral corticosteroids\", \"C\": \"Antiepileptic drugs\", \"D\": \"Surgical decompression\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the standard treatment (Botulinum toxin injection) for hemifacial spasm. (Duplicate of Q66, Q374).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q37",
    "question_text": "A patient with no significant medical history experiences episodes of jerky movements of the right upper limb followed by dystonia with posturing, which occur suddenly when she turns while running. What is the most likely diagnosis?",
    "options": "{\"A\": \"Exercise-related dyskinesia\", \"B\": \"Paroxysmal kinesigenic dyskinesia\", \"C\": \"Tardive dyskinesia\", \"D\": \"Myoclonus\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a classic trigger (sudden movement like turning while running) and semiology for Paroxysmal Kinesigenic Dyskinesia (PKD).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q154",
    "question_text": "A patient on metoclopramide developed dystonia, what is the treatment?",
    "options": "{\"A\": \"Trihexyphenidyl\", \"B\": \"Levodopa\", \"C\": \"Dihydrotetrabenazine\", \"D\": \"Diazepam\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the acute treatment (anticholinergic like Trihexyphenidyl) of drug-induced dystonia.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q30",
    "question_text": "A question describes symptomatic palatal myoclonus and asks what to do (not improved with sleep). What is the next step?",
    "options": "{\"A\": \"MRI of the brain\", \"B\": \"EEG\", \"C\": \"CT of the jaw\", \"D\": \"Electromyography of the palate\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the appropriate investigation (MRI brain) needed when symptomatic palatal myoclonus is suspected, to identify the underlying cause.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q223",
    "question_text": "Inclusion with alpha synucleinopathy contains:",
    "options": "{\"A\": \"Ubiquitin\", \"B\": \"Lewy body\", \"C\": \"Amyloid\", \"D\": \"Neurofibrillary tangles\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the primary protein aggregate (alpha-synuclein forming Lewy bodies) in synucleinopathies like PD, DLB, MSA.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q125",
    "question_text": "A case of essential tremor is noted with a frequency of 6 Hz that improves with alcohol and has a family history. What is the likely diagnosis?",
    "options": "{\"A\": \"Parkinson\\u2019s disease\", \"B\": \"Essential tremor\", \"C\": \"Cerebellar tremor\", \"D\": \"Dystonic tremor\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes classic clinical features (frequency, alcohol response, family history) leading to the diagnosis of Essential Tremor.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q60",
    "question_text": "A case scenario describes a patient with hemineglect, myoclonic jerks, and abnormal movement of one limb. MRI shows parietal atrophy. What is the likely diagnosis?",
    "options": "{\"A\": \"Alzheimer's disease\", \"B\": \"Corticobasal Degeneration (CBD)\", \"C\": \"Progressive Supranuclear Palsy (PSP)\", \"D\": \"Multiple System Atrophy (MSA)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: The combination of asymmetric motor symptoms (myoclonic jerks, abnormal limb movement/apraxia), cognitive deficits (hemineglect), and focal atrophy (parietal) strongly suggests Corticobasal Degeneration (CBD), an atypical parkinsonian syndrome.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q39",
    "question_text": "What is the best way to confirm the diagnosis of synucleinopathy?",
    "options": "{\"A\": \"Clinically\", \"B\": \"Radiologically\", \"C\": \"Neuropathologically\", \"D\": \"Biochemically\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the gold standard for confirming synucleinopathies (like PD, MSA, DLB), which is neuropathological examination.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q114",
    "question_text": "In a patient with Tourette's syndrome and ADHD, which medication is appropriate for treatment (Clonidine was not one of the options)?",
    "options": "{\"A\": \"Methylphenidate\", \"B\": \"Atomoxetine\", \"C\": \"Haloperidol\", \"D\": \"Fluoxetine\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the pharmacological management of comorbid Tourette's syndrome (a tic disorder) and ADHD, considering treatments for tics and/or ADHD.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q398",
    "question_text": "In a patient with corticobasal degeneration (CBD), what would a PET scan most likely reveal?",
    "options": "{\"A\": \"Asymmetrical hypometabolism in the temporal-parietal region\", \"B\": \"Hypometabolism in the precentral and postcentral association cortex with asymmetry within the same hemisphere\", \"C\": \"Frontoportal hypometabolism\", \"D\": \"Normal metabolic activity\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about characteristic neuroimaging findings (asymmetric frontoparietal hypometabolism on FDG-PET) in Corticobasal Degeneration (CBD), an atypical parkinsonian syndrome. (Duplicate concept of Q37 Part 2 2020).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q459",
    "question_text": "What imaging finding is associated with corticobasal degeneration (CBD)?",
    "options": "{\"A\": \"Temporal and parietal association involvement\", \"B\": \"Symmetric frontal lobe atrophy\", \"C\": \"Hippocampal sclerosis\", \"D\": \"Diffuse white matter hyperintensities\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of characteristic neuroimaging findings (asymmetric parietal/temporal atrophy) associated with Corticobasal Degeneration (CBD). (Duplicate concept of Q398/Q37).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q412",
    "question_text": "In a scenario suggestive of Wilson's disease with Parkinsonism and dystonia, what is the recommended treatment?",
    "options": "{\"A\": \"Penicillamine\", \"B\": \"Zinc supplementation\", \"C\": \"Trientine\", \"D\": \"No treatment\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the treatment (chelation therapy) for the neurological manifestations (Parkinsonism, dystonia) of Wilson's disease. (Duplicate of Q132/Q99).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q515",
    "question_text": "A patient presents with mild parkinsonism over a few months, a history of urinary incontinence for several years, and mild cognitive impairment. Imaging reveals mild cerebral atrophy with moderate ventriculomegaly. What is the next best step in management?",
    "options": "{\"A\": \"Ventriculoperitoneal (VP) shunt referral\", \"B\": \"Levodopa trial\", \"C\": \"Lumbar puncture\", \"D\": \"Observation\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes the classic triad and imaging findings suggestive of Normal Pressure Hydrocephalus (NPH), a treatable cause of gait disturbance/parkinsonism. Asks for the next diagnostic/management step (diagnostic lumbar puncture).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q42",
    "question_text": "A Parkinson's patient came with increased hallucinations and memory loss; what is the treatment?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Clozapine\", \"C\": \"Quetiapine\", \"D\": \"Donepezil\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the management of non-motor complications (psychosis, cognitive decline) in a patient with Parkinson's disease. (Similar concept to Q116, Q118).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q150",
    "question_text": "A 67-year-old patient known to have Parkinson's disease presents with sleep disorders. Which sleep disorder is most likely to improve with dopamine agonist treatment?",
    "options": "{\"A\": \"Restless legs syndrome\", \"B\": \"REM behavior disorder\", \"C\": \"Periodic limb movement disorder\", \"D\": \"Narcolepsy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: While involving sleep, the core context is Parkinson's disease, and the question relates the effect of a PD treatment (dopamine agonist) to associated sleep issues common in PD (like RLS).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q490",
    "question_text": "Which of the following disorders is associated with Parkinson's disease treated with dopamine agonists?",
    "options": "{\"A\": \"Restless Legs Syndrome (RLS)\", \"B\": \"Parasomnia\", \"C\": \"Neuropathy\", \"D\": \"REM sleep behavior disorder\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of non-motor symptoms strongly associated with Parkinson's disease (like REM Sleep Behavior Disorder), a core movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q227",
    "question_text": "A patient with Parkinson's disease and excessive sleep with motor fluctuations is experiencing difficulties. What medication should be considered?",
    "options": "{\"A\": \"Selegiline\", \"B\": \"Amantadine\", \"C\": \"Levodopa\", \"D\": \"Dopamine agonist\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on managing symptoms (both motor fluctuations and non-motor excessive sleepiness) within the context of Parkinson's disease treatment.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q168",
    "question_text": "What is the treatment for a patient with Parkinson's Disease (PD) who has features of Restless Legs Syndrome (RLS)?",
    "options": "{\"A\": \"Dopamine agonist\", \"B\": \"Iron supplementation\", \"C\": \"Benzodiazepines\", \"D\": \"Opioids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses treatment of RLS specifically within the context of a patient with Parkinson's Disease, where treatment choices might be influenced by the underlying PD.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q85",
    "question_text": "In a case scenario of hemiballismus, what is the localization?",
    "options": "{\"A\": \"Subthalamic nucleus (STN)\", \"B\": \"Globus pallidus\", \"C\": \"Caudate nucleus\", \"D\": \"Putamen\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Links a specific movement disorder (hemiballismus) to its typical anatomical localization (contralateral STN).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q59",
    "question_text": "In a case of familial Parkinson disease, which gene is associated with autosomal dominant inheritance and is one of the most common causes of familial Parkinson's disease?",
    "options": "{\"A\": \"PARK1 (\\u03b1-synuclein)\", \"B\": \"PARK2 (Parkin)\", \"C\": \"LRRK2 (PARK8)\", \"D\": \"DJ-1\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the genetics of Parkinson's disease, specifically identifying a common autosomal dominant gene (LRRK2).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q109",
    "question_text": "For a patient with rubral tremor associated with multiple sclerosis, what is the recommended treatment?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"Botox\", \"C\": \"Clonazepam\", \"D\": \"Surgical treatment\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the treatment options for a specific type of tremor (rubral tremor), even though the underlying cause is MS. The core is managing the movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q287",
    "question_text": "Which is a Tauopathy?",
    "options": "{\"A\": \"MSA\", \"B\": \"PSP\", \"C\": \"DLB\", \"D\": \"CBD\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the underlying molecular pathology (specifically identifying a tauopathy - PSP) of various neurodegenerative movement disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q40",
    "question_text": "A middle-aged lady presents with problems with attention, tremor, and progressive ataxia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paraneoplastic syndrome\", \"B\": \"Alzheimer type 2 (or 3)\", \"C\": \"Wilson's disease\", \"D\": \"Multiple system atrophy\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: The constellation of cognitive issues (attention), tremor, and ataxia in a middle-aged person strongly suggests Wilson's disease, a treatable movement disorder. The options include the disease and its diagnostic test.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q46",
    "question_text": "What will confirm the diagnosis of Wilson's disease?",
    "options": "{\"A\": \"Liver biopsy\", \"B\": \"Genetic testing\", \"C\": \"Serum ceruloplasmin levels\", \"D\": \"24-hour urinary copper excretion\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the definitive diagnostic confirmation methods (genetic testing or liver biopsy showing copper levels) for Wilson's disease, a disorder primarily classified under movement disorders due to its neurological presentation.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q136",
    "question_text": "In a scenario suggestive of Wilson's disease with Kayser-Fleischer ring and MRI features, what is the next step to confirm the diagnosis?",
    "options": "{\"A\": \"Liver biopsy\", \"B\": \"Genetic test\", \"C\": \"Ceruloplasmin level\", \"D\": \"MRI follow-up\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the diagnostic workup for Wilson's disease, a key movement disorder, after initial suspicion is raised by clinical and imaging findings.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q139",
    "question_text": "For a patient with dyt11, what is the first-line treatment if the condition improves with alcohol?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Zonisamide\", \"C\": \"Trihexyphenidyl\", \"D\": \"Levodopa\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the treatment of a specific genetic movement disorder (DYT11 - Myoclonus-Dystonia), characterized by its response to alcohol.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q160",
    "question_text": "A 50-year-old male patient has a history of cognitive impairment for 6 months, accompanied by depression and abnormal movements. His father died at the age of 60 with a history suggestive of Huntington's disease. What is the gene associated with this condition?",
    "options": "{\"A\": \"CAG repeat\", \"B\": \"CGG repeat\", \"C\": \"GAA repeat\", \"D\": \"CTG repeat\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a classic presentation of Huntington's disease (cognitive, psychiatric, motor symptoms with family history) and asks about the underlying genetic mechanism (CAG repeat expansion).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q161",
    "question_text": "A 9-year-old girl with a known case of developmental delay has a history of 10 months of abnormal postures and twitching of limbs with diurnal events. Genetic testing shows a mutation in the GCH1 gene. What is the proper treatment?",
    "options": "{\"A\": \"Levodopa/carbidopa\", \"B\": \"Baclofen\", \"C\": \"Diazepam\", \"D\": \"Deep brain stimulation\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Identifies Dopa-Responsive Dystonia (via GCH1 gene) based on clinical features (dystonia, diurnal fluctuation implied) and asks for the specific treatment (L-Dopa).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q163",
    "question_text": "A 34-year-old female is brought in by her family due to a history of abnormal movements of her hands and legs, as well as difficulty eating due to sustained contractions of her mouth. Her father had a similar history and died early. On examination, she is found to have orolingual dystonia. What should be done next to reach a diagnosis?",
    "options": "{\"A\": \"Genetic testing\", \"B\": \"MRI of the brain\", \"C\": \"Electromyography (EMG)\", \"D\": \"Trial of anticholinergic medication\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: The presentation (dystonia, family history) strongly suggests a hereditary movement disorder like Huntington's disease, making genetic testing the key next diagnostic step.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q175",
    "question_text": "A pediatric patient had mental retardation, tremor, and ataxia; his sister had ovarian insufficiency. What is the typical imaging finding?",
    "options": "{\"A\": \"Bilateral cerebellar hyperintensity\", \"B\": \"Elongated medulla\", \"C\": \"Cerebral cortical atrophy\", \"D\": \"Basal ganglia calcifications\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The combination of tremor/ataxia in the patient and premature ovarian insufficiency in a female relative suggests Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) in a premutation carrier (or Fragile X syndrome itself). This falls under movement disorders due to the tremor/ataxia focus.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q190",
    "question_text": "A case of Huntington's disease shows CT brain imaging with head of caudate atrophy. What is the expected number of CAG repeats in this patient?",
    "options": "{\"A\": \"48 CAG repeats\", \"B\": \"27 CAG repeats\", \"C\": \"36 CAG repeats\", \"D\": \"40 CAG repeats\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the correlation between CAG repeat length and disease manifestation/severity in Huntington's disease, a core movement disorder concept.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q61",
    "question_text": "A child presented with dystonia and Parkinsonism. Brain MRI reported bilateral hyperintensity in the basal ganglia. What is the most likely diagnosis?",
    "options": "{\"A\": \"Pantothenate kinase-associated neurodegeneration\", \"B\": \"Wilson disease\", \"C\": \"Leigh syndrome\", \"D\": \"Huntington disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes a classic presentation (movement disorder + characteristic imaging finding) suggestive of PKAN, a genetic movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q156",
    "question_text": "Hallervorden-Spatz syndrome is associated with which gene?",
    "options": "{\"A\": \"PKAN-1\", \"B\": \"PANK2\", \"C\": \"ATP7B\", \"D\": \"SLC6A3\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the gene associated with PKAN (formerly Hallervorden-Spatz), a genetic movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q60",
    "question_text": "A young lady with dystonia, chorea, and depression has a Brain MRI that shows caudate atrophy. What will likely be the cause on genetic test? (Case of Huntington disease)",
    "options": "{\"A\": \"27 repeats CAG\", \"B\": \"33 repeats CAG\", \"C\": \"36 repeats CAG\", \"D\": \"48 repeats CAG\"}",
    "correct_answer": "D",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Links the clinical presentation (chorea, dystonia, psychiatric symptoms) and imaging findings suggestive of Huntington's disease to the expected genetic finding (pathogenic CAG repeat number).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q125",
    "question_text": "A case presents with ataxia, slow saccades, and optic atrophy. Which type of spinocerebellar ataxia is most likely indicated?",
    "options": "{\"A\": \"SCA 3\", \"B\": \"SCA 6\", \"C\": \"SCA 7\", \"D\": \"DRBLA\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on differentiating subtypes of Spinocerebellar Ataxia (inherited ataxia syndromes presenting as movement disorders) based on clinical features like ataxia, saccades, and optic atrophy (characteristic of SCA7).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q51",
    "question_text": "A patient came with ataxia, optic atrophy, hearing loss, and slow saccades; what is the diagnosis?",
    "options": "{\"A\": \"Machado-Joseph disease\", \"B\": \"Spinocerebellar Ataxia 6 (SCA6)\", \"C\": \"Spinocerebellar Ataxia 7 (SCA7)\", \"D\": \"NARP\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of a specific inherited ataxia syndrome (SCA7) based on a constellation of neurological signs (ataxia, optic atrophy, hearing loss, slow saccades), falling under the Movement Disorders category.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q146",
    "question_text": "A 75-year-old patient with progressive cognitive decline, chorea, and ataxia has no children, and his father died at age 65. What is the most likely diagnosis?",
    "options": "{\"A\": \"Huntington's disease\", \"B\": \"Neuroacanthocytosis\", \"C\": \"DRPLA\", \"D\": \"Wilson's disease\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Presents a complex movement disorder (chorea, ataxia) with cognitive decline, requiring differentiation between inherited causes like Huntington's disease and DRPLA, both classified under Movement Disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q21",
    "question_text": "A patient with features of Friedreich Ataxia is asked about the associated gene. What is the gene involved?",
    "options": "{\"A\": \"FXN gene with GAA trinucleotide repeat expansion\", \"B\": \"HTT gene\", \"C\": \"SOD1 gene\", \"D\": \"PARK2 gene\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the specific gene/mutation associated with Friedreich Ataxia, a primary inherited ataxia syndrome, which falls under the umbrella of Movement Disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q72",
    "question_text": "A patient presents with muscle weakness, optic atrophy, hearing loss, and a family history of a similar condition. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Spinocerebellar Ataxia Type 7 (SCA7)\", \"B\": \"Spinocerebellar Ataxia Type 6 (SCA6)\", \"C\": \"Friedrich Ataxia\", \"D\": \"Spinocerebellar Ataxia Type 3 (SCA3)\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests recognition of a specific inherited ataxia syndrome (likely SCA7 given optic atrophy/hearing loss) based on multisystem neurological presentation, classified under Movement Disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q167",
    "question_text": "A 16-year-old female presented with oculomotor apraxia and ataxia; she had normal immunoglobulin and high AFP. What is the diagnosis?",
    "options": "{\"A\": \"Ataxia telangiectasia\", \"B\": \"Oculomotor apraxia type 1\", \"C\": \"Oculomotor apraxia type 2\", \"D\": \"Friedreich\\u2019s ataxia\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes clinical and laboratory features pointing towards a specific inherited ataxia syndrome (Ataxia with Oculomotor Apraxia type 2 - AOA2), categorized under Movement Disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q114",
    "question_text": "A patient with a known case of diabetes mellitus presents with axial and appendicular ataxia and has a conduction block. What is the likely gene mutation associated with Friedreich's ataxia?",
    "options": "{\"A\": \"CIG\", \"B\": \"CAG\", \"C\": \"GAA\", \"D\": \"CTG\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the specific genetic mutation (GAA repeat) underlying Friedreich's Ataxia, a prominent inherited ataxia syndrome falling under Movement Disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q164",
    "question_text": "The most common familial gene mutation associated with Parkinson's disease is:",
    "options": "{\"A\": \"LRRK2\", \"B\": \"Parkin\", \"C\": \"SNCA\", \"D\": \"PINK1\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for the most common gene mutation (LRRK2) associated with familial Parkinson's disease, a primary movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q277",
    "question_text": "A 50-year-old female presents with complaints of imbalance and tremor. MRI shows bilateral hyperintense cerebellar peduncles. What is the most likely diagnosis?",
    "options": "{\"A\": \"Fragile X syndrome [FXTAS]\", \"B\": \"Paraneoplastic syndrome\", \"C\": \"Multiple System Atrophy (MSA)\", \"D\": \"Progressive Supranuclear Palsy (PSP)\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links clinical features (ataxia/tremor) with a specific MRI finding (middle cerebellar peduncle sign) characteristic of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), classifying by the presenting movement disorder phenotype.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q110",
    "question_text": "In a scenario of a girl with dystonia and no Parkinsonism features, which genetic mutation is most likely associated?",
    "options": "{\"A\": \"DYT 1\", \"B\": \"DYT 5 (GCH1)\", \"C\": \"DYT 6 (THAP1)\", \"D\": \"DYT 11 (SGCE)\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Connects a specific clinical phenotype (early-onset, isolated generalized dystonia) to its most common genetic cause (DYT1/TOR1A), focusing on a genetic movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q95",
    "question_text": "In a scenario about a patient with Wilson's disease who has chorea, dystonia, and an ophthalmological exam showing a Kayser\u2013Fleischer ring, what is the next step in confirmation of the diagnosis?",
    "options": "{\"A\": \"Liver biopsy\", \"B\": \"Serum ceruloplasmin\", \"C\": \"MRI brain\", \"D\": \"24-hour urinary copper excretion\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the diagnostic workup (biochemical testing like ceruloplasmin) for Wilson's disease, which typically presents with movement disorders (chorea, dystonia, parkinsonism).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q221",
    "question_text": "Which genetic mutation is associated with dystonia accompanied by myoclonus?",
    "options": "{\"A\": \"SCG1\", \"B\": \"SGCE (DYT11)\", \"C\": \"TOR1A (DYT1)\", \"D\": \"THAP1 (DYT6)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly asks for the gene (SGCE) associated with the specific genetic syndrome Myoclonus-Dystonia (DYT11), classified by its core movement disorder features.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q22",
    "question_text": "A 50-year-old female presents with recent intention tremor and memory problems, with MRI findings of cerebellar peduncle changes. What is the likely diagnosis?",
    "options": "{\"A\": \"Fragile X syndrome [FXTAS]\", \"B\": \"Paraneoplastic syndrome\", \"C\": \"Medication overuse headache\", \"D\": \"Basilar migraine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Links a specific constellation of clinical (tremor, cognitive issues) and MRI findings (cerebellar peduncle changes) to Fragile X-associated tremor/ataxia syndrome (FXTAS), classified by the presenting movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q285",
    "question_text": "What is the most common familial gene associated with Parkinson's disease?",
    "options": "{\"A\": \"LRRK2\", \"B\": \"PARK\", \"C\": \"PINK1\", \"D\": \"SNCA\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly asks to identify the most frequent gene (LRRK2) responsible for familial forms of Parkinson's disease, a primary movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q198",
    "question_text": "Dystonia with myoclonus is most commonly associated with which genetic mutation?",
    "options": "{\"A\": \"SGCE (DYT11)\", \"B\": \"TOR1A (DYT1)\", \"C\": \"THAP1 (DYT6)\", \"D\": \"GCH1 (DYT5)\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links a specific movement disorder phenotype (Myoclonus-Dystonia) directly to its associated causative gene (SGCE/DYT11).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q90",
    "question_text": "A patient with a history of abnormal movements and falls, which interfere with his daily routine, is experiencing behavioral and mood changes. What trinucleotide repeat expansion would you expect to find?",
    "options": "{\"A\": \"CAG\", \"B\": \"CTG\", \"C\": \"CGG\", \"D\": \"GAA\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks to identify the type of genetic mutation (trinucleotide repeat) underlying a syndrome presenting with movement, cognitive, and behavioral features suggestive of Huntington's disease, the archetypal genetic movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q252",
    "question_text": "In a case of Wilson's disease with Kayser-Fleischer ring and pyramidal signs, which test confirms the diagnosis?",
    "options": "{\"A\": \"MRI brain\", \"B\": \"Biopsy\", \"C\": \"CT\", \"D\": \"Serum copper and ceruloplasmin\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the diagnostic confirmation of Wilson's disease, classified under movement disorders due to its common neurological presentation.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q128",
    "question_text": "What is the recommended treatment for Wilson's disease during pregnancy?",
    "options": "{\"A\": \"D-Penicillamine\", \"B\": \"Trientine\", \"C\": \"Zinc\", \"D\": \"Liver transplantation\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Deals with the specific management (treatment choice) of Wilson's disease, classified under movement disorders, in the special context of pregnancy.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q247",
    "question_text": "A young female has Kayser-Fleischer rings on slit lamp exam and presents with parkinsonism and dystonia. What is the treatment?",
    "options": "{\"A\": \"Penicillamine\", \"B\": \"Levodopa\", \"C\": \"Trihexyphenidyl\", \"D\": \"Amantadine\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the primary treatment (copper chelation - Penicillamine) of Wilson's disease, presenting with classic movement disorder symptoms.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q291",
    "question_text": "A 78-year-old female presents with ataxia for one year and mild cognitive impairment. MRI showed cerebellar peduncle hyperintensities. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paraneoplastic\", \"B\": \"Premutation fragile X syndrome [FXTAS]\", \"C\": \"Benign multiple sclerosis\", \"D\": \"Spinocerebellar ataxia\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The combination of late-onset ataxia, cognitive impairment, and specific MRI findings (middle cerebellar peduncle sign) is characteristic of Fragile X-associated Tremor/Ataxia Syndrome (FXTAS), classified by its movement disorder phenotype.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q4",
    "question_text": "In the case of Sydenham's chorea, what is the recommended action?",
    "options": "{\"A\": \"ASO titer\", \"B\": \"Start dopamine antagonists\", \"C\": \"Immediate corticosteroid therapy\", \"D\": \"Brain MRI\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: While Sydenham's is pediatric, this question asks about a diagnostic step (ASO titer) related to the etiology (post-streptococcal) of this specific movement disorder (chorea).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q13",
    "question_text": "A 9-year-old boy has a history of 14 months of vocal and motor tics, along with a history of OCD. What is the most likely diagnosis?",
    "options": "{\"A\": \"Tourette syndrome\", \"B\": \"Transient tic disorder\", \"C\": \"Chronic motor tic disorder\", \"D\": \"Obsessive-compulsive disorder\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on applying diagnostic criteria (duration, type of tics, age) to identify Tourette syndrome, a specific movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q14",
    "question_text": "Sydenham chorea",
    "options": "{\"A\": \"Is a movement disorder associated with rheumatic fever\", \"B\": \"Is primarily caused by Huntington's disease\", \"C\": \"Is characterized by rigidity and bradykinesia\", \"D\": \"Is an autoimmune disorder affecting the peripheral nerves\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assumed to be asking about the diagnosis or features of Sydenham chorea, a specific type of chorea (movement disorder).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q15",
    "question_text": "A 12-year-old male patient had a runny nose two weeks ago. He presents with abnormal movements, and a video is attached for reference. What is the likely diagnosis?",
    "options": "{\"A\": \"Huntington disease\", \"B\": \"Sydenham chorea\", \"C\": \"Tourette syndrome\", \"D\": \"Wilson disease\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a scenario highly suggestive of Sydenham chorea (post-infectious onset of abnormal movements), focusing on diagnosing the movement disorder.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q73",
    "question_text": "An 11-year-old boy comes to the office with his parents because of a 14-month history of motor and vocal tics... Which of the following is the most appropriate description of this patient\u2019s symptoms?",
    "options": "{\"A\": \"Chronic tic disorder\", \"B\": \"Stereotypes\", \"C\": \"Tourette syndrome\", \"D\": \"Transient tic disorder\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Requires distinguishing between different tic disorders based on clinical description and diagnostic criteria, focusing on the classification of movement disorders.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q173",
    "question_text": "A 9-year-old boy, previously healthy, develops abnormal movements of the upper and lower limbs with gait instability. The family reports a 6-week history of runny nose. What is the most likely diagnosis?",
    "options": "{\"A\": \"Sydenham chorea\", \"B\": \"Chorea-acanthocytosis\", \"C\": \"Wilson's disease\", \"D\": \"Essential tremor\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of chorea in a child, specifically identifying Sydenham chorea based on the post-infectious history.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q102",
    "question_text": "A patient known to have psychiatric symptoms on antipsychotic medication for a long time presented with abnormal movements of the face and tongue. What is the diagnosis?",
    "options": "{\"A\": \"Tardive dyskinesia\", \"B\": \"Neuroleptic malignant syndrome\", \"C\": \"Acute dystonic reaction\", \"D\": \"Parkinsonism\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the diagnosis of tardive dyskinesia, a specific movement disorder caused by medication exposure.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q199",
    "question_text": "A patient was in a psychiatric hospital and developed abnormal movements. What is the likely diagnosis?",
    "options": "{\"A\": \"Tardive dyskinesia\", \"B\": \"Parkinson's disease\", \"C\": \"Essential tremor\", \"D\": \"Dystonia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The context strongly suggests tardive dyskinesia, a movement disorder resulting from antipsychotic use.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q117",
    "question_text": "A patient presents with blunted affect and rigidity after carbon monoxide exposure. What is the most likely diagnosis?",
    "options": "{\"A\": \"Depression\", \"B\": \"Recurrent seizures\", \"C\": \"Subclinical status epilepticus\", \"D\": \"Neuroleptic malignant syndrome\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links a toxic exposure (carbon monoxide) to a resulting movement disorder phenotype (parkinsonism - rigidity, blunted affect).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q42",
    "question_text": "In the management of Tic disorders and ADHD, which medication is commonly prescribed?",
    "options": "{\"A\": \"Atomoxetine\", \"B\": \"Methylphenidate\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about pharmacological treatment for Tic disorders, which are classified under movement disorders (often co-occurring with ADHD).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q183",
    "question_text": "What test is associated with Sydenham chorea in a girl?",
    "options": "{\"A\": \"ASO titer\", \"B\": \"Anti-DNAse B antibody\", \"C\": \"ESR (Erythrocyte Sedimentation Rate)\", \"D\": \"ANA (Antinuclear Antibody)\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the diagnostic test (ASO titer) confirming the post-streptococcal etiology of Sydenham chorea, a specific type of chorea.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q20",
    "question_text": "A patient with Parkinson's disease presents with hallucinations and forgetfulness. What is the most appropriate management option?",
    "options": "{\"A\": \"Rivastigmine\", \"B\": \"Clozapine\", \"C\": \"Levodopa\", \"D\": \"Amantadine\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Concerns the management of non-motor symptoms (psychosis, cognitive issues) arising within the context of Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q178",
    "question_text": "In a clear scenario of vascular Parkinson's disease, what should be done?",
    "options": "{\"A\": \"Control hypertension\", \"B\": \"Start L-Dopa therapy\", \"C\": \"Refer for surgery\", \"D\": \"No intervention\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: While triggered by vascular events, the question focuses on the management approach specific to vascular parkinsonism (risk factor control, often poor L-dopa response), distinguishing it from idiopathic Parkinson's disease.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q241",
    "question_text": "An elderly female patient wakes up with abnormal left arm and leg involuntary movements. Before she slept, she had no complaints. She presented to the ER, where a CT brain was normal, and an MRI stroke protocol was done. Later, the involuntary movement improved. Where do you expect to find the abnormality in the MRI?",
    "options": "{\"A\": \"Midbrain\", \"B\": \"Sub-thalamic\", \"C\": \"Pons\", \"D\": \"Medulla\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on localizing the lesion responsible for acute hemiballismus/hemichorea, a movement disorder often caused by a lesion (stroke) in the contralateral subthalamic nucleus.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q36",
    "question_text": "A patient with schizophrenia on antipsychotics presents with orolingual dystonia. What is the diagnosis?",
    "options": "{\"A\": \"Tardive Dyskinesia\", \"B\": \"Acute Dystonic Reaction\", \"C\": \"Neuroleptic Malignant Syndrome\", \"D\": \"Parkinsonism\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on identifying a specific drug-induced movement disorder (Tardive Dyskinesia/Dystonia) secondary to antipsychotic use.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q29",
    "question_text": "A patient with schizophrenia is unable to sit and is on antipsychotic medication. What is the likely diagnosis?",
    "options": "{\"A\": \"Chorea\", \"B\": \"Tics\", \"C\": \"Akathisia\", \"D\": \"Dystonia\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Requires identification of akathisia, a common movement disorder side effect associated with antipsychotic medications.",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q181",
    "question_text": "A patient who was in a psychiatric hospital developed abnormal movements. What is the most likely diagnosis?",
    "options": "{\"A\": \"Tardive dyskinesia\", \"B\": \"Parkinson's disease\", \"C\": \"Essential tremor\", \"D\": \"Dystonia\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the most likely diagnosis of a movement disorder (Tardive Dyskinesia) arising in the context of psychiatric treatment (implying antipsychotic exposure).",
    "subspecialty": "Movement Disorders"
  },
  {
    "question_number": "Q37",
    "question_text": "Restless Legs Syndrome (RLS) is most commonly associated with which of the following?",
    "options": "{\"A\": \"Pregnancy is a risk factor\", \"B\": \"Hypertension\", \"C\": \"Diabetes mellitus\", \"D\": \"Chronic obstructive pulmonary disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on a known risk factor for Restless Legs Syndrome, a primary sleep disorder.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q71",
    "question_text": "What treatment is indicated for a young female with excessive daytime sleepiness, hyperphagia, and nighttime sleep issues, with no clear features of narcolepsy?",
    "options": "{\"A\": \"Donepezil\", \"B\": \"Acetazolamide\", \"C\": \"Topiramate\", \"D\": \"Modafinil\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes symptoms suggestive of a central disorder of hypersomnolence (like idiopathic hypersomnia or potentially Kleine-Levin Syndrome without clear cyclic features mentioned) and asks about management.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q70",
    "question_text": "A 65-year-old male presents with disturbed nocturnal sleep. His wife states that he has been shouting and lashing out violently during sleep. What is the best treatment?",
    "options": "{\"A\": \"Levodopa\", \"B\": \"Clonazepam\", \"C\": \"Valproate\", \"D\": \"Deep brain stimulation (DBS)\"}",
    "correct_answer": "B",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes classic symptoms of REM Sleep Behavior Disorder (RBD) and asks for its primary treatment.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q17",
    "question_text": "A patient has difficulty sleeping and is lying in bed looking at the clock. What is the next best treatment option for this sleep issue?",
    "options": "{\"A\": \"Melatonin\", \"B\": \"Benzodiazepine\", \"C\": \"Zolpidem\", \"D\": \"Cognitive Behavioral Therapy for Insomnia (CBT-I)\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the management of insomnia, likely psychophysiological or behavioral insomnia, focusing on pharmacological treatment.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q34",
    "question_text": "A case scenario of a diabetic patient with symptoms suggestive of Restless Legs Syndrome (RLS). What is the next step in management?",
    "options": "{\"A\": \"Check Ferritin and iron\", \"B\": \"Start dopamine agonist therapy\", \"C\": \"Recommend lifestyle modifications including exercise and sleep hygiene\", \"D\": \"Order nerve conduction studies\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the initial workup for Restless Legs Syndrome, specifically checking iron stores, a common secondary cause or contributing factor.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q76",
    "question_text": "Pregnancy is a risk factor for which of the following?",
    "options": "{\"A\": \"Restless Legs Syndrome (RLS)\", \"B\": \"Periodic limb movement disorder\", \"C\": \"Narcolepsy\", \"D\": \"Obstructive sleep apnea\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about conditions exacerbated or caused by pregnancy, specifically focusing on RLS, a primary sleep-related movement disorder.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q51",
    "question_text": "Pregnancy is a risk factor for which of the following?",
    "options": "{\"A\": \"Restless Legs Syndrome (RLS)\", \"B\": \"Periodic limb movement disorder\", \"C\": \"Multiple sclerosis\", \"D\": \"Parkinson\\u2019s disease\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Duplicate of",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q74",
    "question_text": "Excessive daytime sleep and increasing eating habits may be treated with which of the following?",
    "options": "{\"A\": \"SSRI\", \"B\": \"Methylphenidate (According to UpToDate)\", \"C\": \"Sodium oxybate\", \"D\": \"Modafinil\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes symptoms of hypersomnolence and hyperphagia (suggestive of Kleine-Levin Syndrome or atypical depression/hypersomnia) and asks for treatment targeting alertness.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q35",
    "question_text": "A patient is impulsive and a drug seeker with a scenario of Restless Legs Syndrome (RLS). What is the recommended treatment?",
    "options": "{\"A\": \"Clonazepam\", \"B\": \"Gabapentin\", \"C\": \"Pramipexole\", \"D\": \"Iron supplementation\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the treatment of Restless Legs Syndrome (RLS), considering patient characteristics (impulsivity, drug-seeking) that might influence medication choice away from dopamine agonists or opioids.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q77",
    "question_text": "Excessive daytime sleep and an increase in eating habits may indicate which condition?",
    "options": "{\"A\": \"SSRI\", \"B\": \"Methylphenidate\", \"C\": \"Serum oxybate\", \"D\": \"Kleine-Levin Syndrome\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Duplicate of Q74/Q65, but framed as asking for the condition indirectly via treatment options. The core concept is hypersomnolence with hyperphagia, likely pointing towards disorders like Kleine-Levin Syndrome.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q66",
    "question_text": "A female adult with drug-seeking behavior and compulsive actions has irritability in her legs that only improves when she rubs them together. She is pregnant. What should be given to her? (No mention of symptoms of anemia or current hemoglobin level)",
    "options": "{\"A\": \"Pramipexole\", \"B\": \"Clonazepam\", \"C\": \"Ferrous sulfate\", \"D\": \"Gabapentin\"}",
    "correct_answer": "C",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes Restless Legs Syndrome (RLS) in pregnancy with complicating factors (drug-seeking behavior) and asks for appropriate management, considering safety in pregnancy and potential for misuse.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q30",
    "question_text": "A 45-year-old male presents with poor sleeping and recent mood changes, early awakening as reported by his wife. What is true regarding his treatment options?",
    "options": "{\"A\": \"Pharmacotherapy and hypnotic measures have good effects.\", \"B\": \"Sleep hygiene measures always failed.\", \"C\": \"Hypnotic measures are effective in sleep apnea.\", \"D\": \"Use antipsychotics for depression.\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on insomnia symptoms (difficulty maintaining sleep, early awakening) potentially linked to mood changes (depression) and evaluates understanding of general treatment principles for insomnia.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q65",
    "question_text": "Excessive daytime sleep and an increase in eating habits can be treated with which of the following?",
    "options": "{\"A\": \"SSRI\", \"B\": \"Methylphenidate\", \"C\": \"Serum oxybate\", \"D\": \"Modafinil\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Duplicate of",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q68",
    "question_text": "A patient with a history of visual hallucinations and inability to move from the bed, along with frequent episodes of falling asleep, presents for evaluation. What is the likely diagnosis?",
    "options": "{\"A\": \"Narcolepsy\", \"B\": \"Parkinson's Disease\", \"C\": \"Alzheimer's disease\", \"D\": \"Multiple sclerosis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes symptoms highly suggestive of narcolepsy type 1 (excessive daytime sleepiness, cataplexy implied by \"inability to move,\" hypnagogic/hypnopompic hallucinations).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q73",
    "question_text": "A child presents with a history of falling and loss of tone usually after laughing. What is the most likely diagnosis?",
    "options": "{\"A\": \"Gelastic seizures\", \"B\": \"Cataplexy\", \"C\": \"Hyperekplexia\", \"D\": \"Catalepsy\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes cataplexy, a cardinal symptom of narcolepsy type 1, triggered by emotion (laughter).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q29",
    "question_text": "A 43-year-old man presents with complaints of unrefreshing sleep, excessive daytime sleepiness, and snoring at night. What is the best next step in management?",
    "options": "{\"A\": \"EEG\", \"B\": \"Polysomnogram\", \"C\": \"Multiple sleep latency test\", \"D\": \"Overnight pulse oximetry\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes classic symptoms of Obstructive Sleep Apnea (OSA) and asks for the diagnostic gold standard (polysomnogram).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q67",
    "question_text": "A patient came with symptoms of restlessness during nighttime, improving when she rubs her feet together (restless leg syndrome). What will you do?",
    "options": "{\"A\": \"Check iron stores/level\", \"B\": \"Sleep study\", \"C\": \"Prescribe dopamine agonists\", \"D\": \"Recommend leg massage and stretching exercises\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes classic symptoms of Restless Legs Syndrome (RLS) and asks for the appropriate initial investigation (checking iron stores).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q75",
    "question_text": "Pregnancy is a risk factor for which of the following conditions?",
    "options": "{\"A\": \"Restless legs syndrome (RLS)\", \"B\": \"Periodic limb movement disorder\", \"C\": \"Iron deficiency anemia\", \"D\": \"Gestational hypertension\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Duplicate of Q76/",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q72",
    "question_text": "A patient is sleeping and exhibits aggressive movements in the legs while sleeping, and he used to walk around at night. What is the most likely diagnosis?",
    "options": "{\"A\": \"Parasomnia\", \"B\": \"Restless Leg Syndrome\", \"C\": \"REM Sleep Behavior Disorder\", \"D\": \"Nocturnal Seizures\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes complex nocturnal behaviors including possible REM Sleep Behavior Disorder (leg movements) and sleepwalking/confusional arousals (walking around), falling under the umbrella of parasomnias.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q31",
    "question_text": "A 45-year-old male presents with poor sleeping and recent mood changes, with early awakening as reported by his wife. Which of the following is true?",
    "options": "{\"A\": \"Diffuse low glucose uptake in PET scan\", \"B\": \"Increased temporalis single in EMG\", \"C\": \"Absence of beta activity in EEG\", \"D\": \"Increased cortisol levels in the night\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Relates insomnia and mood changes (likely depression) to potential biological markers, specifically testing knowledge of polysomnographic or endocrine findings in depression/insomnia (e.g., cortisol changes).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q36",
    "question_text": "With destruction of the anterior hypothalamic nucleus, you will find:",
    "options": "{\"A\": \"Insomnia and hyperthermia\", \"B\": \"Hypersomnolence\", \"C\": \"REM sleep behavior disorder\", \"D\": \"Hypothermia\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests neuroanatomical knowledge specifically related to sleep-wake regulation centers in the hypothalamus.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q32",
    "question_text": "A 45-year-old male is experiencing poor sleep and recent mood changes, with early awakening as reported by his wife. What is true regarding his condition?",
    "options": "{\"A\": \"Pharmacotherapy and hypnotic measures have good effects.\", \"B\": \"Sleep hygiene measures always fail.\", \"C\": \"Hypnotic measures are effective in sleep apnea.\", \"D\": \"Use antipsychotics for depression.\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Duplicate of",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q33",
    "question_text": "A 45-year-old male with poor sleeping and recent mood changes, early awakening reported by his wife. What is true?",
    "options": "{\"A\": \"Diffuse low glucose uptake in PET scan\", \"B\": \"Increased temporalis single in EMG\", \"C\": \"Elevated CSF protein levels\", \"D\": \"Reduced REM sleep latency\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Duplicate/Partial of",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q124",
    "question_text": "Pregnancy is a risk factor for which of the following conditions?",
    "options": "{\"A\": \"Restless legs syndrome (RLS)\", \"B\": \"Periodic limb movement disorder\", \"C\": \"Iron deficiency anemia\", \"D\": \"Narcolepsy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about a condition (Restless Legs Syndrome) strongly associated with sleep disturbances and often managed within sleep neurology, specifically its link to pregnancy.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q124",
    "question_text": "Pregnancy is a risk factor for which of the following conditions?",
    "options": "{\"A\": \"Restless legs syndrome (RLS)\", \"B\": \"Periodic limb movement disorder\", \"C\": \"Narcolepsy\", \"D\": \"Sleep apnea\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about Restless Legs Syndrome and its association with pregnancy, a core sleep disorder topic.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q124",
    "question_text": "Pregnancy is a risk factor for which of the following conditions?",
    "options": "{\"A\": \"Restless legs syndrome (RLS)\", \"B\": \"Periodic limb movement disorder\", \"C\": \"Narcolepsy\", \"D\": \"Sleep apnea\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about Restless Legs Syndrome and its association with pregnancy, a core sleep disorder topic.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q127",
    "question_text": "A woman presents with her husband, who complains of her movements at night that usually improve with movement. What factor is likely to worsen these movements?",
    "options": "{\"A\": \"Pregnancy\", \"B\": \"Caffeine intake\", \"C\": \"Exercise before bedtime\", \"D\": \"Use of iron supplements\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes symptoms characteristic of Restless Legs Syndrome (RLS), a common sleep-related movement disorder, and asks about known exacerbating factors (like pregnancy).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q362",
    "question_text": "A patient is sleeping all day and binge eating with increased weight. What medication would you consider?",
    "options": "{\"A\": \"SSRI\", \"B\": \"Oxybutynin\", \"C\": \"Sildenafil\", \"D\": \"Methylphenidate\"}",
    "correct_answer": "D",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes symptoms (hypersomnolence, binge eating) suggestive of conditions like Kleine-Levin Syndrome or atypical depression with hypersomnia, asking for an appropriate alerting agent/treatment.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q289",
    "question_text": "A patient with narcolepsy is treated with which of the following medications?",
    "options": "{\"A\": \"Modafinil\", \"B\": \"Hydroxyamphetamine\", \"C\": \"SSRI\", \"D\": \"Lithium\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the first-line treatment (Modafinil) for excessive daytime sleepiness in narcolepsy.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q51",
    "question_text": "A patient presents with excessive daytime sleepiness and increased eating habits. What is the first-line treatment? [Suggests Kleine-Levin Syndrome or potentially narcolepsy variant]",
    "options": "{\"A\": \"SSRI\", \"B\": \"Methylphenidate\", \"C\": \"Sodium oxybate\", \"D\": \"Modafinil\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes symptoms characteristic of a primary hypersomnia disorder (like Kleine-Levin Syndrome or Narcolepsy Type 2) and asks for treatment options (stimulants like Methylphenidate), falling under Sleep Neurology.",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q258",
    "question_text": "What is the sleep disorder associated with Parkinson's disease?",
    "options": "{\"A\": \"REM sleep behavior disorder\", \"B\": \"Obstructive sleep apnea\", \"C\": \"Narcolepsy\", \"D\": \"Restless legs syndrome\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Directly asks to identify a specific sleep disorder (RBD) strongly associated with a neurological condition (Parkinson's disease).",
    "subspecialty": "Sleep Neurology"
  },
  {
    "question_number": "Q291",
    "question_text": "Between the optic tract and the visual cortex, which structure is located?",
    "options": "{\"A\": \"Lateral geniculate body\", \"B\": \"Medial geniculate body\", \"C\": \"Superior colliculus\", \"D\": \"Pulvinar nucleus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly tests knowledge of the anatomical structures within the visual pathway between the optic tract and cortex.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q1",
    "question_text": "Prosopagnosia is primarily associated with which brain region?",
    "options": "{\"A\": \"Temporo-occipital gyrus\", \"B\": \"Prefrontal cortex\", \"C\": \"Parietal lobe\", \"D\": \"Hippocampus\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific brain region (fusiform gyrus within the temporo-occipital area) associated with facial recognition deficits (prosopagnosia).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q10",
    "question_text": "A patient presented with 3rd nerve palsy and ipsilateral ataxia. Where is the localization?",
    "options": "{\"A\": \"Weber\", \"B\": \"Claude\", \"C\": \"Nothangle\", \"D\": \"Bendekit\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Requires localizing a lesion within the brainstem (midbrain) based on specific cranial nerve (CN III) and cerebellar pathway signs (ataxia), referencing classic named syndromes.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q48",
    "question_text": "A patient has tongue deviation to the left. Which area of the brain is likely affected?",
    "options": "{\"A\": \"Right medulla\", \"B\": \"Left medulla\", \"C\": \"Right midbrain\", \"D\": \"Left midbrain\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of cranial nerve (Hypoglossal, CN XII) pathway localization based on the clinical sign of tongue deviation and its relation to brainstem nuclei.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q49",
    "question_text": "Which area of the brain is primarily associated with prosopagnosia, the inability to recognize faces?",
    "options": "{\"A\": \"Temporal\", \"B\": \"Parietal\", \"C\": \"Frontal\", \"D\": \"Occipito-temporal\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Directly asks for the brain region (occipitotemporal, specifically fusiform gyrus) primarily responsible for facial recognition, the function lost in prosopagnosia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q96",
    "question_text": "What is the localization of prosopagnosia?",
    "options": "{\"A\": \"Frontal lobe\", \"B\": \"Parietal lobe\", \"C\": \"Corpus callosum\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "D",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests localization of prosopagnosia, requiring identification of the most relevant lobe (occipital part of the occipitotemporal fusiform gyrus) among the limited choices provided.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q40",
    "question_text": "In a case of Gerstmann syndrome, where is the lesion typically found?",
    "options": "{\"A\": \"Angular gyrus\", \"B\": \"Supramarginal gyrus\", \"C\": \"Precentral gyrus\", \"D\": \"Postcentral gyrus\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of functional neuroanatomy, specifically the localization of Gerstmann syndrome to the dominant angular gyrus.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q123",
    "question_text": "Which of the following embryogenic cells gives rise to the cerebral cortex?",
    "options": "{\"A\": \"Telencephalon\", \"B\": \"Mesencephalon\", \"C\": \"Diencephalon\", \"D\": \"Rhombencephalon\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of basic neuroembryology, specifically the developmental origin (telencephalon) of the cerebral cortex, which is a core neuroanatomy topic.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q103",
    "question_text": "A patient presents with fluent speech, impaired comprehension, naming, and repetition. Where is the lesion?",
    "options": "{\"A\": \"Frontoparietal operculum\", \"B\": \"Posterior perisylvian temporal\", \"C\": \"Posterior-inferior temporal\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks to localize a specific aphasia type (Wernicke's aphasia) based on clinical language features, testing knowledge of language network anatomy.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q102",
    "question_text": "A patient presented with ipsilateral tremor and Horner syndrome, and contralateral complete loss of pain and temperature sensation. Normal vibration and position sensation were noted. Where is the localization?",
    "options": "{\"A\": \"Upper Pons\", \"B\": \"Lower Pons\", \"C\": \"Dorsolateral Midbrain\", \"D\": \"Ventral Midbrain\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks to localize a brainstem lesion based on a complex combination of neurological signs involving motor control pathways (tremor), sympathetic pathways (Horner's), and sensory tracts (spinothalamic).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q33",
    "question_text": "Prosopagnosia is localized to which area?",
    "options": "{\"A\": \"Dominant occipital lobe\", \"B\": \"Dominant parietal lobe\", \"C\": \"Right temporal lobe\", \"D\": \"Occipitotemporal\"}",
    "correct_answer": "D",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly tests knowledge of the neuroanatomical localization (occipitotemporal region, often bilateral or right-sided fusiform gyrus) of prosopagnosia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q24",
    "question_text": "A patient has impaired fluency and repetition but intact comprehension. Where is the localization?",
    "options": "{\"A\": \"Frontoparietal operculum\", \"B\": \"Inferior perisylvian\", \"C\": \"Parietotemporal perisylvian\", \"D\": \"Posterior superior temporal gyrus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the specific brain region (typically Broca's area in the frontal operculum/inferior frontal gyrus) responsible for a described language deficit pattern (Broca's or potentially conduction aphasia), testing knowledge of functional neuroanatomy related to language.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q51",
    "question_text": "Impaired immediate recall is associated with lesions of:",
    "options": "{\"A\": \"Prefrontal cortex\", \"B\": \"Medial temporal\", \"C\": \"Occipital\", \"D\": \"Mediodorsal thalamus\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Directly tests knowledge of the neuroanatomical structures (medial temporal lobes, including hippocampus) crucial for a specific memory function (immediate recall/encoding).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q110",
    "question_text": "How can one differentiate between conus medullaris syndrome and cauda equina syndrome?",
    "options": "{\"A\": \"Upper and lower motor neuron signs\", \"B\": \"Loss of reflexes\", \"C\": \"Loss of sphincter control\", \"D\": \"Sensory level on the trunk\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the clinical differentiation between two syndromes based on the anatomical location of the lesion (spinal cord terminus vs nerve roots) and the resulting pattern of neurological signs (UMN vs LMN features, reflex changes, sphincter involvement).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q241",
    "question_text": "Which of the following is suggestive of a dominant parietal lobe lesion?",
    "options": "{\"A\": \"Neglect\", \"B\": \"Finger agnosia\", \"C\": \"Right-left disorientation\", \"D\": \"Agraphia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of cortical localization, specifically identifying the components of Gerstmann syndrome (finger agnosia, R-L disorientation, agraphia, acalculia) associated with dominant parietal lobe lesions.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q258",
    "question_text": "Case about Gasterman syndrome (I did not remember the choices).",
    "options": "{\"A\": \"Agraphia\", \"B\": \"Acalculia\", \"C\": \"Hemispatial neglect\", \"D\": \"Prosopagnosia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Refers to Gerstmann (likely misspelled as Gasterman) syndrome, which involves deficits related to dominant parietal lobe function, thus testing neuroanatomical localization.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q98",
    "question_text": "A patient presents with loss of sensation in the bilateral upper extremities, with later involvement of the lower extremities. What condition is most likely?",
    "options": "{\"A\": \"Central Cord Syndrome\", \"B\": \"Syringomyelia\", \"C\": \"Brown-S\\u00e9quard Syndrome\", \"D\": \"Anterior Cord Syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires identifying a neurological syndrome (Central Cord Syndrome or Syringomyelia) based on a specific pattern of sensory loss related to the anatomy of the spinal cord tracts (crossing spinothalamic fibers).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q63",
    "question_text": "A patient exhibits agraphia, acalculia, and finger agnosia (Gerstmann Syndrome). What type of aphasia is typically associated with this condition?",
    "options": "{\"A\": \"Anomia\", \"B\": \"Broca's aphasia\", \"C\": \"Wernicke's aphasia\", \"D\": \"Conduction aphasia\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of cortical localization by associating a specific neurological syndrome (Gerstmann syndrome) with its typical location (dominant parietal lobe, near language areas) and related language deficits (often anomia or fluent aphasia).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q91",
    "question_text": "In a patient with obstructive hydrocephalus, which cranial nerve is most likely involved?",
    "options": "{\"A\": \"CN 6\", \"B\": \"CN 3\", \"C\": \"CN 4\", \"D\": \"CN 7\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the anatomical relationship between cranial nerves and brain structures, specifically identifying the cranial nerve (CN VI) most vulnerable to stretching or compression due to increased intracranial pressure from hydrocephalus because of its long intracranial course.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q44",
    "question_text": "A patient presents with right-sided weakness, non-fluent speech, impaired repetition and naming, but intact comprehension. Which area of the brain is likely affected in this case of Broca's aphasia?",
    "options": "{\"A\": \"Supramarginal Gyrus\", \"B\": \"Frontal Perisylvian\", \"C\": \"Temporal posterior, superior\", \"D\": \"Wernicke's area\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the neuroanatomical localization of specific language functions, associating the clinical features of Broca's aphasia with the corresponding brain region (frontal perisylvian area/Broca's area).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q90",
    "question_text": "What is colpocephaly?",
    "options": "{\"A\": \"Enlarged lateral ventricle\", \"B\": \"Enlarged occipital ventricle\", \"C\": \"Narrowing of the third ventricle\", \"D\": \"Enlargement of the temporal horn of the lateral ventricle\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the definition of colpocephaly, which is a specific morphological/neuroanatomical finding describing the disproportionate enlargement of the occipital horns of the lateral ventricles.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q435",
    "question_text": "A picture shows left tongue deviation and left Horner's syndrome. What type of lesion is indicated?",
    "options": "{\"A\": \"Postganglionic\", \"B\": \"Preganglionic\", \"C\": \"Intermediolateral\", \"D\": \"Central (first-order neuron)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires anatomical localization of a lesion based on combined neurological signs involving a cranial nerve (Hypoglossal nerve, CN XII) and the sympathetic pathway (Horner's syndrome), focusing on differentiating levels within the sympathetic chain.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q155",
    "question_text": "A female presents with decreased sensation to pinprick in bilateral upper limbs. What is the likely diagnosis?",
    "options": "{\"A\": \"Syringomyelia\", \"B\": \"Multiple sclerosis\", \"C\": \"Peripheral neuropathy\", \"D\": \"Cervical radiculopathy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis (Syringomyelia) based on a characteristic pattern of sensory loss (\"cape-like\" distribution) related to a central lesion affecting crossing spinothalamic fibers within the spinal cord anatomy.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q390",
    "question_text": "In a long scenario of a patient with trigeminal neuralgia involving V1, which artery is likely causing vascular compression?",
    "options": "{\"A\": \"PCA\", \"B\": \"SCA\", \"C\": \"MCA\", \"D\": \"AICA\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the neurovascular anatomy, specifically the anatomical relationship between the trigeminal nerve (near its root entry zone relevant for V1 fibers) and adjacent blood vessels (like branches of SCA or PCA) potentially causing compression.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q83",
    "question_text": "A patient presents with Horner's syndrome and a left deviated uvula. What other finding would you expect?",
    "options": "{\"A\": \"Right ptosis\", \"B\": \"Left tongue deviation\", \"C\": \"Right facial droop\", \"D\": \"Left hemiparesis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests localization within the brainstem (likely lateral medulla for Wallenberg syndrome) based on combined cranial nerve (Vagus - X causing uvula deviation away from lesion) and sympathetic pathway involvement (Horner's), asking for associated signs based on adjacent anatomical structures.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q272",
    "question_text": "What is the localization of postganglionic Horner's syndrome?",
    "options": "{\"A\": \"Preganglionic\", \"B\": \"Postganglionic\", \"C\": \"Central (first-order neuron)\", \"D\": \"Sympathetic chain trunk lesion\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests understanding of the anatomical pathway of oculosympathetic innervation and the ability to define or recognize the location corresponding to a postganglionic lesion (distal to the superior cervical ganglion).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q376",
    "question_text": "Localization of down-beating nystagmus is most commonly associated with which anatomical region?",
    "options": "{\"A\": \"Cervicomedullary junction\", \"B\": \"Midbrain\", \"C\": \"Thalamus\", \"D\": \"Basal ganglia\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the specific neuroanatomical localization (typically the cervicomedullary junction or cerebellum) associated with a specific neurological sign (downbeat nystagmus).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q351",
    "question_text": "Syringomyelia (SCA) is commonly associated with which of the following?",
    "options": "{\"A\": \"Ipsilateral Horner's syndrome\", \"B\": \"Fourth cranial nerve palsy\", \"C\": \"Bilateral lower limb spasticity\", \"D\": \"Loss of pain and temperature sensation in a cape-like distribution\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of neurological signs (like Horner's syndrome) commonly associated with syringomyelia due to the anatomical proximity and potential involvement of nearby structures like the sympathetic pathway in the spinal cord.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q162",
    "question_text": "A patient presents with upper limb numbness and pinprick sensation around the shoulder. The preserved position sense and weakness suggest which diagnosis?",
    "options": "{\"A\": \"Syringomyelia\", \"B\": \"Myoshi disease\", \"C\": \"CIDP\", \"D\": \"DADS\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests localization based on a dissociated sensory loss pattern (loss of pain/temperature with preserved proprioception/vibration) in a \"cape-like\" distribution, characteristic of a central cord syndrome like syringomyelia related to spinal cord anatomy.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q218",
    "question_text": "Which imaging study is indicated in virtually all patients suspected of having glossopharyngeal neuralgia?",
    "options": "{\"A\": \"Plain skull films\", \"B\": \"MRI/MRA\", \"C\": \"CT scan\", \"D\": \"Ultrasound\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the appropriate neuroimaging modality (MRI/MRA) required to visualize the relevant neurovascular anatomy (glossopharyngeal nerve root entry zone, adjacent vessels) when investigating potential structural causes like vascular compression.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q259",
    "question_text": "Frontal operculum",
    "options": "{\"A\": \"Is part of the primary visual cortex\", \"B\": \"Contains Broca\\u2019s area involved in speech production\", \"C\": \"Is located in the occipital lobe\", \"D\": \"Is primarily responsible for balance and coordination\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Refers to a specific anatomical brain region, testing basic neuroanatomical knowledge.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q213",
    "question_text": "Which type of aphasia is similar to that seen in thalamic lesions?",
    "options": "{\"A\": \"Transcortical sensory aphasia\", \"B\": \"Broca's aphasia\", \"C\": \"Wernicke's aphasia\", \"D\": \"Global aphasia\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of aphasia classification and its relation to anatomical lesion sites, specifically linking thalamic lesions (disrupting cortico-thalamic pathways) to certain aphasia profiles (often transcortical types).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q414",
    "question_text": "An 18-year-old female presents with hearing loss and vision loss. What will you see on MRI?",
    "options": "{\"A\": \"Corpus callosum lesion\", \"B\": \"Cerebellar atrophy\", \"C\": \"Temporal lobe sclerosis\", \"D\": \"Brainstem demyelination\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Correlates clinical symptoms (hearing and vision loss suggestive of certain syndromes like Susac) with expected neuroanatomical findings on MRI (e.g., characteristic corpus callosum lesions), testing knowledge of imaging correlates of clinical syndromes.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q98",
    "question_text": "In a scenario of Broca's aphasia, where is the lesion typically located?",
    "options": "{\"A\": \"Frontal lobe\", \"B\": \"Frontoparietal operculum\", \"C\": \"Temporal lobe\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific neuroanatomical location (inferior frontal gyrus/frontal operculum) associated with a defined neurological deficit (Broca's aphasia).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q103",
    "question_text": "What is the localization of laryngeal spasms?",
    "options": "{\"A\": \"Insula\", \"B\": \"Amygdala\", \"C\": \"Frontal lobe\", \"D\": \"Temporal lobe\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of functional neuroanatomy, specifically localizing potential origins (e.g., seizure focus, autonomic control centers) related to laryngeal function/spasms to brain regions like the insula or temporal lobe.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q92",
    "question_text": "In a case scenario about Weber's syndrome, where is the lesion located?",
    "options": "{\"A\": \"Midbrain basis\", \"B\": \"Medulla\", \"C\": \"Pons\", \"D\": \"Cerebellum\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the precise anatomical localization (ventral midbrain/basis pedunculi) of a classic, named brainstem stroke syndrome (Weber's syndrome).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q238",
    "question_text": "A patient with headache, MRI showed a picture of Arnold Chiari malformation. What is the next step?",
    "options": "{\"A\": \"Spine MRI\", \"B\": \"Start acetazolamide\", \"C\": \"Immediate posterior fossa decompression\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the appropriate diagnostic workup following the identification of a structural brain abnormality (Chiari malformation), specifically recommending further imaging (spine MRI) based on the known high anatomical association with syringomyelia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q48",
    "question_text": "A patient presents with Broca\u2019s aphasia. What is the localization of the affected area?",
    "options": "{\"A\": \"Frontoparietal operculum\", \"B\": \"Temporal lobe\", \"C\": \"Occipital lobe\", \"D\": \"Frontal lobe\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of classical neuroanatomy, specifically the localization of Broca's area (typically in the inferior frontal gyrus/frontal operculum) responsible for expressive language function.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q98",
    "question_text": "A 40-year-old man developed ankle dorsiflexion weakness, and sensation over the dorsum of the foot was decreased. What structure is most likely affected?",
    "options": "{\"A\": \"Lateral portion of the sciatic nerve\", \"B\": \"Medial portion of the sciatic nerve\", \"C\": \"Tibial nerve\", \"D\": \"Femoral nerve\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve anatomy (specifically the origin of the common peroneal nerve from the sciatic nerve) based on clinical localization.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q15",
    "question_text": "In a case of alexia without agraphia with a visual field defect, the lesion is located in:",
    "options": "{\"A\": \"Angular gyrus\", \"B\": \"Splenium of corpus callosum\", \"C\": \"Left occipital lobe\", \"D\": \"Posterior limb of internal capsule\"}",
    "correct_answer": "B",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the specific anatomical localization (splenium and likely left occipital lobe) required to produce the syndrome of alexia without agraphia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q8",
    "question_text": "Prosopagnosia localization is associated with which area of the brain?",
    "options": "{\"A\": \"Frontal lobe\", \"B\": \"Parietal lobe\", \"C\": \"Corpus callosum\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "D",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the brain region (typically fusiform gyrus in the occipitotemporal cortex) responsible for a specific neurological function (facial recognition).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q281",
    "question_text": "What is the location of the olfactory gyrus?",
    "options": "{\"A\": \"Parahippocampal gyrus\", \"B\": \"Hippocampus\", \"C\": \"Cingulate gyrus\", \"D\": \"Fusiform gyrus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of basic gross brain anatomy, specifically the location of the olfactory structures.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q55",
    "question_text": "Which language disorder is associated with Gerstmann syndrome?",
    "options": "{\"A\": \"Broca's aphasia\", \"B\": \"Anomia\", \"C\": \"Transcortical motor aphasia\", \"D\": \"Alexia without agraphia\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: While involving a syndrome, the core question relates components of the syndrome (agraphia, acalculia) often associated with language deficits like anomia/alexia, linking function to the known anatomical location (angular gyrus).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q512",
    "question_text": "Which of the following thalamic structures connects the optic tracts to the visual cortex?",
    "options": "{\"A\": \"Lateral geniculate\", \"B\": \"Pulvinar nucleus\", \"C\": \"Medial geniculate\", \"D\": \"Ventral posterior nucleus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the visual pathway anatomy, specifically the role of the lateral geniculate nucleus.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q57",
    "question_text": "A patient presents with a clear description of left fourth cranial nerve palsy and a head tilted to the right. Where is the lesion located in the brainstem?",
    "options": "{\"A\": \"Two choices in medulla\", \"B\": \"Right rostral midbrain\", \"C\": \"Left rostral midbrain\", \"D\": \"Left pons\"}",
    "correct_answer": "C",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires localizing a lesion within the brainstem based on a specific cranial nerve palsy and compensatory head posture, focusing on the anatomical pathway of the trochlear nerve.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q19",
    "question_text": "A 20-year-old female presented to the clinic with a history of progressive bilateral upper limb decrease in pain sensation, with no weakness. Examination was significant for decreased pinprick sensation bilaterally over the upper limbs. Motor and vibration sensation were intact. What is the most likely diagnosis?",
    "options": "{\"A\": \"Syringomyelia\", \"B\": \"Multiple sclerosis\", \"C\": \"Peripheral neuropathy\", \"D\": \"Brown-S\\u00e9quard syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: The diagnosis (Syringomyelia) is directly inferred from the clinical signs which reflect damage to a specific anatomical structure (crossing spinothalamic tracts in the central spinal cord).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q50",
    "question_text": "What is the characteristic feature of syringomyelia?",
    "options": "{\"A\": \"Fluid-filled cyst in the spinal cord parenchyma\", \"B\": \"Cystic expansion of the central canal with ependymal lining preserved\", \"C\": \"Disruption of the ependyma\", \"D\": \"Cavitation within the spinal cord without ependymal lining\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the defining anatomical or pathological characteristic of syringomyelia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q53",
    "question_text": "In the lateral geniculate nucleus (LGN), visual information from the ipsilateral eye synapses in which layers?",
    "options": "{\"A\": \"1, 4, 6\", \"B\": \"2, 3, 5\", \"C\": \"1, 2, 3\", \"D\": \"4, 5, 6\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests detailed knowledge of the laminar structure and connections within the lateral geniculate nucleus, part of the visual pathway.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q12",
    "question_text": "In Wernicke's Aphasia, the lesion is located in:",
    "options": "{\"A\": \"Posteroinferior perisylvian\", \"B\": \"Posterior perisylvian\", \"C\": \"Frontoparietal operculum\", \"D\": \"Broca's area\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the specific anatomical location associated with Wernicke's aphasia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q87",
    "question_text": "What is the Schaffer collateral?",
    "options": "{\"A\": \"Entorhinal cortex to CA1.\", \"B\": \"CA3 pyramidal neurons to CA1 pyramidal neurons.\", \"C\": \"Dentate gyrus granule cells to CA3 pyramidal neurons.\", \"D\": \"CA1 pyramidal neurons to subiculum.\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of specific intra-hippocampal pathways.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q84",
    "question_text": "A lesion of the facial nerve in the stylomastoid foramen leads to which of the following?",
    "options": "{\"A\": \"Absent gag reflex\", \"B\": \"Paralysis of facial muscles\", \"C\": \"Altered taste in the anterior 2/3 of the tongue\", \"D\": \"Decreased salivary flow\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of functional neuroanatomy by asking for the specific deficit resulting from a facial nerve lesion at a precise anatomical point (distal to chorda tympani branching).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q177",
    "question_text": "Which muscle is supplied by the 12th cranial nerve?",
    "options": "{\"A\": \"Hyoid muscle\", \"B\": \"Iliopsoas\", \"C\": \"Quadriceps\", \"D\": \"Obturator internus\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of cranial nerve function, specifically the motor innervation of the hypoglossal nerve (tongue muscles, some extrinsic muscles like hyoglossus).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q91",
    "question_text": "A patient came with Broca\u2019s aphasia. What is the localization?",
    "options": "{\"A\": \"Frontoparietal operculum\", \"B\": \"Wernicke\\u2019s area\", \"C\": \"Angular gyrus\", \"D\": \"Primary auditory cortex\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the specific anatomical location associated with Broca's aphasia.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q13",
    "question_text": "A young female presents with symptoms of bilateral lower limb weakness, loss of all sensory modalities up to the umbilicus, and bladder involvement. Where is the lesion?",
    "options": "{\"A\": \"Thoracic\", \"B\": \"Lumbosacral\", \"C\": \"Cervical\", \"D\": \"Lumbar\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Requires localization of a spinal cord lesion level based on the pattern of motor, sensory (sensory level at T10), and autonomic deficits.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q56",
    "question_text": "A patient presents with third nerve palsy and ipsilateral ataxia. Which of the following syndromes is most likely?",
    "options": "{\"A\": \"Claude syndrome\", \"B\": \"Weber syndrome\", \"C\": \"Benedikt syndrome\", \"D\": \"Nothnagel syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of classic brainstem syndromes defined by specific combinations of cranial nerve deficits and long tract signs, requiring anatomical localization.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q51",
    "question_text": "Which structure is involved in vision and not in pupillary responses?",
    "options": "{\"A\": \"Optic nerves\", \"B\": \"Inferior parietal\", \"C\": \"Lateral geniculate body\", \"D\": \"Chiasma\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests understanding of the anatomical pathways for vision versus pupillary light reflex, identifying a structure unique to the visual pathway (LGN).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q54",
    "question_text": "A patient presents with third nerve palsy and contralateral weakness. Where is the likely localization of the lesion?",
    "options": "{\"A\": \"Pons\", \"B\": \"Medulla\", \"C\": \"Base of midbrain\", \"D\": \"Thalamus\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires localization within the brainstem (specifically midbrain basis pedunculi for Weber syndrome) based on a combination of cranial nerve palsy and contralateral motor deficit.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q9",
    "question_text": "A patient with headache, MRI showed a picture of Arnold Chiari malformation. What is the next step?",
    "options": "{\"A\": \"Spine MRI\", \"B\": \"Start corticosteroids\", \"C\": \"Refer for immediate neurosurgery\", \"D\": \"EEG monitoring\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: While presenting with a symptom (headache), the core of the question is about the appropriate diagnostic workup for a specific structural/anatomical abnormality (Chiari) and its common association (syringomyelia).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q2",
    "question_text": "Gerstmann syndrome is linked to which area of the brain?",
    "options": "{\"A\": \"Angular gyrus\", \"B\": \"Broca\\u2019s area\", \"C\": \"Hippocampus\", \"D\": \"Cerebellum\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the direct anatomical localization of a named neurological syndrome.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q89",
    "question_text": "Which of the following arteries arise from the internal carotid artery?",
    "options": "{\"A\": \"AICA\", \"B\": \"PICA\", \"C\": \"PCA\", \"D\": \"SCA\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of cerebrovascular anatomy, specifically the origins of major cerebral arteries. (Note: Options provided are mostly posterior circulation; PComm connecting ICA to PCA might be the intended link, or Anterior Choroidal/Ophthalmic artery are expected ICA branches).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q46",
    "question_text": "What is the nerve supply for shoulder adduction and internal rotation?",
    "options": "{\"A\": \"Axillary nerve\", \"B\": \"Suprascapular nerve\", \"C\": \"Subscapular nerve\", \"D\": \"Musculocutaneous nerve\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of peripheral nerve innervation of specific muscles/actions.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q88",
    "question_text": "A patient presents with upper limb numbness, loss of pain sensation, and is burning her hands. What is the diagnosis?",
    "options": "{\"A\": \"Syringomyelia\", \"B\": \"Multiple sclerosis\", \"C\": \"Peripheral neuropathy\", \"D\": \"Cervical radiculopathy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Similar to Q19, the diagnosis is directly inferred from symptoms reflecting damage to specific anatomical pathways (central cord/spinothalamic tracts).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q52",
    "question_text": "In Gerstmann syndrome, which area of the brain is typically involved in localization?",
    "options": "{\"A\": \"Temporal\", \"B\": \"Parietal\", \"C\": \"Occipital\", \"D\": \"Frontal\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks for the primary anatomical lobe associated with Gerstmann syndrome (dominant parietal lobe).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q74",
    "question_text": "A patient presents with a visual field defect, impaired reading, and intact writing. This is a case of alexia without agraphia. What is the localization?",
    "options": "{\"A\": \"Splenium of the corpus callosum\", \"B\": \"Left angular gyrus\", \"C\": \"Left occipital cortex\", \"D\": \"Left inferior frontal gyrus\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the specific anatomical localization required to produce the syndrome.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q86",
    "question_text": "Which of the following paired muscles is supplied by L5?",
    "options": "{\"A\": \"Tibialis anterior & tibialis posterior\", \"B\": \"Tibialis anterior & abductor hallucis longus\", \"C\": \"Tibialis anterior & adductor digiti minimi\", \"D\": \"Extensor hallucis longus & gluteus medius\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of spinal nerve root innervation (myotomes).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q93",
    "question_text": "A patient with C5-C6 radiculopathy. What muscle is involved?",
    "options": "{\"A\": \"Infraspinatus\", \"B\": \"Biceps brachii\", \"C\": \"Deltoid\", \"D\": \"Triceps brachii\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of muscle innervation by specific cervical nerve roots.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q288",
    "question_text": "One of the branches of the Internal Carotid Artery (ICA) is:",
    "options": "{\"A\": \"SCA\", \"B\": \"Posterior Communicating\", \"C\": \"Anterior Choroidal\", \"D\": \"AICA\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of cerebrovascular anatomy, specifically branches of the ICA. Both B and C are correct.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q290",
    "question_text": "An elderly patient with quadriplegia presents with horizontal gaze palsy but has spared vertical gaze. What is the likely localization of the lesion?",
    "options": "{\"A\": \"Pons\", \"B\": \"Thalamus\", \"C\": \"Basis pontis\", \"D\": \"Midbrain\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Requires localizing a neurological lesion (likely pons) based on specific brainstem signs (horizontal gaze palsy with spared vertical gaze).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q224",
    "question_text": "Which area of the brain is primarily associated with prosopagnosia?",
    "options": "{\"A\": \"Parietal\", \"B\": \"Fronto-temporal\", \"C\": \"Inferior occipital temporal\", \"D\": \"Mid-temporal\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of functional neuroanatomy, specifically the localization of facial recognition (prosopagnosia) to the fusiform gyrus (inferior occipito-temporal region).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q132",
    "question_text": "A patient known to have multiple sclerosis presents with double vision. Examination showed left impaired adduction and right abduction nystagmus. Where is the localization?",
    "options": "{\"A\": \"Left MLF\", \"B\": \"Right MLF\", \"C\": \"Left oculomotor nerve nucleus\", \"D\": \"Right abducens nerve nucleus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to localize a neurological deficit (internuclear ophthalmoplegia - INO) to a specific anatomical structure (Medial Longitudinal Fasciculus - MLF) based on clinical signs, even though it occurs in an MS patient.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q132",
    "question_text": "Which condition is characterized by ipsilateral Horner's syndrome due to dorsal cerebellar SCA?",
    "options": "{\"A\": \"Multiple sclerosis\", \"B\": \"Amyotrophic lateral sclerosis\", \"C\": \"Chiari malformation\", \"D\": \"Cerebellar ataxia\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: This question tests the neuroanatomical localization of Horner's syndrome to potential lesions, including vascular territories like the Superior Cerebellar Artery (SCA), although the options are broad conditions rather than specific locations.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q12",
    "question_text": "A patient with a CT scan showing a \"molar tooth\" appearance is suspected to have which condition?",
    "options": "{\"A\": \"Joubert syndrome\", \"B\": \"Dandy-Walker malformation\", \"C\": \"Arnold-Chiari malformation\", \"D\": \"Sturge-Weber syndrome\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests the recognition of a specific neuroanatomical sign (molar tooth appearance) on imaging and its association with Joubert syndrome.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q23",
    "question_text": "In a scenario about AICA syndrome, which artery is involved?",
    "options": "{\"A\": \"AICA\", \"B\": \"PCA\", \"C\": \"SCA\", \"D\": \"PICA\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly tests knowledge of the vascular territory associated with a specific named stroke syndrome (AICA syndrome), linking clinical neurology to vascular neuroanatomy.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q50",
    "question_text": "A patient with trigeminal neuralgia, what artery is usually involved?",
    "options": "{\"A\": \"PCA\", \"B\": \"AICA\", \"C\": \"SCA\", \"D\": \"Basilar artery\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The core of the question is identifying the specific vascular structure (SCA) most commonly associated with neurovascular compression causing trigeminal neuralgia, testing anatomical knowledge related to the condition.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q113",
    "question_text": "A patient diagnosed with trigeminal neuralgia, what artery is the cause?",
    "options": "{\"A\": \"Superior Cerebellar\", \"B\": \"Inferior Cerebellar\", \"C\": \"Posterior Cerebellar\", \"D\": \"Posterior communicating\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks to identify the specific artery (SCA) typically responsible for vascular compression in trigeminal neuralgia, focusing on the underlying anatomical relationship.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q3",
    "question_text": "What are the signs of intracranial hypotension observed in brain MRI?",
    "options": "{\"A\": \"Enlargement of the pituitary gland\", \"B\": \"Leptomeningeal enhancement\", \"C\": \"Pachymeningeal enhancement (most common finding)\", \"D\": \"Increased venous blood volume\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of specific neuroimaging findings (e.g., pachymeningeal enhancement) associated with intracranial hypotension, focusing on the interpretation of anatomical/radiological signs.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q60",
    "question_text": "In a case of trigeminal neuralgia involving the V2 distribution with decreased sensation in V3, which artery is likely involved?",
    "options": "{\"A\": \"SCA\", \"B\": \"PCA\", \"C\": \"Pcom\", \"D\": \"AICA\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: While related to trigeminal neuralgia, the question requires correlating clinical signs (distribution, sensory loss) with the likely underlying anatomical cause (vascular compression, often SCA), emphasizing the neuroanatomical aspect.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q95",
    "question_text": "A patient with trigeminal neuralgia, what artery is usually involved?",
    "options": "{\"A\": \"PCA\", \"B\": \"AICA\", \"C\": \"SCA\", \"D\": \"Basilar artery\"}",
    "correct_answer": "C",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Directly asks for the identification of the most common artery (SCA) causing trigeminal neuralgia via neurovascular compression, testing knowledge of relevant neurovascular anatomy.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q184",
    "question_text": "What is the most common artery to cause trigeminal neuralgia (TN)?",
    "options": "{\"A\": \"Superior cerebellar artery (SCA)\", \"B\": \"Anterior inferior cerebellar artery (AICA)\", \"C\": \"Posterior inferior cerebellar artery (PICA)\", \"D\": \"Basilar artery\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the specific anatomical structure (SCA) responsible for the most common cause of trigeminal neuralgia, testing neurovascular anatomical knowledge.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q63",
    "question_text": "What is the commonest presentation in Arnold-Chiari malformation?",
    "options": "{\"A\": \"Ataxia\", \"B\": \"Hydrocephalus\", \"C\": \"Headache\", \"D\": \"Visual disturbances\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the most frequent clinical manifestation (headache) associated with a specific structural brain malformation (Chiari I malformation).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q26",
    "question_text": "Where is prosopagnosia localized in the brain?",
    "options": "{\"A\": \"Occipito-temporal\", \"B\": \"Occipito-parietal\", \"C\": \"Temporal lobe\", \"D\": \"Parietal lobe\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of functional neuroanatomy, specifically the localization of facial recognition (prosopagnosia) to the fusiform gyrus in the occipito-temporal region.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q40",
    "question_text": "A lady presents with abnormal eye movements characterized by large amplitude and low frequency toward the right. What is the likely location of the lesion?",
    "options": "{\"A\": \"Cervicomedullary junction\", \"B\": \"Cerebellopontine angle\", \"C\": \"Medial longitudinal fasciculus\", \"D\": \"Paramedian pontine reticular formation\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Requires localization of a lesion based on the description of nystagmus, linking specific eye movement patterns to neuroanatomical structures.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q32",
    "question_text": "A patient presents with right-sided ptosis and deviation of the uvula. Which of the following could be the underlying cause?",
    "options": "{\"A\": \"Pre-ganglionic lesion\", \"B\": \"Post-ganglionic lesion\", \"C\": \"Lesion of the hypoglossal nerve\", \"D\": \"Lesion of the facial nerve\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: This question requires localization based on cranial nerve signs (CN III for ptosis, CN X for uvula deviation) and understanding autonomic pathways (pre- vs post-ganglionic sympathetic involvement for ptosis), focusing purely on anatomical localization.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q193",
    "question_text": "Where is the localization of internuclear ophthalmoplegia (INO)?",
    "options": "{\"A\": \"Pons (MLF)\", \"B\": \"Medulla\", \"C\": \"Midbrain\", \"D\": \"Cerebellum\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Directly tests knowledge of the specific neuroanatomical structure (Medial Longitudinal Fasciculus - MLF) and its location (pons) responsible for INO.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q24",
    "question_text": "An elderly man with a one-month history of right-side weakness and confusion has a brain CT attached. What is the mechanism of this lesion (Subdural hematoma)?",
    "options": "{\"A\": \"Bridging veins rupture\", \"B\": \"Middle meningeal artery rupture\", \"C\": \"Rupture of cortical veins\", \"D\": \"Rupture of dural arteries\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses specifically on the anatomical structure (bridging veins) and mechanism (rupture due to shear forces/atrophy) responsible for the formation of a subdural hematoma, testing knowledge of cranial anatomy and pathophysiology rather than clinical stroke management.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q54",
    "question_text": "What favors central nystagmus over peripheral nystagmus?",
    "options": "{\"A\": \"Absence of latency\", \"B\": \"Direction-changing nystagmus\", \"C\": \"Nystagmus suppressed by visual fixation\", \"D\": \"Severe vertigo\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the distinguishing clinical characteristics (latency) used to differentiate central versus peripheral causes of nystagmus, relating directly to neuroanatomical localization.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q174",
    "question_text": "A patient with a history of posterior inferior cerebellar artery (PICA) infarction presents with vertical and torsional oscillation. Where is the lesion likely located?",
    "options": "{\"A\": \"Interstitial nucleus of Cajal\", \"B\": \"Inferior cerebellar peduncle\", \"C\": \"Inferior olive\", \"D\": \"Medial longitudinal fasciculus\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires localizing the neuroanatomical structure responsible for specific eye movement abnormalities (vertical/torsional nystagmus/oscillopsia) within the context of a known vascular territory (PICA).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q4",
    "question_text": "A patient with a history of pica infarction two years ago presents with oscillopsia. Where is the lesion likely located?",
    "options": "{\"A\": \"Interstitial nucleus of Cajal\", \"B\": \"Inferior cerebellar peduncle\", \"C\": \"Inferior olive\", \"D\": \"Medial longitudinal fasciculus\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Similar to Q174, this requires localizing the anatomical correlate (likely involving vestibular pathways/cerebellum affected by PICA territory) for a specific symptom (oscillopsia) following a stroke.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q97",
    "question_text": "A patient with restricted vertical gaze and convergence nystagmus, with pupillary response to light intact, what is the localization?",
    "options": "{\"A\": \"Red nucleus\", \"B\": \"Midbrain tectum\", \"C\": \"Medial thalami\", \"D\": \"Oculomotor nucleus\"}",
    "correct_answer": "B",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the precise neuroanatomical localization (dorsal midbrain/tectum) based on the classic signs of Parinaud's syndrome.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q59",
    "question_text": "A patient has impaired adduction of the right eye and nystagmus in the left eye when looking to the left. What is the likely localization of the lesion?",
    "options": "{\"A\": \"Left MLF\", \"B\": \"Right MLF\", \"C\": \"Right occipital lobe\", \"D\": \"Left frontal lobe\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires identifying the specific neuroanatomical structure (right Medial Longitudinal Fasciculus - MLF) responsible for a classic Internuclear Ophthalmoplegia (INO).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q4",
    "question_text": "A patient presents with one-and-a-half syndrome (unable to move both eyes to the left and cannot adduct the left eye). What is the likely localization?",
    "options": "{\"A\": \"Ipsilateral frontal eye field\", \"B\": \"Ipsilateral paramedian pontine reticular formation (PPRF) and medial longitudinal fasciculus (MLF)\", \"C\": \"Contralateral superior colliculus\", \"D\": \"Ipsilateral oculomotor nucleus\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the specific brainstem neuroanatomical localization (ipsilateral PPRF/CN VI nucleus + ipsilateral MLF) of a named complex eye movement disorder.* (Localization structure missing from options).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q100",
    "question_text": "In a case of internuclear ophthalmoplegia (INO) with left impaired adduction and right abduction nystagmus, what is the localization?",
    "options": "{\"A\": \"Left medial longitudinal fasciculus (MLF)\", \"B\": \"Right medial longitudinal fasciculus (MLF)\", \"C\": \"Left oculomotor nucleus\", \"D\": \"Right abducens nucleus\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks for the precise anatomical localization (left MLF) of a clearly described left INO.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q5",
    "question_text": "In a case of ocular bobbing (eyes fast downward then slowly return to primary position), which area of the brain is likely affected?",
    "options": "{\"A\": \"Pons\", \"B\": \"Medulla\", \"C\": \"Midbrain\", \"D\": \"Cerebellum\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links a specific abnormal eye movement pattern (ocular bobbing) to its typical neuroanatomical localization within the brainstem (pons).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q24",
    "question_text": "In a scenario about Parinaud's syndrome, where is the lesion located?",
    "options": "{\"A\": \"Midbrain tectum (dorsal midbrain)\", \"B\": \"Thalamus\", \"C\": \"Cerebral cortex\", \"D\": \"Brainstem\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the specific neuroanatomical localization (dorsal midbrain/tectum) of Parinaud's syndrome.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q13",
    "question_text": "A patient with Neuromyelitis Optica (NMO) presents with intractable vomiting. Which area of the brain is likely involved?",
    "options": "{\"A\": \"Area postrema\", \"B\": \"Cerebellum\", \"C\": \"Thalamus\", \"D\": \"Medulla oblongata\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of functional neuroanatomy, specifically the location of the area postrema (vomiting center) in the brainstem, relevant to understanding symptoms in conditions like NMO.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q22",
    "question_text": "In a scenario of an elderly patient who had a stroke and became hyperactive with flight of ideas and pressured speech (mania), where would you expect the lesion to be located?",
    "options": "{\"A\": \"Caudate\", \"B\": \"Thalamus\", \"C\": \"Frontal lobe\", \"D\": \"Temporal lobe\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks for the neuroanatomical localization (caudate/thalamus circuits involved in mood/behavior) of post-stroke mania, linking behavior to specific brain regions.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q82",
    "question_text": "A patient is diagnosed with a rostral vermis defect. What is a common clinical presentation associated with this condition?",
    "options": "{\"A\": \"Wide base gait\", \"B\": \"Intention tremor\", \"C\": \"Dysarthria\", \"D\": \"Nystagmus\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of structure-function correlation in the cerebellum, linking a specific anatomical defect (rostral vermis) to its typical clinical sign (gait ataxia).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q111",
    "question_text": "What is the resulting lesion due to a lesion in the splenium of the corpus callosum?",
    "options": "{\"A\": \"Alexia without agraphia\", \"B\": \"Agraphia without alexia\", \"C\": \"Alexia with agraphia\", \"D\": \"Pure word deafness\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Assesses knowledge of functional neuroanatomy and disconnection syndromes, specifically the clinical syndrome resulting from a splenial lesion.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q7",
    "question_text": "What brain structures are involved in peduncular hallucinosis?",
    "options": "{\"A\": \"Midbrain and thalamus\", \"B\": \"Cerebellum and pons\", \"C\": \"Cortex and basal ganglia\", \"D\": \"Hippocampus and amygdala\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Connects a specific clinical phenomenon (peduncular hallucinosis) to its underlying neuroanatomical substrates (midbrain/thalamus).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q58",
    "question_text": "In a patient experiencing hallucinations, where is the lesion likely located?",
    "options": "{\"A\": \"Midbrain\", \"B\": \"Temporal lobe\", \"C\": \"Occipital lobe\", \"D\": \"Frontal lobe\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks for general neuroanatomical localization associated with hallucinations, linking a symptom to potential brain regions (though localization can be complex and varied).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q309",
    "question_text": "Pendular hallucination is associated with which type of lesion?",
    "options": "{\"A\": \"Midbrain lesion\", \"B\": \"Occipital lobe lesion\", \"C\": \"Temporal lobe lesion\", \"D\": \"Parietal lobe lesion\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links a specific type of visual hallucination (peduncular hallucinosis) to its typical lesion location (midbrain/thalamus).",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q20",
    "question_text": "A patient presented with nystagmus at primary gaze and a slow amplitude fast beat to the right. Which area is most likely affected?",
    "options": "{\"A\": \"Tectal midbrain\", \"B\": \"Cerebellar hemisphere\", \"C\": \"Pontocerebellar angle\", \"D\": \"Medulla\"}",
    "correct_answer": "B",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires localization of a specific neurological sign (nystagmus) to a particular CNS region based on its clinical characteristics, testing knowledge of functional neuroanatomy.",
    "subspecialty": "Neuroanatomy"
  },
  {
    "question_number": "Q5",
    "question_text": "A multiple sclerosis (MS) patient who is receiving natalizumab and developed progressive multifocal leukoencephalopathy (PML), what should be done?",
    "options": "{\"A\": \"Stop natalizumab\", \"B\": \"Continue natalizumab and monitor closely\", \"C\": \"Switch to interferon beta therapy\", \"D\": \"Initiate high-dose corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Addresses a critical complication (PML) directly related to an MS disease-modifying therapy (natalizumab) and its immediate management.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q8",
    "question_text": "A multiple sclerosis (MS) patient who is receiving natalizumab developed progressive multifocal leukoencephalopathy (PML). What should be done next? (Stopping natalizumab was not an option in the choices)",
    "options": "{\"A\": \"Start plasmapheresis\", \"B\": \"Administer intravenous immunoglobulin (IVIG)\", \"C\": \"Initiate steroids\", \"D\": \"Continue natalizumab\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the management of PML occurring as a complication of MS therapy (natalizumab), specifically interventions beyond stopping the drug.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q18",
    "question_text": "A 16-year-old patient presents with confusion. An MRI shows bilateral white matter changes. What is the likely diagnosis?",
    "options": "{\"A\": \"Acute disseminated encephalomyelitis (ADEM)\", \"B\": \"Primary CNS angiitis\", \"C\": \"Multiple sclerosis (MS)\", \"D\": \"Metabolic leukoencephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Presents a pediatric case with MRI findings characteristic of demyelinating conditions like ADEM or MS, requiring differentiation within the neuroimmunological spectrum.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q22",
    "question_text": "A patient diagnosed with relapsing-remitting multiple sclerosis (RRMS) started on disease-modifying therapy (DMT) but lost follow-up. Upon return, the patient had a platelet count of 30 and a skin issue. Which DMT was the patient on?",
    "options": "{\"A\": \"Alemtuzumab\", \"B\": \"Teriflunomide\", \"C\": \"Fingolimod\", \"D\": \"Interferon beta\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of specific side effects (thrombocytopenia, skin issues) associated with particular MS DMTs (likely Alemtuzumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q28",
    "question_text": "What is the cardinal feature in a case scenario suggestive of Neuromyelitis Optica (NMO)?",
    "options": "{\"A\": \"Optic neuritis\", \"B\": \"Peripheral neuropathy\", \"C\": \"Cerebellar ataxia\", \"D\": \"Cognitive decline\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for a key clinical feature characteristic of NMO, a specific neuroinflammatory disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q31",
    "question_text": "A female known to have relapsing-remitting multiple sclerosis (RRMS) is stopping disease-modifying therapy (DMT) for 2 months in order to get pregnant. What medication was she likely started on?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Glatiramer acetate\", \"C\": \"Interferons\", \"D\": \"Beta interferon\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with MS treatment considerations (DMT choice, likely safer options like Glatiramer Acetate or Interferons) specifically related to pregnancy planning.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q38",
    "question_text": "In the scenario of a patient with Giant Cell Arteritis (GCA), which vessel is most commonly involved?",
    "options": "{\"A\": \"Posterior ciliary artery\", \"B\": \"Middle cerebral artery\", \"C\": \"Anterior cerebral artery\", \"D\": \"Basilar artery\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific vascular involvement pattern in GCA, an autoimmune large vessel vasculitis often managed by neurologists/neuroophthalmologists.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q53",
    "question_text": "In a patient with bilateral optic neuritis and longitudinally extensive transverse myelitis (LETM), which tests are used to confirm the diagnosis?",
    "options": "{\"A\": \"Oligoclonal bands (OCB)\", \"B\": \"Aquaporin 4 antibodies\", \"C\": \"Myelin oligodendrocyte glycoprotein (MOG) antibodies\", \"D\": \"Anti-nuclear antibody (ANA)\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on diagnostic markers (AQP4 antibodies) used to confirm NMO spectrum disorder, based on typical clinical features (ON, LETM).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q54",
    "question_text": "A case scenario describes a patient with recurrent oral ulcers presenting with neurological deficits. What is the likely diagnosis?",
    "options": "{\"A\": \"Neuro Beh\\u00e7et's disease\", \"B\": \"Systemic lupus erythematosus\", \"C\": \"Multiple sclerosis\", \"D\": \"Sj\\u00f6gren's syndrome\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Involves diagnosing a specific neuroinflammatory condition (Neuro Beh\u00e7et's) based on systemic features (oral ulcers) and neurological symptoms.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q66",
    "question_text": "The most common cause of myelopathy in young adults in temperate zones is:",
    "options": "{\"A\": \"Multiple Sclerosis\", \"B\": \"Cervical spondylotic myelopathy\", \"C\": \"Neuromyelitis Optica\", \"D\": \"Sarcoidosis\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Assesses knowledge of the epidemiology of myelopathy, specifically identifying MS as the leading cause in a particular demographic/geographic context.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q67",
    "question_text": "In a case of multiple sclerosis, the criteria for diagnosis were questioned due to the presence of enhancing and non-enhancing lesions, but only two periventricular lesions were noted. Which of the following statements is true?",
    "options": "{\"A\": \"Both dissemination in space and time were met\", \"B\": \"Only dissemination in space was met\", \"C\": \"Only dissemination in time was met\", \"D\": \"Neither dissemination in space nor time was met\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests understanding and application of MS diagnostic criteria (McDonald criteria), specifically relating MRI findings (enhancing/non-enhancing lesions, location) to dissemination in space and time.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q72",
    "question_text": "MRI findings in patients with NMOSD typically show which of the following?",
    "options": "{\"A\": \"Leptomeningeal enhancement\", \"B\": \"Nodular or linear lesions on the surface of the cord\", \"C\": \"No significant findings\", \"D\": \"Periventricular white matter lesions\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about characteristic MRI findings in Neuromyelitis Optica Spectrum Disorder (NMOSD), distinguishing it from other conditions like MS or sarcoidosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q73",
    "question_text": "A patient with multiple sclerosis (MS) who was on disease-modifying therapy (DMT) stopped her medication 2 months ago because she wants to get pregnant. An MRI of the brain shows new white matter subcortical enhancing lesions. What is the mechanism of these lesions?",
    "options": "{\"A\": \"Demyelination due to direct viral infection\", \"B\": \"Rebound inflammatory activity due to immune reconstitution after stopping DMT\", \"C\": \"Ischemic injury secondary to vasculitis\", \"D\": \"Neurodegeneration from chronic axonal loss\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Addresses the pathophysiology of new MS lesion formation, likely related to rebound inflammation after stopping certain DMTs, in the context of pregnancy planning.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q74",
    "question_text": "In a patient with Multiple Sclerosis, what finding is expected on Visual Evoked Potentials (VEP)?",
    "options": "{\"A\": \"Prolonged P100\", \"B\": \"Shortened P100\", \"C\": \"Absent P100\", \"D\": \"Normal P100 latency\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a characteristic neurophysiological finding (prolonged P100 latency on VEP) used in the diagnosis and monitoring of MS, reflecting optic nerve demyelination.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q75",
    "question_text": "For patients who cannot tolerate high-dose corticosteroids or have refractory disease, which of the following treatments is an alternative?",
    "options": "{\"A\": \"Infliximab\", \"B\": \"Rituximab\", \"C\": \"Mycophenolate mofetil\", \"D\": \"Azathioprine\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Discusses alternative immunosuppressive therapies used in various refractory neuroimmunological conditions when standard treatments fail or are contraindicated.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q93",
    "question_text": "A young female presents with a new relapse of sudden left-sided weakness for 5 days after a history of exhaustion. What is the most appropriate management?",
    "options": "{\"A\": \"Start fingolimod\", \"B\": \"Start interferon\", \"C\": \"Emergent pulse steroid\", \"D\": \"MRI brain\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Focuses on the acute management of a suspected MS relapse (sudden neurological deficit), with high-dose steroids being the standard approach.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q102",
    "question_text": "A patient with multiple sclerosis (MS) presented with shortness of breath (SOB) and an allergic reaction during the third infusion of natalizumab. What is the most appropriate action to take next?",
    "options": "{\"A\": \"Stop infusion and treat the patient\", \"B\": \"Refer the patient to immunology to start desensitization\", \"C\": \"Start a lower dose of natalizumab next time\", \"D\": \"Administer antihistamines and continue infusion cautiously\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Concerns the immediate management of an infusion reaction to an MS DMT (natalizumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q107",
    "question_text": "What is the risk of developing clinically definite MS (CDMS) in patients with no MRI lesions after 5 years?",
    "options": "{\"A\": \"16%\", \"B\": \"25%\", \"C\": \"51%\", \"D\": \"72%\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of MS prognosis and the predictive value of baseline MRI findings for conversion to CDMS after a clinically isolated syndrome (CIS).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q119",
    "question_text": "An elderly patient with confusion, seizure, and weakness is brought to the emergency department. An MRI of the brain shows multiple microhemorrhages. What is the treatment?",
    "options": "{\"A\": \"IV methylprednisolone\", \"B\": \"IVIG\", \"C\": \"Plasmapheresis\", \"D\": \"Supportive care\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: The presentation with microhemorrhages plus potential treatments like steroids/IVIG/PLEX suggests an inflammatory process, possibly Cerebral Amyloid Angiopathy-related inflammation or CNS vasculitis, falling under Neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q120",
    "question_text": "Which of the following is suggestive of Multiple Sclerosis, but not vascular white matter disease?",
    "options": "{\"A\": \"Cortical involvement\", \"B\": \"Involving U fibers\", \"C\": \"Corona radiata\", \"D\": \"Pons\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on distinguishing MS lesions from vascular white matter changes based on characteristic MRI location (e.g., U-fiber involvement).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q134",
    "question_text": "A 24-year-old female developed abrupt vision loss (not specified as painful or painless) in the left eye 5 days ago, then the right eye was affected after two to three days and was static thereafter. Exam showed decreased visual acuity, what to do next?",
    "options": "{\"A\": \"No treatment needed\", \"B\": \"Pulse steroids\", \"C\": \"Plasmapheresis\", \"D\": \"IVIG\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes rapidly sequential bilateral optic neuropathy, raising high suspicion for NMO spectrum disorder, and asks about acute treatment (steroids, PLEX, IVIG).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q135",
    "question_text": "A patient known to have Neuromyelitis Optica (NMO) after a long episode of cervical myelitis reported experiencing pain in her upper limbs triggered by sudden movement. What is the best treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Gabapentin\", \"C\": \"Amitriptyline\", \"D\": \"Baclofen\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Addresses the management of neuropathic pain (Lhermitte's phenomenon or similar) occurring as a specific symptom within NMO.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q136",
    "question_text": "Which of the following is considered a red flag for Multiple Sclerosis (or demyelinating disease)?",
    "options": "{\"A\": \"Persistent enhancement for 3 months\", \"B\": \"Presence of Dawson\\u2019s fingers on MRI\", \"C\": \"Oligoclonal bands in cerebrospinal fluid\", \"D\": \"Lesions involving periventricular white matter\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of imaging features that might argue against a typical MS diagnosis (red flags), such as prolonged lesion enhancement.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q139",
    "question_text": "Patient was diagnosed with Multiple Sclerosis and suffers from lower limb tonic spasm. What is the treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Baclofen\", \"C\": \"Diazepam\", \"D\": \"Tizanidine\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the symptomatic treatment (carbamazepine for tonic spasms) of a specific neurological symptom occurring in MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q141",
    "question_text": "To prevent PML in patients receiving Tysabri, what is the best approach?",
    "options": "{\"A\": \"Check JC virus before starting treatment\", \"B\": \"Serial MRI\", \"C\": \"CT without contrast\", \"D\": \"Periods of drug wash out\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Concerns risk mitigation strategies (JCV antibody testing) for PML associated with natalizumab (Tysabri) therapy in MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q145",
    "question_text": "An MS patient on natalizumab started to have shortness of breath, tachycardia, and tachypnea after the 3rd dose. What will you do next?",
    "options": "{\"A\": \"Stop the dose and start prophylaxis management\", \"B\": \"Continue the medication\", \"C\": \"Give half the dose next time\", \"D\": \"Send her for desensitization\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Deals with the management of a suspected infusion reaction or hypersensitivity to an MS DMT (natalizumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q151",
    "question_text": "A young female presents with symptoms of bilateral lower limb weakness, loss of all sensory modalities up to the umbilicus, and bladder involvement. What is the diagnosis?",
    "options": "{\"A\": \"Transverse myelitis\", \"B\": \"Myasthenia gravis (MG)\", \"C\": \"Multiple sclerosis\", \"D\": \"Guillain-Barr\\u00e9 syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a classic presentation of acute transverse myelitis, a common manifestation within the spectrum of neuroinflammatory disorders.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q159",
    "question_text": "A young female treated for confirmed HSV presents with behavioral changes, a normal MRI of the brain, and focal facial myoclonic seizures. What is the likely diagnosis?",
    "options": "{\"A\": \"Anti-NMDA receptor encephalitis\", \"B\": \"Anti-Caspr2 antibody syndrome\", \"C\": \"Limbic encephalitis associated with voltage-gated potassium channel antibodies\", \"D\": \"Post-infectious acute disseminated encephalomyelitis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Presents a scenario highly suggestive of post-HSV anti-NMDA receptor encephalitis, an autoimmune encephalitis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q160",
    "question_text": "A 22-year-old female presented with acute confusion and later developed seizures and orofacial dyskinesia. CSF analysis was suggestive of autoimmune encephalitis. What is the most common paraneoplastic antibody to look for?",
    "options": "{\"A\": \"Anti-Yo antibodies\", \"B\": \"Anti-Hu antibodies\", \"C\": \"Anti-MGLUR5 antibodies\", \"D\": \"Anti-NMDA receptor antibodies\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on identifying the most likely antibody (Anti-NMDA) in a classic presentation of autoimmune encephalitis, asking about its paraneoplastic association.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q164",
    "question_text": "A patient came with a 1-month history of fever, headache, and personality changes. Brain MRI shows bilateral cortical/subcortical hypodensities involving frontal, parietal, and occipital lobes. CSF analysis shows elevated protein. Which diagnosis can be demonstrated by T2 lesions in at least two areas of the CNS?",
    "options": "{\"A\": \"Multiple sclerosis\", \"B\": \"Bacterial meningitis\", \"C\": \"Viral meningitis\", \"D\": \"Neurosyphilis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: While presenting symptoms could be infectious, the question asks which diagnosis requires T2 lesions in multiple CNS areas, a key concept in MS diagnosis (dissemination in space), placing it in the context of differentiating inflammatory from infectious causes.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q169",
    "question_text": "A young lady presents with acute right diplopia. No previous attacks. Brain MRI shows enhancement of lesions. What is the next step in management?",
    "options": "{\"A\": \"Start steroids\", \"B\": \"Interferon therapy\", \"C\": \"Observe while doing more diagnostic tests\", \"D\": \"Annual MRI follow-up\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Describes a clinically isolated syndrome (CIS) suggestive of MS (acute neurological deficit with enhancing lesions) and asks about initial management, typically steroids for the acute relapse.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q174",
    "question_text": "A young male patient with isolated optic neuritis is concerned that he may have multiple sclerosis. What is the most appropriate next step investigation?",
    "options": "{\"A\": \"Visual evoked potential\", \"B\": \"Brain MRI\", \"C\": \"Lumbar puncture\", \"D\": \"Blood tests for autoimmune markers\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the standard workup following optic neuritis (a common CIS) to assess the risk of developing MS, with brain MRI being the key investigation.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q175",
    "question_text": "A young male is brought by his father with complaints of catatonia, psychosis, seizure, and dysautonomia. Which of the following antibodies is most likely associated with his condition?",
    "options": "{\"A\": \"Anti-GABA\", \"B\": \"Anti-NMDA\", \"C\": \"Anti-CASPR2\", \"D\": \"Anti-LGI1\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes a clinical picture highly suggestive of anti-NMDA receptor encephalitis and asks to identify the associated antibody.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q185",
    "question_text": "A patient presents with symptoms of stiff person syndrome. What is the most likely antibody associated with this condition?",
    "options": "{\"A\": \"Anti-GAD\", \"B\": \"Anti-Ma\", \"C\": \"Anti-NMDA\", \"D\": \"Anti-CRMP-1\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the primary antibody (Anti-GAD) associated with Stiff Person Syndrome, an autoimmune neurological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q186",
    "question_text": "What is the most appropriate diagnostic method for primary CNS angiitis (PACNS)?",
    "options": "{\"A\": \"CTA\", \"B\": \"Biopsy\", \"C\": \"MRI\", \"D\": \"Color duplex sonography\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the gold standard diagnostic procedure (brain biopsy) for Primary Angiitis of the CNS (PACNS), an inflammatory vasculopathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q197",
    "question_text": "Opsoclonus-myoclonus syndrome presents with subacute opsoclonus (irregular, rapid eye movements) and multifocal or generalized myoclonus. In adults, this syndrome may be due to which of the following aetiologies?",
    "options": "{\"A\": \"Infectious\", \"B\": \"Autoimmune\", \"C\": \"Paraneoplastic\", \"D\": \"Drug-induced\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about the common etiologies of Opsoclonus-Myoclonus Syndrome in adults, which is frequently autoimmune or paraneoplastic.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q218",
    "question_text": "Which of the following MRI characteristics is the best predictor of future disability in patients with multiple sclerosis?",
    "options": "{\"A\": \"Baseline enhancing lesion number\", \"B\": \"Baseline T2 lesion number\", \"C\": \"Baseline T2 lesion volume\", \"D\": \"Number of new enhancing lesions\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of MRI markers used for prognostication in MS, linking imaging findings to long-term disability.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q219",
    "question_text": "Which medication is used to improve MS-related fatigue?",
    "options": "{\"A\": \"Pemoline\", \"B\": \"Modafinil\", \"C\": \"Amantadine\", \"D\": \"Dalfampridine\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on symptomatic management of fatigue, a common and disabling symptom in Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q242",
    "question_text": "In a case of transverse myelitis, MRI reveals multiple enhancing lesions in the brain and spinal cord. Which of the following is the most likely diagnosis?",
    "options": "{\"A\": \"Clinically isolated syndrome (CIS)\", \"B\": \"Multiple sclerosis (MS)\", \"C\": \"Neuromyelitis optica (NMO)\", \"D\": \"Radiologically isolated syndrome (RIS)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires integrating clinical presentation (transverse myelitis) with MRI findings (dissemination in space and time) to arrive at an MS diagnosis according to diagnostic criteria.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q244",
    "question_text": "Which MRI feature is most closely associated with the progression of disability in multiple sclerosis patients?",
    "options": "{\"A\": \"Gadolinium-enhancing plaques\", \"B\": \"T1 hypointensities\", \"C\": \"T2 lesions\", \"D\": \"Cerebral atrophy\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on MRI markers (T1 hypointensities/\"black holes\", atrophy) that correlate with long-term disability accumulation in MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q254",
    "question_text": "What is the estimated risk of developing multiple sclerosis (MS) in patients with normal brain MRI and transverse myelitis?",
    "options": "{\"A\": \"10%\", \"B\": \"30%\", \"C\": \"60%\", \"D\": \"70%\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge of MS risk stratification based on initial presentation (transverse myelitis) and baseline brain MRI findings.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q256",
    "question_text": "A 45-year-old woman with a greater-than-20-year history of multiple sclerosis is nonambulatory and dependent for all activities of daily living. She is taking 100 mg of baclofen daily. Which of the following therapies is most likely to improve this patient's quality of life?",
    "options": "{\"A\": \"Steroids\", \"B\": \"Carbamazepine (CMZ)\", \"C\": \"Anti-viral therapy\", \"D\": \"Pregabalin\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Concerns symptomatic management (likely pain or spasticity related, given options like CMZ/Pregabalin) in advanced MS, aiming to improve quality of life.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q260",
    "question_text": "What does the absence of brain lesions predict regarding the risk of MS over the next 15 years?",
    "options": "{\"A\": \"High risk (>50%)\", \"B\": \"Moderate risk (20-50%)\", \"C\": \"Low risk (<20%)\", \"D\": \"No risk\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses understanding of the prognostic significance of a normal baseline brain MRI after a CIS regarding long-term MS risk.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q262",
    "question_text": "In idiopathic partial transverse myelitis, what is the likelihood of evolving multiple sclerosis at 15-44%?",
    "options": "{\"A\": \"10%\", \"B\": \"30%\", \"C\": \"60%\", \"D\": \"70%\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the conversion rate from idiopathic transverse myelitis (specifically partial TM) to clinically definite MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q274",
    "question_text": "A 19-year-old man presents with confusion. MRI shows right thalamic hyperintensity on FLAIR and around the 3rd ventricle, suggestive of diencephalic syndrome. He has no fever. What should be checked?",
    "options": "{\"A\": \"NMO antibodies\", \"B\": \"MOG antibodies\", \"C\": \"Anti-NMDA receptor antibodies\", \"D\": \"Paraneoplastic antibodies\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Presents a case with MRI findings suggestive of MOG antibody disease or potentially NMOSD affecting the diencephalon, prompting specific antibody testing.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q276",
    "question_text": "A female patient with optic neuritis has one periventricular MRI lesion. What is the next step in management?",
    "options": "{\"A\": \"Start natalizumab\", \"B\": \"Start interferon\", \"C\": \"Observation until further investigation\", \"D\": \"Repeat MRI in 6 months\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with the management decision (starting DMT vs. observation) after a CIS (optic neuritis) based on MRI findings (presence of one lesion satisfying dissemination in space criteria).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q303",
    "question_text": "Which of the following infections is more common with a B-cell lysis agent compared to interferon?",
    "options": "{\"A\": \"Upper respiratory infections\", \"B\": \"Oral herpes\", \"C\": \"Genital herpes\", \"D\": \"Urinary tract infections\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Compares the side effect profiles, specifically infection risks (herpes reactivation), of different classes of MS DMTs (B-cell depleting vs. interferons).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q304",
    "question_text": "What is the risk of malignancies associated with the use of a B-cell lysis agent?",
    "options": "{\"A\": \"0.8%\", \"B\": \"1.3%\", \"C\": \"1.5%\", \"D\": \"2.0%\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge regarding potential long-term risks (malignancy) associated with B-cell depleting therapies used in MS and other autoimmune diseases.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q305",
    "question_text": "A young female with bilateral optic neuritis, brain MRI showed enhanced contrast in the posterior segment of the optic nerve extending to the optic chiasm, partially improved after pulse steroid after 5 days but visual acuity still 20/200. What is the best next step?",
    "options": "{\"A\": \"Send for Aquaporin-4 & wait for the result.\", \"B\": \"Start her on prednisolone with taper over 1 month.\", \"C\": \"Urgent Rituximab.\", \"D\": \"PLEX.\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the management of severe optic neuritis, possibly NMO-related given bilateral involvement and chiasmal extension, particularly when response to steroids is incomplete (considering PLEX).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q314",
    "question_text": "A case of relapsing-remitting multiple sclerosis (RRMS) with a history of type 1 diabetes mellitus and depression is presented. What is the best treatment for her?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Interferon beta-1a\", \"C\": \"Glatiramer acetate\", \"D\": \"Dimethyl fumarate\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Requires selecting an appropriate MS DMT (Fingolimod is presented as an option) considering patient comorbidities (T1DM, depression) which might influence treatment choice.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q315",
    "question_text": "A patient presents with painful visual loss in one eye with disc edema. What is the recommended treatment?",
    "options": "{\"A\": \"IV methylprednisolone\", \"B\": \"Oral steroids\", \"C\": \"Observation\", \"D\": \"Topical corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes typical optic neuritis and asks for the standard acute treatment (IV methylprednisolone).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q319",
    "question_text": "In a scenario involving a patient with multiple sclerosis, what criteria are applied for diagnosis?",
    "options": "{\"A\": \"Time and space criteria\", \"B\": \"McDonald criteria\", \"C\": \"Revised criteria\", \"D\": \"Clinical criteria\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks to identify the specific diagnostic criteria (McDonald criteria) used for Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q326",
    "question_text": "A female patient is admitted to the psychiatric ward with delusions and hallucinations, and then develops seizures and fever. What is the most likely diagnosis?",
    "options": "{\"A\": \"Anti-NMDA receptor encephalitis\", \"B\": \"Herpes simplex encephalitis\", \"C\": \"Schizophrenia\", \"D\": \"Neuroleptic malignant syndrome\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes a classic presentation of anti-NMDA receptor encephalitis, an autoimmune encephalitis often presenting with psychiatric symptoms followed by neurological deterioration.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q334",
    "question_text": "A 28-year-old female with a history of multiple sclerosis (MS) on natalizumab presents with left-sided weakness and visual disturbances. She received 5 days of methotrexate with no response and was found to have positive neutralizing antibodies against natalizumab. MRI shows evidence of new lesions. What should be done next?",
    "options": "{\"A\": \"IVIG\", \"B\": \"PLEX (5 sessions)\", \"C\": \"Give more methotrexate for 3 days\", \"D\": \"Switch to fingolimod\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Deals with a complex MS management scenario involving treatment failure (neutralizing antibodies to natalizumab), new disease activity, and potential need for rescue therapy like PLEX or switching DMT.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q336",
    "question_text": "A 32-year-old female presents with bilateral blurry vision and decreased visual acuity. Initial MRI of the brain is normal. Later, she develops paraplegia, numbness, and sphincter dysfunction. ANA is positive, AQP-4 antibody is negative, and CSF shows negative OCB. MRI reveals increased signal from T6 to T10. What is the diagnosis?",
    "options": "{\"A\": \"Progressive MS\", \"B\": \"NMOSD\", \"C\": \"Acute transverse myelitis\", \"D\": \"MOG antibody-associated disease\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires differential diagnosis between MS and NMOSD based on clinical presentation (optic neuritis, LETM), MRI findings, and antibody/CSF results (AQP4 negative, OCB negative potentially suggesting MOGAD or seronegative NMO).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q353",
    "question_text": "A young female with subacute behavioral change is admitted under psychiatric care. An MRI shows mesial temporal hyperintensity. The suspected condition is associated with which tumor?",
    "options": "{\"A\": \"Ovarian teratoma\", \"B\": \"Lung cancer\", \"C\": \"Breast cancer\", \"D\": \"Thymoma\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Links a clinical presentation suggestive of limbic encephalitis (behavioral change, temporal MRI changes) to its most common paraneoplastic association (ovarian teratoma in anti-NMDA receptor encephalitis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q360",
    "question_text": "A 35-year-old female patient, medically free, came with heat intolerance, lower limb weakness, and sensory symptoms, along with urinary incontinence. Her symptoms increased after stress at work. What will you do next?",
    "options": "{\"A\": \"Methylprednisolone\", \"B\": \"Brain MRI\", \"C\": \"Nerve conduction studies\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "B",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes symptoms suggestive of an MS relapse (Uhthoff's phenomenon, neurological deficits) and asks about the next step, which could be acute treatment (steroids) or further investigation (MRI).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q363",
    "question_text": "A patient with multiple sclerosis (MS) presents with tonic spasms. What is the treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Baclofen\", \"C\": \"Diazepam\", \"D\": \"Phenytoin\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the specific symptomatic treatment (carbamazepine) for tonic spasms occurring in MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q366",
    "question_text": "In a typical scenario of a stiff person, an EMG showed continuous contractions. What is the antibody associated with this condition?",
    "options": "{\"A\": \"Anti-GAD\", \"B\": \"Anti-AChR\", \"C\": \"Anti-Hu\", \"D\": \"Anti-NMDA\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links the clinical diagnosis of Stiff Person Syndrome, supported by EMG findings, to its characteristic associated antibody (Anti-GAD).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q367",
    "question_text": "A patient came with bilateral optic neuritis; MRI showed high signal intensity in the bilateral optic nerves. What is the diagnosis?",
    "options": "{\"A\": \"Anti-MOG\", \"B\": \"Multiple sclerosis\", \"C\": \"Neuromyelitis optica spectrum disorder\", \"D\": \"Ischemic optic neuropathy\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Suggests a diagnosis (likely MOG Antibody Disease) based on the specific clinical presentation of bilateral optic neuritis with characteristic MRI findings.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q377",
    "question_text": "A patient known to have multiple sclerosis (MS) but also has psoriasis. What disease-modifying therapy (DMT) should be given?",
    "options": "{\"A\": \"Dimethyl fumarate (DMF)\", \"B\": \"Interferon beta\", \"C\": \"Fingolimod\", \"D\": \"Natalizumab\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Requires choosing an MS DMT considering a comorbidity (psoriasis), as some DMTs might worsen or improve psoriasis (DMF is often used for both).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q382",
    "question_text": "What is the pathophysiology of sarcoidosis?",
    "options": "{\"A\": \"Granuloma formation\", \"B\": \"Demyelination of peripheral nerves\", \"C\": \"Autoimmune antibody-mediated neuronal damage\", \"D\": \"Vascular occlusion and ischemia\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about the fundamental pathological mechanism (non-caseating granuloma formation) of sarcoidosis, an inflammatory disease that frequently affects the nervous system (neurosarcoidosis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q238",
    "question_text": "A patient with type 1 diabetes mellitus presents with a history of stiffness. What is the most likely antibody associated with this condition?",
    "options": "{\"A\": \"Anti-NMDA\", \"B\": \"Anti-GAD65\", \"C\": \"Anti-GABA\", \"D\": \"Anti-AMPA\"}",
    "correct_answer": "B",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Links Stiff Person Syndrome (suggested by stiffness) with its common association with Type 1 Diabetes and the relevant antibody (Anti-GAD).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q21",
    "question_text": "A 20-year-old female patient known to have multiple sclerosis is on interferon therapy. She had right-sided weakness and was managed with methylprednisolone, improving significantly. A few days later, her symptoms returned but were milder. What is the next step in management?",
    "options": "{\"A\": \"Change disease-modifying therapy (DMT)\", \"B\": \"Urinalysis\", \"C\": \"Repeat MRI brain with contrast\", \"D\": \"Start oral prednisone taper\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses management of recurrent symptoms post-steroid treatment in MS, specifically considering pseudo-relapse triggers like UTI.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q27",
    "question_text": "A female patient came in with encephalitis (history of seizure, fever, psychosis). What is the likely antibody involved?",
    "options": "{\"A\": \"Anti-NMDA (the common cause of limbic encephalitis in young females)\", \"B\": \"Anti-GLU\", \"C\": \"Anti-VGKC\", \"D\": \"Anti-GAD\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the most common antibody associated with autoimmune encephalitis presenting with characteristic features in a young female.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q29",
    "question_text": "A child presents with symptoms suggestive of multiple sclerosis (MS). What is the most significant risk factor for developing MS?",
    "options": "{\"A\": \"Epstein-Barr Virus (EBV)\", \"B\": \"Cytomegalovirus (CMV)\", \"C\": \"Vitamin D deficiency\", \"D\": \"Smoking\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about a major environmental risk factor (EBV infection) strongly associated with the development of Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q123",
    "question_text": "A patient diagnosed with multiple sclerosis and started on disease-modifying therapy (DMT) one year later had a relapse. MRI shows long extensive spinal hyperintensity of the spinal cord with an axial view showing a trident sign. What is the pathophysiology of this diagnosis?",
    "options": "{\"A\": \"Demyelination\", \"B\": \"Astrocytopathy\", \"C\": \"Granuloma formation\", \"D\": \"Axonal degeneration\"}",
    "correct_answer": "B",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests the ability to recognize MRI findings (LETM, trident sign) atypical for MS, suggesting an alternative diagnosis like NMOSD (astrocytopathy) or sarcoidosis (granuloma).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q127",
    "question_text": "A 16-year-old with symptoms of optic neuritis and brain MRI showing bilateral extensive enhancement in the optic nerve, with the rest of the MRI normal, what is the diagnosis? (No NMOSD in the choices)",
    "options": "{\"A\": \"MOGAD\", \"B\": \"ADEM\", \"C\": \"MS\", \"D\": \"Optic neuritis secondary to infection\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on diagnosing MOGAD based on typical clinical (bilateral ON) and MRI findings (extensive optic nerve enhancement) in a young patient.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q150",
    "question_text": "A patient with one clinical attack of multiple sclerosis has:",
    "options": "{\"A\": \"Objective clinical evidence of one lesion\", \"B\": \"Objective clinical evidence of two or more lesions\", \"C\": \"Historical evidence of a prior attack involving a lesion in a distinct CNS location\", \"D\": \"Normal neurological examination\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests understanding of the definition of a Clinically Isolated Syndrome (CIS) as the first clinical attack suggestive of MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q162",
    "question_text": "A 7-year-old boy has recurrent focal seizures involving the right side of his body. Sometimes, these evolve to epilepsia partialis continua. On examination, he has right-sided weakness and his MRI shows perisylvian atrophy. Which of the following antibodies is likely to be present in his CSF?",
    "options": "{\"A\": \"mGluR5\", \"B\": \"mGluR3\", \"C\": \"Caspr2\", \"D\": \"None of the above\"}",
    "correct_answer": "D",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about antibodies potentially associated with Rasmussen's encephalitis, an immune-mediated cause of refractory focal epilepsy and neurological decline.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q275",
    "question_text": "A child presents with decreased vision in both eyes, papilledema, and no confusion. An orbital MRI shows anterior bilateral optic nerve enhancement. What is the diagnosis?",
    "options": "{\"A\": \"ADEM\", \"B\": \"MOG\", \"C\": \"Multiple sclerosis\", \"D\": \"Neuromyelitis optica\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on diagnosing MOG Antibody Disease (MOGAD) based on characteristic presentation in children (bilateral optic neuritis, often with disc edema) and MRI findings.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q316",
    "question_text": "A young patient presents with a history of encephalopathy, weakness, and hearing loss. An MRI of the brain is performed. Which condition is most likely indicated by these symptoms?",
    "options": "{\"A\": \"Susac syndrome\", \"B\": \"Multiple sclerosis\", \"C\": \"Amyotrophic lateral sclerosis\", \"D\": \"Guillain-Barr\\u00e9 syndrome\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests recognition of Susac syndrome based on its characteristic clinical triad.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q1",
    "question_text": "A patient with multiple sclerosis presented with leg weakness that improved with steroids but recurred after one week. What is the next step in management?",
    "options": "{\"A\": \"Urinalysis\", \"B\": \"Pulse steroids\", \"C\": \"Change disease-modifying therapy (DMT)\", \"D\": \"MRI brain and spine\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses management of recurrent symptoms post-steroid treatment in MS, specifically considering pseudo-relapse triggers like UTI.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q13",
    "question_text": "A woman with multiple sclerosis on fingolimod has a brain MRI showing new active lesions in the left frontal lobe. What is the most appropriate next step in management?",
    "options": "{\"A\": \"Continue on fingolimod\", \"B\": \"Start interferon therapy\", \"C\": \"Switch to natalizumab\", \"D\": \"Initiate corticosteroids\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses management decisions (specifically DMT choice) in MS following breakthrough disease activity.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q152",
    "question_text": "Which of the following has an indication in multiple sclerosis disease progression?",
    "options": "{\"A\": \"Cortical atrophy\", \"B\": \"T2 lesions\", \"C\": \"Gadolinium-enhancing lesions\", \"D\": \"T1 lesions\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests understanding of MRI markers relevant to MS disease progression.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q97",
    "question_text": "In the same scenario of the young female with sudden left-sided weakness, what would you give for her symptoms over the last 5 days?",
    "options": "{\"A\": \"Pulse steroid\", \"B\": \"Aspirin\", \"C\": \"Intravenous immunoglobulin (IVIG)\", \"D\": \"Oral antibiotics\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Although the scenario isn't fully provided, the context likely implies an acute MS relapse, and the question asks about acute treatment (steroids).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q6",
    "question_text": "In which case would steroids have an effect?",
    "options": "{\"A\": \"Brain cancer with vasogenic edema\", \"B\": \"Traumatic brain injury\", \"C\": \"Multiple sclerosis\", \"D\": \"Alzheimer's disease\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of conditions responsive to steroid treatment, specifically including MS (for relapses).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q6",
    "question_text": "In which case would steroids have an effect?",
    "options": "{\"A\": \"Brain cancer with vasogenic edema\", \"B\": \"Traumatic brain injury\", \"C\": \"Multiple sclerosis\", \"D\": \"Alzheimer's disease\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of conditions responsive to steroid treatment, specifically including MS (for relapses).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q124",
    "question_text": "A patient with optic neuritis symptoms and brain MRI showing multiple white matter lesions periventricular, which of the following is true?",
    "options": "{\"A\": \"30% of patients will progress to multiple sclerosis in 15 years, recommend starting DMT\", \"B\": \"30% of patients will progress to multiple sclerosis in 15 years, recommend not to start DMT\", \"C\": \"50% of patients will progress to multiple sclerosis in 15 years, recommend starting DMT\", \"D\": \"50% of patients will progress to multiple sclerosis in 15 years, recommend not to start DMT\"}",
    "correct_answer": "C",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of the risk of conversion from Clinically Isolated Syndrome (CIS) with high-risk features (optic neuritis + MRI lesions) to MS and the indication for DMT.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q248",
    "question_text": "In patients with high-risk clinically isolated syndrome (CIS), which of the following factors is predictive of future rapid disability worsening as measured by EDSS?",
    "options": "{\"A\": \"Younger age\", \"B\": \"Absence of disease-modifying treatment (DMT)\", \"C\": \"Presence of T2 lesions\", \"D\": \"Older age\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on prognostic factors in early MS (high-risk CIS), including the impact of DMT.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q269",
    "question_text": "Which symptom indicates worsening in primary progressive multiple sclerosis (PPMS)?",
    "options": "{\"A\": \"Leg weakness\", \"B\": \"Upper limb weakness\", \"C\": \"Fatigue\", \"D\": \"Visual disturbances\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about typical patterns of disability progression specifically in PPMS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q220",
    "question_text": "Which of the following is considered a red flag in multiple sclerosis (MS)?",
    "options": "{\"A\": \"Bilateral internuclear ophthalmoplegia (INO)\", \"B\": \"Extensive transverse myelitis (TM)\", \"C\": \"Enhancing lesion greater than 3 months\", \"D\": \"Complete gaze palsy\"}",
    "correct_answer": "C",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of clinical or radiological features that are atypical for MS and suggest alternative diagnoses.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q58",
    "question_text": "AQP4-IgG is a specific, pathogenic biomarker of which condition?",
    "options": "{\"A\": \"Multiple Sclerosis\", \"B\": \"Neuromyelitis Optica Spectrum Disorder (NMOSD)\", \"C\": \"Amyotrophic Lateral Sclerosis\", \"D\": \"Guillain-Barr\\u00e9 Syndrome\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a specific autoantibody (AQP4-IgG) diagnostic for NMOSD, a distinct neuroinflammatory condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q385",
    "question_text": "What is the risk of multiple sclerosis (MS) in 15 years if there is a history of optic neuritis and several T2 supratentorial lesions?",
    "options": "{\"A\": \"50% with need to start DMT\", \"B\": \"30% with need to start DMT\", \"C\": \"30% without need to start DMT\", \"D\": \"10% with no MRI lesions\"}",
    "correct_answer": "B",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of MS conversion risk from CIS based on clinical presentation (optic neuritis) and MRI findings, and the indication for DMT.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q177",
    "question_text": "A young male had an isolated single attack of focal neurological deficit and did not start on DMT. What is the percentage chance of having a second attack?",
    "options": "{\"A\": \"5%\", \"B\": \"10%\", \"C\": \"15%\", \"D\": \"20%\"}",
    "correct_answer": "D",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about the natural history/risk of relapse after a first demyelinating event (CIS) without treatment.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q23",
    "question_text": "A male patient with limbic encephalitis (seizures, psychosis) is asked about the most common antibody associated with this condition. Which of the following is the correct answer?",
    "options": "{\"A\": \"Anti-NMDA\", \"B\": \"Anti-glutamate\", \"C\": \"Anti-glycine\", \"D\": \"Anti-VGKC\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the specific autoantibody associated with autoimmune limbic encephalitis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q128",
    "question_text": "A patient diagnosed with Multiple Sclerosis is being evaluated. What would be a favorable factor in her case?",
    "options": "{\"A\": \"Brainstem onset\", \"B\": \"Male gender\", \"C\": \"Young age of onset\", \"D\": \"Relapsing-remitting disease course\"}",
    "correct_answer": "C",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on prognostic factors in MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q144",
    "question_text": "A 19-year-old female presented with a history of seizures. One month before presentation, she had depression, social isolation, personality changes, and hallucinations. She was taken to a psychiatrist and was given antipsychotic medications. The examination was unremarkable except for orofacial dyskinesia. What is the most likely diagnosis?",
    "options": "{\"A\": \"NMDA encephalitis\", \"B\": \"Tardive dyskinesia\", \"C\": \"Schizophrenia\", \"D\": \"Temporal lobe epilepsy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a classic presentation of anti-NMDA receptor encephalitis, requiring recognition of this autoimmune condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q154",
    "question_text": "Which of the following MRI characteristics is the best predictor of future disability in patients with multiple sclerosis?",
    "options": "{\"A\": \"Baseline enhancing lesion number\", \"B\": \"Baseline T2 lesion number\", \"C\": \"Baseline T2 lesion volume\", \"D\": \"Number of new enhancing lesions\"}",
    "correct_answer": "C",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests understanding of MRI features as predictors of long-term disability in MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q306",
    "question_text": "Which of the following treatments causes rebound multiple sclerosis (MS) if stopped?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Alemtuzumab\", \"C\": \"Ocrelizumab\", \"D\": \"Dimethyl fumarate\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge of specific side effects/risks associated with stopping certain MS DMTs, specifically rebound activity.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q373",
    "question_text": "What is the most important risk factor for multiple sclerosis (MS)?",
    "options": "{\"A\": \"Epstein-Barr virus (EBV)\", \"B\": \"Smoking\", \"C\": \"Vitamin D deficiency\", \"D\": \"Family history of MS\"}",
    "correct_answer": "A",
    "source_file": "part 2 2024_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of key environmental risk factors associated with MS development.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q273",
    "question_text": "A patient was treated for multiple sclerosis and presents with myelitis, showing a trident sign and LETM with expansile and avidly enhancing dorsal cord on imaging. What is the likely etiology?",
    "options": "{\"A\": \"Granuloma formation\", \"B\": \"Astrocytopathy\", \"C\": \"Tumor\", \"D\": \"Demyelinating plaque\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on interpreting MRI findings (LETM, specific signs) in the context of myelitis, potentially differentiating MS/NMOSD/MOGAD or other inflammatory/neoplastic causes.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q245",
    "question_text": "What type of cell is primarily involved in MS lesions?",
    "options": "{\"A\": \"T cell\", \"B\": \"B cell\", \"C\": \"Eosinophils\", \"D\": \"Neutrophils\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of the basic pathophysiology and cellular components of MS lesions.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q156",
    "question_text": "A female with pure sensory neuropathy and NCS showing demyelinating neuropathy is likely to have:",
    "options": "{\"A\": \"Anti-MAG (the rest all axonal)\", \"B\": \"Hepatitis C\", \"C\": \"SSa/SSb (Sjogren)\", \"D\": \"Anti-GM1\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on associating a specific clinical (pure sensory) and electrophysiological (demyelinating neuropathy) pattern with a characteristic antibody (Anti-MAG), representing an immune-mediated neuropathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q282",
    "question_text": "Which of the following is a characteristic of primary progressive multiple sclerosis according to McDonald criteria 2017?",
    "options": "{\"A\": \"39-year-old man with progressive symptoms over 2 months with periventricular hyperintense lesion\", \"B\": \"30-year-old man with progressive symptoms over one year\", \"C\": \"40-year-old with progressive ataxia over one year and T2 hyperintensity with no oligoclonal bands (OCB)\", \"D\": \"39-year-old man with progressive symptoms over 12 months, cortical hyperintense lesion, and OCB\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the specific diagnostic criteria (McDonald 2017) for Primary Progressive MS (PPMS).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q121",
    "question_text": "A patient was diagnosed with Multiple Sclerosis for 8 months, based on an initial attack of transverse myelitis causing lower limb symptoms. Now she is pregnant and off disease-modifying therapy (DMT). She presented with lower limb numbness and reported a change in her urine smell and odor. What is the diagnosis?",
    "options": "{\"A\": \"MS pseudorelapse\", \"B\": \"MS relapse\", \"C\": \"MS rebound activity\", \"D\": \"Urinary tract infection-related symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks to differentiate between a true MS relapse and a pseudorelapse (triggered by infection, here suggested by UTI symptoms) in a pregnant MS patient.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q253",
    "question_text": "A female patient with MS on glatiramer acetate wants to take the flu vaccine. What is the best recommendation?",
    "options": "{\"A\": \"She should taper glatiramer acetate before taking the vaccine\", \"B\": \"Influenza has no effect on MS relapse\", \"C\": \"She should receive steroids before taking the flu vaccine\", \"D\": \"It's up to her to take the vaccine or not because there is no evidence\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge regarding vaccinations in MS patients on specific DMTs (glatiramer acetate).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q20",
    "question_text": "A patient with relapsing-remitting multiple sclerosis has had no disease activity for two years. What is the percentage of benign multiple sclerosis?",
    "options": "{\"A\": \"5%\", \"B\": \"10%\", \"C\": \"15%\", \"D\": \"20%\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge about the concept and approximate prevalence of \"benign MS,\" a specific course definition within MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q80",
    "question_text": "Gadolinium contrast enhancement is present in essentially all cases of which condition?",
    "options": "{\"A\": \"Multiple Sclerosis\", \"B\": \"Neuromyelitis Optica Spectrum Disorder (NMOSD)\", \"C\": \"Acute Disseminated Encephalomyelitis\", \"D\": \"Transverse Myelitis\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of typical MRI characteristics (specifically contrast enhancement) differentiating inflammatory CNS conditions, focusing on ADEM.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q101",
    "question_text": "For patients without brain lesions at the onset of optic neuritis, when was the risk of developing MS greatest?",
    "options": "{\"A\": \"First year\", \"B\": \"First 5 years\", \"C\": \"Between 10 and 15 years\", \"D\": \"After 15 years\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Assesses understanding of the temporal risk profile for developing MS after optic neuritis, based on initial MRI findings (prognosis/natural history).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q129",
    "question_text": "Which DMT causes ITP? (attached picture of purpura)",
    "options": "{\"A\": \"Alemtuzumab\", \"B\": \"Fingolimod\", \"C\": \"Natalizumab\", \"D\": \"Ocrelizumab\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of specific adverse effects (Immune Thrombocytopenic Purpura - ITP) associated with MS DMTs (Alemtuzumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q271",
    "question_text": "An MS patient with a history of recurrent relapses has been stable on natalizumab for the past 7 months. However, he has started to show signs of confusion, suggestive of progressive multifocal leukoencephalopathy (PML). What should be done next?",
    "options": "{\"A\": \"Check JCV antibodies\", \"B\": \"Brain MRI with contrast\", \"C\": \"Discontinue natalizumab immediately\", \"D\": \"Perform lumbar puncture for JC virus PCR\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: While PML is an infection, this question focuses on the management steps (diagnostic workup) in an MS patient on a specific DMT (Natalizumab) suspected of having this known complication.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q115",
    "question_text": "A patient presents with autonomic dysfunction and pupillary changes (miosis). What is the antibody associated with this condition?",
    "options": "{\"A\": \"Anti-Ganglionic Acetylcholine antibody\", \"B\": \"Anti-NMDA receptor antibody\", \"C\": \"Anti-Hu antibody\", \"D\": \"Anti-Aquaporin-4 antibody\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the specific antibody associated with autoimmune autonomic ganglionopathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q92",
    "question_text": "A woman who had repeated episodes of vomiting for one month visited the ER and was given omeprazole. She experienced visual changes in both eyes at different times. Now, she presents with symptoms of transverse myelitis (TM). What is the diagnosis?",
    "options": "{\"A\": \"Neuromyelitis Optica (NMO)\", \"B\": \"Multiple Sclerosis (MS)\", \"C\": \"Acute Disseminated Encephalomyelitis (ADEM)\", \"D\": \"Myasthenia Gravis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a clinical scenario highly suggestive of Neuromyelitis Optica Spectrum Disorder (NMOSD), particularly the area postrema syndrome (vomiting) preceding optic neuritis and myelitis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q95",
    "question_text": "In patients with optic neuritis, what was the risk of developing MS when MRI evidence of prior demyelination was present?",
    "options": "{\"A\": \"25%\", \"B\": \"50%\", \"C\": \"72%\", \"D\": \"16%\"}",
    "correct_answer": "C",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the prognostic significance of baseline MRI findings in patients presenting with optic neuritis regarding future MS risk.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q125",
    "question_text": "What DMT has a 30% increased risk of secondary autoimmune disorders?",
    "options": "{\"A\": \"Alemtuzumab\", \"B\": \"Fingolimod\", \"C\": \"Ocrelizumab\", \"D\": \"Natalizumab\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses knowledge of specific risks (secondary autoimmunity) associated with a particular MS DMT (Alemtuzumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q173",
    "question_text": "The periventricular white lesion typical of multiple sclerosis (MS) follows a specific pattern in the distribution of which following structure?",
    "options": "{\"A\": \"Oligodendrocyte cell body\", \"B\": \"Arterioles\", \"C\": \"Venules\", \"D\": \"Capillaries\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the specific pathological distribution of MS lesions related to underlying vascular structures (venules).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q17",
    "question_text": "Which of the following is considered a red flag in multiple sclerosis?",
    "options": "{\"A\": \"Partial myelitis\", \"B\": \"Decreased facial sensation\", \"C\": \"Complete ophthalmoplegia\", \"D\": \"Erectile dysfunction\"}",
    "correct_answer": "C",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests the ability to identify clinical signs (complete ophthalmoplegia) that are atypical for MS and suggest alternative diagnoses.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q143",
    "question_text": "Typical multiple sclerosis (MS) presentation includes one or more episodes of:",
    "options": "{\"A\": \"Unilateral optic neuritis\", \"B\": \"Painless binocular diplopia\", \"C\": \"Focal brainstem or cerebellar syndrome\", \"D\": \"Partial transverse myelitis with sensory and/or motor symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses knowledge of the classic clinical presentations characteristic of MS relapses.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q359",
    "question_text": "A patient with a known case of Multiple Sclerosis (MS) used a medication that causes flushing. What is the mechanism of action of that drug?",
    "options": "{\"A\": \"NRF2\", \"B\": \"Sphingosine-1-phosphate receptor modulation\", \"C\": \"Interleukin-2 receptor blockade\", \"D\": \"Inhibition of dihydroorotate dehydrogenase\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of the mechanism of action (NRF2 pathway activation) of an MS medication known to cause flushing (Dimethyl Fumarate).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q3",
    "question_text": "An MS patient on disease-modifying therapy (DMT) lost follow-up and presented to the ER with low platelets and a skin rash. What medication might they be on?",
    "options": "{\"A\": \"Ofatumumab\", \"B\": \"Alemtuzumab\", \"C\": \"Fingolimod\", \"D\": \"Natalizumab\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of specific adverse effects (thrombocytopenia, rash, likely ITP) associated with certain MS DMTs (Alemtuzumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q11",
    "question_text": "Which of the following statements is true regarding multiple sclerosis?",
    "options": "{\"A\": \"Activation of unmyelinated axons will result in Uhthoff phenomenon\", \"B\": \"It primarily affects the peripheral nervous system\", \"C\": \"It is caused by a viral infection\", \"D\": \"It is characterized by demyelination of motor neurons\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests fundamental knowledge about the characteristics and pathophysiology (Uhthoff phenomenon) of multiple sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q298",
    "question_text": "A patient with multiple sclerosis on fingolimod for a couple of years developed weakness and slurred speech. VZV test was positive, and his JCV before starting treatment was negative. What should be done next?",
    "options": "{\"A\": \"This is a relapse; give methylprednisolone\", \"B\": \"Repeat JCV and perform an urgent MRI of the brain\", \"C\": \"Start intravenous acyclovir immediately\", \"D\": \"Discontinue fingolimod and observe clinically\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Involves differentiating an MS relapse from a treatment complication (like PML) in a patient on DMT, requiring specific diagnostic steps (repeat JCV, MRI).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q279",
    "question_text": "A child with a history of vaccination presents with confusion. What is the likely diagnosis?",
    "options": "{\"A\": \"ADEM\", \"B\": \"Acute hemorrhagic leukoencephalitis\", \"C\": \"Viral encephalitis\", \"D\": \"Post-vaccination encephalopathy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Presents a scenario highly suggestive of Acute Disseminated Encephalomyelitis (ADEM), a post-infectious/post-vaccinal autoimmune demyelinating disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q161",
    "question_text": "Demyelination is commonly linked to which organism?",
    "options": "{\"A\": \"HIV\", \"B\": \"HHV-6\", \"C\": \"EBV\", \"D\": \"CMV\"}",
    "correct_answer": "C",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Explores the known associations between infectious agents (specifically viruses like EBV) and the triggering or occurrence of demyelinating diseases like MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q96",
    "question_text": "A woman who had an episode of nausea and vomiting, along with visual changes in both eyes at different times, now presents with symptoms of transverse myelitis (TM). What is the treatment?",
    "options": "{\"A\": \"Pulse steroid\", \"B\": \"Plasma exchange\", \"C\": \"Intravenous immunoglobulin (IVIG)\", \"D\": \"Oral prednisone\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Describes a clinical picture strongly suggestive of NMOSD (area postrema syndrome, optic neuritis, transverse myelitis) and asks for the standard acute treatment (steroids).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q168",
    "question_text": "A patient with relapsing-remitting multiple sclerosis (RRMS) has been stable on disease-modifying therapy (DMT) but stopped it 2 months ago as she wants to get pregnant. She presents with new MRI findings showing active enhancing brain lesions. What is the mechanism of the DMT that she was taking?",
    "options": "{\"A\": \"Sphingosine 1 phosphate receptor modulator\", \"B\": \"CD52 inhibitor\", \"C\": \"B cell depletor\", \"D\": \"CSF inhibitor\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of the mechanisms of action of different MS disease-modifying therapies in the context of managing treatment cessation and relapse.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q126",
    "question_text": "Young lady, with encephalopathy and hearing impairment, no visual symptoms mentioned, MRI attached showed corpus callosum lesions typical of snowball sign, asking about the pathophysiology of the diagnosis?",
    "options": "{\"A\": \"Microvascular endothelial proliferation damage\", \"B\": \"Demyelination of central nervous system neurons\", \"C\": \"Autoimmune-mediated peripheral nerve destruction\", \"D\": \"Neuronal mitochondrial dysfunction\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes characteristic features (clinical, imaging) of Susac Syndrome and asks about its underlying pathophysiology (microvascular endothelial damage), a neuroinflammatory condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q142",
    "question_text": "A middle-aged female presents with lower limb stiffness mainly affecting hip muscles and has lumbar hyperlordosis. What antibody is likely to be found?",
    "options": "{\"A\": \"Anti-GAD and amphiphysin\", \"B\": \"Anti-NMDA receptor\", \"C\": \"Anti-AQP4\", \"D\": \"Anti-MOG\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes classic symptoms of Stiff Person Syndrome and asks for the associated autoantibodies (Anti-GAD, Amphiphysin), indicating an autoimmune neurological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q122",
    "question_text": "Patient was diagnosed with Multiple sclerosis and has psoriasis. What is an appropriate DMT for her case?",
    "options": "{\"A\": \"Dimethyl fumarate\", \"B\": \"Interferon beta-1a\", \"C\": \"Natalizumab\", \"D\": \"Fingolimod\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on selecting an appropriate MS disease-modifying therapy while considering a relevant autoimmune comorbidity (psoriasis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q172",
    "question_text": "A patient with intractable vomiting and nausea was admitted under GI and investigated with no identifiable cause. An MRI was done. Which of the following is a core feature for the suspected diagnosis?",
    "options": "{\"A\": \"Optic neuritis\", \"B\": \"Cerebellitis\", \"C\": \"Transverse myelitis\", \"D\": \"Peripheral neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Describes Area Postrema Syndrome, a core clinical feature supporting a diagnosis of NMOSD, and asks to identify another core feature (Optic Neuritis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q147",
    "question_text": "A female with a history of Type 1 diabetes mellitus presented with symptoms of axial and peripheral muscle stiffness. What antibodies are usually found in this condition?",
    "options": "{\"A\": \"Anti-GAD\", \"B\": \"Anti-MAG\", \"C\": \"Anti-AChR\", \"D\": \"Anti-Hu\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes a patient with T1DM and stiffness likely representing Stiff Person Syndrome or a related condition, asking for the commonly associated autoantibody (Anti-GAD).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q138",
    "question_text": "Young lady presented with acute decrease in vision bilaterally, MRI brain done showed hyperintensity in optic nerve, rest of MRI was normal, what is the management? (case of optic neuritis)",
    "options": "{\"A\": \"IV methylprednisolone\", \"B\": \"Oral prednisone\", \"C\": \"Plasma exchange\", \"D\": \"Observation and follow-up\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Focuses on the acute management (IV steroids) of bilateral optic neuritis, a common presentation of neuroinflammatory conditions.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q364",
    "question_text": "A scenario presents a case of limbic encephalitis. What is the most likely diagnosis?",
    "options": "{\"A\": \"Anti-NMDA receptor encephalitis\", \"B\": \"Hashimoto's encephalopathy\", \"C\": \"Viral encephalitis\", \"D\": \"Neurosarcoidosis\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Similar to Q183, asks to identify likely diagnoses within the spectrum of limbic encephalitis, focusing on specific autoimmune/inflammatory causes (Anti-NMDA, Hashimoto's, Neurosarcoidosis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q266",
    "question_text": "A lady diagnosed with RRMS is about to start DMT. What will you give her?",
    "options": "{\"A\": \"Ocrelizumab\", \"B\": \"Dimethyl fumarate\", \"C\": \"Glatiramer acetate\", \"D\": \"Interferon\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Concerns the selection of an initial disease-modifying therapy for Relapsing-Remitting Multiple Sclerosis (RRMS).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q361",
    "question_text": "A female patient with a known case of multiple sclerosis (MS) came with increased sensory symptoms and mentioned a change in her urine smell. What is the diagnosis?",
    "options": "{\"A\": \"Pseudorelapse\", \"B\": \"True MS relapse\", \"C\": \"Urinary tract infection\", \"D\": \"Neuropathic bladder dysfunction\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests the clinical concept of distinguishing a true MS relapse from a pseudorelapse triggered by an intercurrent illness (like a UTI, suggested by urine smell change).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q16",
    "question_text": "An elderly patient presents with areflexia (tendon reflex not obtained), ophthalmoplegia, and impaired finger-to-nose test for the past 2 days, with no history of infection or vaccination. What is the next step in management?",
    "options": "{\"A\": \"IVIG\", \"B\": \"Methylprednisolone\", \"C\": \"Acetylcholine\", \"D\": \"Plasmapheresis\"}",
    "correct_answer": "A",
    "source_file": "Sleep_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Describes the classic triad of Miller Fisher Syndrome (ataxia, areflexia, ophthalmoplegia), a variant of Guillain-Barr\u00e9 Syndrome (GBS), and asks for the appropriate acute treatment (IVIG), which falls under neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q23",
    "question_text": "A patient with relapsing-remitting multiple sclerosis (RRMS) and psoriasis started on disease-modifying therapy (DMT) and showed improvement in his psoriasis. What is the DMT?",
    "options": "{\"A\": \"Dimethyl fumarate\", \"B\": \"Natalizumab\", \"C\": \"Interferon beta\", \"D\": \"Glatiramer acetate\"}",
    "correct_answer": "A",
    "source_file": "Critical_Care_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests knowledge of a specific MS DMT (Dimethyl fumarate) and its known effect on comorbid psoriasis, linking treatment choice to side effect/benefit profiles within neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q27",
    "question_text": "A patient on Natalizumab develops progressive multifocal leukoencephalopathy (PML). What is the appropriate management?",
    "options": "{\"A\": \"Stop Natalizumab\", \"B\": \"Increase Natalizumab dose\", \"C\": \"Start corticosteroids immediately\", \"D\": \"Continue Natalizumab and monitor closely\"}",
    "correct_answer": "A",
    "source_file": "Sleep_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Focuses on managing a major complication (PML) directly related to a specific immunomodulatory therapy (Natalizumab) used in neuroimmunological disorders like MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q28",
    "question_text": "A young man diagnosed with left eye optic neuritis was planned to start Teriflunomide. He has no previous history of neurological symptoms and is not interested in starting the treatment. Which of the following statements is true regarding the suspected differential diagnosis?",
    "options": "{\"A\": \"Bilateral onset should suspect a diagnosis other than multiple sclerosis\", \"B\": \"Incomplete visual recovery should suspect a diagnosis other than multiple sclerosis\", \"C\": \"Pain on eye movement is uncommon in multiple sclerosis-related optic neuritis\", \"D\": \"Optic disc swelling is always present in multiple sclerosis-related optic neuritis\"}",
    "correct_answer": "A",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Addresses the differential diagnosis of optic neuritis, specifically clinical features that help distinguish MS-related ON from other causes (like NMO or MOGAD), which is central to neuroimmunological diagnosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q29",
    "question_text": "A patient with multiple sclerosis (MS) on disease-modifying therapy (DMT) developed hyperthyroidism. What is the most likely medication used?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Teriflunomide\", \"C\": \"Alemtuzumab\", \"D\": \"Dimethyl fumarate\"}",
    "correct_answer": "C",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests knowledge of specific adverse effects (secondary autoimmunity like thyroid disease) associated with a particular MS DMT (Alemtuzumab), relevant to managing neuroimmunological therapies.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q38",
    "question_text": "A patient with a known case of Multiple Sclerosis used a medication that causes flushing. What is the mechanism of action of that drug?",
    "options": "{\"A\": \"NRF2\", \"B\": \"Sphingosine-1-phosphate receptor modulation\", \"C\": \"Interleukin-2 receptor blockade\", \"D\": \"Inhibition of dihydroorotate dehydrogenase\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Links a common side effect (flushing) to a specific MS medication (dimethyl fumarate) and asks for its mechanism of action (NRF2 pathway), pertaining to the pharmacology of neuroimmunological treatments.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q41",
    "question_text": "A patient with multiple sclerosis developed tonic spasms. Which medication is most appropriate for treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Baclofen\", \"C\": \"Gabapentin\", \"D\": \"Clonazepam\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Concerns the symptomatic treatment (using carbamazepine) of tonic spasms, a characteristic paroxysmal symptom occurring in the context of MS, a core neuroimmunological disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q43",
    "question_text": "A 35-year-old female patient, medically free, came with heat intolerance, lower limb weakness, and sensory symptoms, along with urinary incontinence. Her symptoms increased after stress at work. What will you do next?",
    "options": "{\"A\": \"Methylprednisolone\", \"B\": \"Brain MRI\", \"C\": \"Nerve conduction studies\", \"D\": \"Thyroid function tests\"}",
    "correct_answer": "B",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Describes a clinical presentation highly suggestive of a first demyelinating event (potentially MS) and asks about the next diagnostic/management step (MRI or steroids), central to neuroimmunology clinical practice.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q58",
    "question_text": "A female patient with a known case of multiple sclerosis (MS) came with increased sensory symptoms and mentioned a change in her urine smell. What is the diagnosis?",
    "options": "{\"A\": \"Pseudorelapse\", \"B\": \"True MS relapse\", \"C\": \"Urinary tract infection without relapse\", \"D\": \"Neuropathic bladder dysfunction\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Focuses on differentiating a true MS relapse from a pseudorelapse triggered by an underlying issue (like a UTI, suggested by urine smell change), a common clinical challenge in managing MS patients.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q60",
    "question_text": "A patient came with bilateral optic neuritis; MRI showed high signal intensity in the bilateral optic nerves. What is the diagnosis?",
    "options": "{\"A\": \"Anti-MOG\", \"B\": \"Multiple sclerosis\", \"C\": \"Neuromyelitis optica spectrum disorder\", \"D\": \"Ischemic optic neuropathy\"}",
    "correct_answer": "A",
    "source_file": "Sleep_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests the ability to recognize a clinical presentation (bilateral optic neuritis) highly suggestive of a specific neuroimmunological condition (Anti-MOG associated disease).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q64",
    "question_text": "What is the odds ratio for infectious mononucleosis as a risk factor for multiple sclerosis?",
    "options": "{\"A\": \"1.3\", \"B\": \"2.0\", \"C\": \"2.1\", \"D\": \"2.5\"}",
    "correct_answer": "D",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Assesses knowledge of key epidemiological risk factors (specifically EBV/infectious mononucleosis) associated with the development of Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q67",
    "question_text": "A young lady known to have MS is pregnant and asks about the percentage risk of her baby having MS. What is the estimated risk?",
    "options": "{\"A\": \"2 - 4%\", \"B\": \"15 - 20%\", \"C\": \"30 - 40%\", \"D\": \"As general population\"}",
    "correct_answer": "A",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Addresses the genetic/familial risk component of Multiple Sclerosis, relevant to patient counseling in neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q69",
    "question_text": "A patient with optic neuritis and one periventricular lesion is evaluated. What do the McDonald criteria indicate?",
    "options": "{\"A\": \"Fulfilling both space and time\", \"B\": \"Fulfilling only space but not time\", \"C\": \"Not fulfilling both space and time\", \"D\": \"Fulfilling only time but not space\"}",
    "correct_answer": "B",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests the application of the McDonald criteria for diagnosing Multiple Sclerosis based on clinical and radiological findings, a core skill in neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q70",
    "question_text": "In neuromyelitis optica (NMO), which statement is correct?",
    "options": "{\"A\": \"It is 10 times more common in males than females\", \"B\": \"It is monophasic with no relapses\", \"C\": \"NMO lesions show immunoglobulin and complement deposits in a characteristic vasculo-concentric rim and rosette pattern around hyalinized blood vessels\", \"D\": \"It primarily affects the peripheral nervous system\"}",
    "correct_answer": "C",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Assesses knowledge of the specific features (epidemiology, clinical course, pathology) of Neuromyelitis Optica (NMO), a distinct neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q71",
    "question_text": "A case scenario about temporal arteritis presents the following: Age more than 50, presenting with headache and visual changes. If no ESR is done, what should be done next?",
    "options": "{\"A\": \"Perform ESR\", \"B\": \"Start prednisolone 60-80 mg/day\", \"C\": \"Start prednisolone 40-60 mg/day\", \"D\": \"Arrange temporal artery biopsy\"}",
    "correct_answer": "B",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Focuses on the urgent management (initiating high-dose steroids) of suspected Giant Cell Arteritis (Temporal Arteritis), an autoimmune vasculitis, to prevent complications like vision loss.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q76",
    "question_text": "What is the estimated risk of progressive multifocal leukoencephalopathy (PML) with rituximab?",
    "options": "{\"A\": \"1 in 10,000\", \"B\": \"1 in 30,000\", \"C\": \"1 in 50,000\", \"D\": \"1 in 100,000\"}",
    "correct_answer": "A",
    "source_file": "Neuroanatomy",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Queries the risk of a specific complication (PML) associated with an immunomodulatory therapy (rituximab) used in various neuroimmunological conditions.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q81",
    "question_text": "A young female has a history of left-sided weakness that lasted for 10 days and then improved. She now presents with fatigue. What is the most appropriate step of management for her current complaint?",
    "options": "{\"A\": \"Level a regular exercise and conservative measures\", \"B\": \"Non-pharmacological management\", \"C\": \"Amantadine\", \"D\": \"Pulse steroid course\"}",
    "correct_answer": "A",
    "source_file": "Critical_Care_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Focuses on managing a common symptom (fatigue) in a patient with a history suggestive of MS, considering both pharmacological (Amantadine) and non-pharmacological approaches used in neuroimmunology practice.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q83",
    "question_text": "A patient known to have multiple sclerosis (MS) on natalizumab develops an infusion reaction. What is the most appropriate action?",
    "options": "{\"A\": \"Continue natalizumab infusion and monitor the patient\", \"B\": \"Stop natalizumab infusion and treat the reaction\", \"C\": \"Administer premedication and restart the infusion\", \"D\": \"Refer the patient for desensitization procedure\"}",
    "correct_answer": "B",
    "source_file": "Critical_Care_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Addresses the acute management of an adverse event (infusion reaction) related to a specific MS disease-modifying therapy (natalizumab).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q84",
    "question_text": "A patient diagnosed with multiple sclerosis (MS) is on treatment but shows no improvement, continuing to have recurrent attacks and an increase in disability. A detailed history reveals a recurrent history of dry eyes. What will you do?",
    "options": "{\"A\": \"Perform Schirmer's test\", \"B\": \"Increase MS medication dosage\", \"C\": \"Refer to a psychiatrist\", \"D\": \"Schedule a follow-up in 6 months\"}",
    "correct_answer": "A",
    "source_file": "Critical_Care_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Involves considering and investigating potential alternative or comorbid autoimmune diagnoses (like Sjogren's syndrome, suggested by dry eyes and tested by Schirmer's test) when a presumed MS patient responds poorly to therapy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q85",
    "question_text": "Which of the following indicates disease progression in Multiple Sclerosis (MS)?",
    "options": "{\"A\": \"Cerebral atrophy\", \"B\": \"Disability progression/number of relapses\", \"C\": \"New T2 lesions\", \"D\": \"All of the above\"}",
    "correct_answer": "D",
    "source_file": "Critical_Care_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Asks about the clinical and radiological markers used to monitor disease activity and progression specifically in Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q111",
    "question_text": "A patient with multiple sclerosis developed a tremor. What is the most appropriate treatment?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Gabapentin\", \"C\": \"Levodopa\", \"D\": \"Clonazepam\"}",
    "correct_answer": "A",
    "source_file": "Critical_Care_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Focuses on the symptomatic treatment (using agents like propranolol or clonazepam) of tremor occurring as a consequence of Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q130",
    "question_text": "Which of the following antibodies is associated with myoclonus dystonia?",
    "options": "{\"A\": \"Anti-GD1\", \"B\": \"Anti-GB1\", \"C\": \"Anti-GM1\", \"D\": \"Anti-GAD65\"}",
    "correct_answer": "B",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests knowledge of antibody associations with specific neurological syndromes. While classic myoclonus-dystonia is often genetic, antibodies like Anti-GABA-B (GB1) can be linked to autoimmune encephalitis presenting with myoclonus or seizures, placing this in the neuroimmunology domain.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q141",
    "question_text": "MS pathophysiology is most commonly associated with which of the following?",
    "options": "{\"A\": \"EBV\", \"B\": \"Vitamin B12\", \"C\": \"HHV-6\", \"D\": \"Herpes Simplex Virus\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Directly asks about key factors implicated in the pathophysiology of Multiple Sclerosis (e.g., Epstein-Barr Virus - EBV).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q142",
    "question_text": "Which risk factor has an odds ratio of 0.5 and is considered unknown in its association with multiple sclerosis?",
    "options": "{\"A\": \"Oral tobacco\", \"B\": \"Coffee\", \"C\": \"Alcohol\", \"D\": \"Passive smoking\"}",
    "correct_answer": "C",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Discusses epidemiological factors and their associated risk (interpreting odds ratios) for developing Multiple Sclerosis, specifically factors with potential protective effects (like alcohol in some studies).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q166",
    "question_text": "An MS patient developed a tremor. What is the recommended treatment?",
    "options": "{\"A\": \"Propranolol\", \"B\": \"Levodopa\", \"C\": \"Carbamazepine\", \"D\": \"Baclofen\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Addresses the symptomatic management of tremor specifically occurring as a complication of Multiple Sclerosis, falling under neuroimmunological care.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q176",
    "question_text": "A young female presented with unilateral optic neuritis features. She has positive oligoclonal bands (OCB) and brain MRI shows one enhancing lesion. According to the 2017 McDonald\u2019s criteria, what is her diagnosis?",
    "options": "{\"A\": \"She has DIS but not DIT\", \"B\": \"She has DIS and DIT\", \"C\": \"She has DIT but not DIS\", \"D\": \"She has RRMS\"}",
    "correct_answer": "B",
    "source_file": "Neuromuscular",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Requires application of the McDonald criteria to diagnose Multiple Sclerosis based on clinical presentation, MRI findings (Dissemination in Space - DIS), and CSF results (supporting Dissemination in Time - DIT in this context), core to neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q186",
    "question_text": "A young patient with multiple new acute strokes on MRI has a history of sensorineural hearing loss. What condition is suspected?",
    "options": "{\"A\": \"Susac syndrome\", \"B\": \"Antiphospholipid syndrome\", \"C\": \"MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes)\", \"D\": \"Cogan syndrome\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests recognition of Susac syndrome, a rare immune-mediated microangiopathy presenting with encephalopathy (including stroke-like lesions), retinal artery occlusions, and hearing loss. Its underlying mechanism is autoimmune.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q204",
    "question_text": "A 34-year-old male presents with myoclonus and abnormal eye movements. What is the most likely underlying condition?",
    "options": "{\"A\": \"Autoimmune encephalitis\", \"B\": \"Wilson's disease\", \"C\": \"Metabolic disorder\", \"D\": \"Toxic exposure\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: The combination of myoclonus and abnormal eye movements (like opsoclonus) strongly suggests an autoimmune etiology, such as paraneoplastic opsoclonus-myoclonus syndrome or autoimmune encephalitis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q208",
    "question_text": "In a case of testicular cancer, which antibody is most likely to be present?",
    "options": "{\"A\": \"Anti-MA\", \"B\": \"Anti-GAD\", \"C\": \"Anti-NMDA\", \"D\": \"Anti-CRMP\"}",
    "correct_answer": "A",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Tests knowledge of paraneoplastic antibodies associated with specific cancers; Anti-Ma antibodies (specifically Ma2/Ta) are linked to testicular cancer and specific paraneoplastic neurological syndromes (brainstem/limbic encephalitis), falling under neuroimmunology/neuro-oncology interface, best classified here due to antibody focus.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q210",
    "question_text": "A patient with optic neuritis and one periventricular lesion. What is her McDonald criteria?",
    "options": "{\"A\": \"Fulfilling both space and time\", \"B\": \"Fulfilling only space but not time\", \"C\": \"Not fulfilling both space and time\", \"D\": \"Fulfilling only time but not space\"}",
    "correct_answer": "B",
    "source_file": "Movement_Disorders",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Requires applying the McDonald diagnostic criteria for Multiple Sclerosis based on limited clinical and MRI data.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q274",
    "question_text": "A female patient came with relapsing-remitting multiple sclerosis (RRMS) and an attached MRI of the brain and spine. What is the mechanism of the disease?",
    "options": "{\"A\": \"T Cell\", \"B\": \"B Cell\", \"C\": \"Unknown\", \"D\": \"Autoimmune\"}",
    "correct_answer": "A",
    "source_file": "Neuromuscular",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Asks about the fundamental immunopathophysiology (role of T cells and B cells) underlying Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q275",
    "question_text": "A patient diagnosed with multiple sclerosis (MS) continues to experience relapses despite starting disease-modifying therapy (DMT). The spinal cord MRI shows a \"trident sign.\" What is the most likely diagnosis?",
    "options": "{\"A\": \"Sarcoidosis\", \"B\": \"Neuromyelitis optica (NMO)\", \"C\": \"Lymphoma\", \"D\": \"Multiple sclerosis (MS)\"}",
    "correct_answer": "A",
    "source_file": "Neuromuscular",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Focuses on interpreting an MRI finding (\"trident sign,\" often associated with spinal cord infarct but here considered in the differential of inflammatory myelopathies) to distinguish between MS and its mimics (NMO, sarcoidosis) in a non-responding patient.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q319",
    "question_text": "A patient with a long history of multiple sclerosis presents with fatigue. What medication would you consider as a first-line treatment?",
    "options": "{\"A\": \"Amantadine\", \"B\": \"Sildenafil\", \"C\": \"Modafinil\", \"D\": \"Baclofen\"}",
    "correct_answer": "A",
    "source_file": "Neuromuscular",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Concerns the symptomatic management of fatigue, a common and disabling symptom in Multiple Sclerosis, using appropriate first-line agents like Amantadine or Modafinil.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q451",
    "question_text": "A patient receiving their third infusion of Natalizumab develops an allergy with shortness of breath. What should be done?",
    "options": "{\"A\": \"Stop infusion and treat anaphylaxis\", \"B\": \"Desensitization\", \"C\": \"Make the next dose 150 mg\", \"D\": \"Administer antihistamines and continue infusion cautiously\"}",
    "correct_answer": "A",
    "source_file": "Neuromuscular",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Deals with the management of an acute hypersensitivity/anaphylactic reaction to Natalizumab, an immunomodulatory therapy used for MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q3",
    "question_text": "A lady known to have multiple sclerosis (MS) presents with a history of leg numbness for one year. She is currently on teriflunomide but shows no improvement. What is the next appropriate step in her management?",
    "options": "{\"A\": \"Repeat workup of MS\", \"B\": \"Initiate corticosteroids\", \"C\": \"Refer for physical therapy\", \"D\": \"Change to a different disease-modifying therapy\"}",
    "correct_answer": "D",
    "source_file": "Sleep_Neurology",
    "exam_type": null,
    "exam_year": null,
    "explanation": "Classification Reason: Addresses treatment strategy in MS, specifically considering a change in disease-modifying therapy due to lack of efficacy/disease progression despite current treatment.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q118",
    "question_text": "Which factor is associated with a worse prognosis in multiple sclerosis (MS)?",
    "options": "{\"A\": \"Male sex\", \"B\": \"Female sex\", \"C\": \"Age at onset\", \"D\": \"Initial symptoms\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on prognostic factors specifically related to Multiple Sclerosis (MS), a primary neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q220",
    "question_text": "Patient came with focal seizure with secondary generalization; he has focal atrophy in the brain; what is the antibody associated with this disease?",
    "options": "{\"A\": \"GluR3\", \"B\": \"NMDA receptor\", \"C\": \"LGI1\", \"D\": \"CASPR2\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Links seizures and focal atrophy to a specific antibody (GluR3, associated with Rasmussen's encephalitis), pointing to an autoimmune/neuroimmunological etiology, which is the core concept being tested.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q115",
    "question_text": "In a paraneoplastic case, what should be done next?",
    "options": "{\"A\": \"Treat underlying etiology\", \"B\": \"Initiate immunotherapy\", \"C\": \"Perform symptomatic management\", \"D\": \"Monitor neurological status closely\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Directly addresses the management principle of paraneoplastic neurological syndromes, which are immune-mediated conditions.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q103",
    "question_text": "A patient with relapsing-remitting multiple sclerosis (RRMS) received 5 days of intravenous methylprednisolone (IVMP) without improvement. What should be done next?",
    "options": "{\"A\": \"PLEX\", \"B\": \"IVIG\", \"C\": \"More steroids\", \"D\": \"Symptomatic treatment\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the management of acute MS relapses refractory to first-line steroid treatment, involving second-line immunomodulatory therapies like PLEX.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q279",
    "question_text": "An MS patient developed tonic spasms. What is the appropriate treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Baclofen\", \"C\": \"Gabapentin\", \"D\": \"Diazepam\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on managing a specific paroxysmal symptom (tonic spasms) commonly occurring in the context of Multiple Sclerosis (MS). While treated with an AED, the primary disease context is immunological.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q104",
    "question_text": "A patient with multiple sclerosis experiences painful muscle spasms multiple times per day. Which medication is commonly used for this condition?",
    "options": "{\"A\": \"Carbamazepine (CBZ)\", \"B\": \"Baclofen\", \"C\": \"Gabapentin\", \"D\": \"Tizanidine\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the symptomatic treatment of spasticity, a common issue in Multiple Sclerosis (MS), an autoimmune disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q69",
    "question_text": "Which of the following indicates disease progression in multiple sclerosis (MS)?",
    "options": "{\"A\": \"Brain atrophy\", \"B\": \"T2 lesions\", \"C\": \"Lesion enhancement\", \"D\": \"New clinical relapses\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of biomarkers and imaging findings used to monitor disease activity and progression in Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q193",
    "question_text": "A patient presented with focal seizures that progressed to complex partial seizures and multiple episodes of status epilepticus with hemiparesis. MRI showed hemispheric perisylvian atrophy. What will you send for?",
    "options": "{\"A\": \"Glur3 antibody\", \"B\": \"Anti-NMDA receptor antibody\", \"C\": \"Voltage-gated potassium channel antibody\", \"D\": \"Anti-GAD antibody\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes a clinical scenario highly suggestive of Rasmussen's encephalitis, an autoimmune disorder causing refractory seizures and progressive hemispheric atrophy, prompting specific antibody testing. The core concept is identifying the underlying autoimmune cause.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q79",
    "question_text": "Patient came with focal seizure with secondary generalization; he has focal atrophy in the brain. What is the antibody associated with this disease?",
    "options": "{\"A\": \"GluR3\", \"B\": \"NMDA receptor\", \"C\": \"LGI1\", \"D\": \"GAD65\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Similar to Q193/Q220, the combination of refractory focal seizures and focal atrophy points towards an autoimmune etiology like Rasmussen's encephalitis, associated with GluR3 antibodies. The question tests knowledge of this specific neuroimmunological condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q124",
    "question_text": "In a scenario involving diabetes mellitus with stiff person syndrome, what is the most likely antibody present?",
    "options": "{\"A\": \"Anti-GAD\", \"B\": \"Anti-NMDA receptor\", \"C\": \"Anti-Aquaporin-4\", \"D\": \"Anti-MOG\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the specific autoantibody (Anti-GAD65) associated with Stiff Person Syndrome, an autoimmune neurological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q87",
    "question_text": "Which condition is based on astrocyte pathology?",
    "options": "{\"A\": \"NMOSD\", \"B\": \"Anti-MOG\", \"C\": \"Multiple sclerosis\", \"D\": \"Acute disseminated encephalomyelitis\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the primary cell type targeted by the autoimmune process in specific neuroinflammatory disorders, identifying Neuromyelitis Optica Spectrum Disorder (NMOSD) as an astrocytopathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q88",
    "question_text": "What is known about the pathology of multiple sclerosis (MS)?",
    "options": "{\"A\": \"Diffuse white matter disease and focal grey matter involvement\", \"B\": \"Grey matter disease may be related to a progressive course\", \"C\": \"Both A and B\", \"D\": \"None of the above\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the key neuropathological characteristics of multiple sclerosis (MS).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q49",
    "question_text": "A patient presents with onset of right optic neuritis. MRI of the brain shows a brain stem lesion that is possibly enhancing and periventricular non-enhancing. What can be said about dissemination in time and space?",
    "options": "{\"A\": \"No dissemination in time or space\", \"B\": \"Dissemination in both time and space\", \"C\": \"Only dissemination in space\", \"D\": \"Only dissemination in time\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the application of Multiple Sclerosis (MS) diagnostic criteria (specifically McDonald criteria), a core concept in diagnosing this neuroimmunological condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q129",
    "question_text": "A patient has worsening neurological symptoms for 3 years with positive oligoclonal bands (OCB). What is the treatment for primary progressive multiple sclerosis (PPMS)?",
    "options": "{\"A\": \"Cladribine\", \"B\": \"Ocrelizumab\", \"C\": \"Interferon beta-1a\", \"D\": \"Natalizumab\"}",
    "correct_answer": "B",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about approved disease-modifying therapy options specifically for the Primary Progressive form of Multiple Sclerosis (PPMS).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q247",
    "question_text": "A 24-year-old female patient presents with fever and symptoms of meningitis, along with psychiatric manifestations. Her HSV PCR is positive, and MRI shows temporal lobe petechial hemorrhage with encephalomalacia. After treatment, she improves but then has a seizure. What is the cause of the seizure?",
    "options": "{\"A\": \"Expected sequelae of HSV\", \"B\": \"Anti-NMDA receptor encephalitis\", \"C\": \"Recurrent HSV\", \"D\": \"Post-infectious gliosis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Addresses the differential diagnosis of neurological deterioration following treated HSV encephalitis, highlighting the possibility of a secondary post-infectious autoimmune encephalitis (like Anti-NMDA receptor encephalitis), a neuroimmunological condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q117",
    "question_text": "A patient with RRMS on Natalizumab presents with worsening lower limb weakness and blurred vision over 2 months. What is the next step in management?",
    "options": "{\"A\": \"Stop Natalizumab\", \"B\": \"Start a new disease-modifying therapy (DMT)\", \"C\": \"Perform MRI brain and spinal cord with contrast\", \"D\": \"Initiate high-dose corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses the critical management decision in an RRMS patient on Natalizumab experiencing worsening, balancing MS treatment against potential immunologically relevant complications like PML versus MS relapse/progression.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q405",
    "question_text": "What is the next step to confirm small vessel CNS vasculitis?",
    "options": "{\"A\": \"Brain Biopsy\", \"B\": \"Conventional Angiography\", \"C\": \"MRA\", \"D\": \"Intracranial Doppler\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the diagnostic confirmation of CNS vasculitis, an inflammatory condition of CNS blood vessels.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q82",
    "question_text": "In a long scenario for a patient with neuropathy and asthma, what is the next step in management?",
    "options": "{\"A\": \"ANCA testing for Churg-Strauss syndrome\", \"B\": \"Nerve conduction studies\", \"C\": \"High-dose corticosteroids\", \"D\": \"Chest X-ray\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Relates peripheral neuropathy symptoms (in the context of likely eosinophilia/asthma described) to a systemic autoimmune vasculitis (EGPA/Churg-Strauss), requiring specific immunological testing (ANCA).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q205",
    "question_text": "In the scenario of Susac syndrome, which of the following findings can be seen on MRI?",
    "options": "{\"A\": \"High signals in the corpus callosum\", \"B\": \"Atrophy of the cerebellum\", \"C\": \"Lesions in the brainstem\", \"D\": \"No significant findings\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about characteristic MRI findings in Susac syndrome, a suspected autoimmune microangiopathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q541",
    "question_text": "What is the first-line treatment for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?",
    "options": "{\"A\": \"IV Immunoglobulin (IVIG)\", \"B\": \"Plasmapheresis\", \"C\": \"Corticosteroids\", \"D\": \"Antidepressants\"}",
    "correct_answer": "A",
    "source_file": "part 2 2021 (2",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks for the standard first-line immunomodulatory treatments for CIDP, an immune-mediated peripheral neuropathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q440",
    "question_text": "A patient has stiffness and neuromyotonia on EMG, recurrent loss of consciousness, but is currently stable. He has positive potassium antibodies. What is the diagnosis?",
    "options": "{\"A\": \"Isaac's syndrome\", \"B\": \"Morvan's syndrome\", \"C\": \"Lambert-Eaton myasthenic syndrome\", \"D\": \"Stiff-person syndrome\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Concerns the diagnosis of Isaac's/Morvan's syndrome, autoimmune disorders associated with voltage-gated potassium channel antibodies causing neurological symptoms.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q13",
    "question_text": "In the same case of Mononeuritis Multiplex with weight loss and fever, what is the most appropriate treatment?",
    "options": "{\"A\": \"Cyclophosphamide\", \"B\": \"Azathioprine\", \"C\": \"Cyclosporine\", \"D\": \"Methotrexate\"}",
    "correct_answer": "A",
    "source_file": "Part 2 - 2023_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks for the appropriate immunosuppressive treatment for Mononeuritis Multiplex, which is often caused by systemic vasculitis (an immune-mediated process).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q8",
    "question_text": "A patient with MS on medication presents with blurry vision and macular edema. What medication is likely responsible?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Interferon beta\", \"C\": \"Glatiramer acetate\", \"D\": \"Natalizumab\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Relates a specific side effect (macular edema) to a medication (Fingolimod) used for treating Multiple Sclerosis, focusing on the management/complications of treating this neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q358",
    "question_text": "A lady with sleep disturbances and increased sleep has an MRI showing diencephalic hyperintensity. What will you do?",
    "options": "{\"A\": \"MRI of the spine\", \"B\": \"AQP4 antibody test\", \"C\": \"Lumbar puncture\", \"D\": \"Sleep study\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Links clinical symptoms (hypersomnia) and specific MRI findings (diencephalic hyperintensity) to potential autoimmune conditions like NMOSD or autoimmune encephalitis affecting the hypothalamus, prompting specific immunological antibody testing (AQP4).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q122",
    "question_text": "A patient with symptoms suggestive of chronic inflammatory demyelinating polyneuropathy (CIDP) was not responding to intravenous immunoglobulin (IVIG) and was found to have positive neurofascin 155 antibodies. What is the pathophysiology of these antibodies?",
    "options": "{\"A\": \"Paranodal dissection\", \"B\": \"Onion bulb\", \"C\": \"Complement mediated\", \"D\": \"Macrophage mediated\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: Delves into the specific immunopathophysiology associated with anti-Neurofascin 155 antibodies, a specific subtype of the immune-mediated neuropathy CIDP.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q336",
    "question_text": "A female with a history of systemic lupus erythematosus (SLE) presents with a scenario suggestive of cavernous sinus syndrome, no fever, and a brain CT that is unremarkable. What is the next step in management?",
    "options": "{\"A\": \"Brain MRI/MRV\", \"B\": \"Sinus and orbital CT\", \"C\": \"Lumbar puncture (LP)\", \"D\": \"Initiate high-dose corticosteroids\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Involves diagnosing the cause (potentially immune-mediated inflammation or thrombosis secondary to SLE) of a neurological syndrome in a patient with a systemic autoimmune disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q197",
    "question_text": "A young patient in his 30s presented to the emergency room with limb weakness that started one week ago. He has a history of pharyngitis 6 weeks ago and was treated with antibiotics. After that, he started to complain of difficulty swallowing and change in voice. Then he developed weakness involving all four limbs. On physical examination, he has bilateral flaccid weakness with absent reflexes. Which of the following is the pathophysiology responsible for the patient\u2019s diagnosis (likely Guillain-Barr\u00e9 Syndrome)?",
    "options": "{\"A\": \"Peripheral demyelination.\", \"B\": \"Inhibition of acetylcholine release from the presynaptic neuromuscular junction.\", \"C\": \"Inhibition of acetylcholine function on the postsynaptic neuromuscular junction.\", \"D\": \"Axonal degeneration of motor neurons.\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about the underlying immunopathophysiology (most commonly peripheral demyelination via molecular mimicry) of Guillain-Barr\u00e9 Syndrome, a primary neuroimmunological disorder of the peripheral nervous system.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q204",
    "question_text": "In patients treated with natalizumab, which of the following is considered a risk factor for developing PML?",
    "options": "{\"A\": \"Low index of JC virus in serum\", \"B\": \"High index of JC virus in serum\", \"C\": \"Previous history of migraines\", \"D\": \"Age over 60 years\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses risk stratification (JC virus antibody index) for Progressive Multifocal Leukoencephalopathy (PML), a critical consideration directly related to the immunomodulatory effects of natalizumab treatment for MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q84",
    "question_text": "An MS patient presents with tonic spasms. What is the treatment?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Clonazepam\", \"C\": \"Baclofen\", \"D\": \"Gabapentin\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the symptomatic treatment of a specific paroxysmal symptom (tonic spasms) in Multiple Sclerosis, an immunological disease. Similar to",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q279",
    "question_text": "Which of the following cranial nerves is primarily responsible for controlling the muscles of mastication?",
    "options": "{\"A\": \"Facial nerve (VII)\", \"B\": \"Trigeminal nerve (V)\", \"C\": \"Glossopharyngeal nerve (IX)\", \"D\": \"Hypoglossal nerve (XII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q378",
    "question_text": "A patient with a history of MS relapse 3 weeks ago while on interferon presents with worsening weakness for 2 days. What should be the next step in management?",
    "options": "{\"A\": \"Urinalysis (Rule out UTI as trigger)\", \"B\": \"MRI with contrast (Assess for new relapse)\", \"C\": \"Change interferon to another disease-modifying therapy (DMT)\", \"D\": \"High-dose corticosteroids (Treat presumed relapse)\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Involves the diagnostic workup (distinguishing pseudo-relapse from true relapse) in a patient with Multiple Sclerosis experiencing new symptoms, a common clinical challenge in managing this neuroimmunological condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q338",
    "question_text": "A patient with multiple sclerosis (MS) is experiencing fatigue but has stable disease and no mood symptoms. What is the most appropriate treatment?",
    "options": "{\"A\": \"Amantadine\", \"B\": \"Modafinil\", \"C\": \"SSRI\", \"D\": \"Physical therapy\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the symptomatic management of fatigue, a common and often debilitating symptom directly related to the underlying neuroimmunological disease process in Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q295",
    "question_text": "A female patient had optic neuritis with one non-enhancing periventricular lesion. According to McDonald's criteria and with Oligoclonal Bands negative, what is the diagnosis?",
    "options": "{\"A\": \"Dissemination in Space but not Time\", \"B\": \"Dissemination in Time but no Space\", \"C\": \"Dissemination in Space and Time\", \"D\": \"Meets neither\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests the application of diagnostic criteria (McDonald criteria for MS) based on clinical presentation and imaging, fundamental to the diagnosis of MS. Similar to",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q49",
    "question_text": "Which of the following cranial nerves is primarily responsible for the sense of smell?",
    "options": "{\"A\": \"Optic nerve (CN II)\", \"B\": \"Olfactory nerve (CN I)\", \"C\": \"Trigeminal nerve (CN V)\", \"D\": \"Facial nerve (CN VII)\"}",
    "correct_answer": "B",
    "source_file": "",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q357",
    "question_text": "A female patient with a known case of multiple sclerosis (MS) shows MRI findings consistent with neuromyelitis optica (NMO). What is the underlying pathophysiology?",
    "options": "{\"A\": \"Demyelination (Astrocytopathy in NMO)\", \"B\": \"Axonal degeneration\", \"C\": \"Vascular occlusion\", \"D\": \"Neuroinflammation\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Asks about the underlying pathology of NMO (typically astrocytopathy targeting aquaporin-4), differentiating it from MS within the spectrum of neuroinflammatory/neuroimmunological disorders.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q415",
    "question_text": "A female patient with optic neuritis and multiple MRI lesions but no activity, who also has psoriasis, what is the appropriate DMT for her?",
    "options": "{\"A\": \"Teriflunomide\", \"B\": \"Dimethyl fumarate\", \"C\": \"Glatiramer acetate\", \"D\": \"Interferon beta\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on selecting an appropriate disease-modifying therapy (DMT) for Multiple Sclerosis (MS), considering the clinical presentation and a relevant comorbidity (psoriasis) that impacts immunological treatment choice.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q318",
    "question_text": "A long scenario describes a lady who came with optic neuritis and had papilledema. What will you send for her?",
    "options": "{\"A\": \"Anti-MOG\", \"B\": \"MRI of the brain\", \"C\": \"Corticosteroids\", \"D\": \"Lumbar puncture\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on diagnosing the cause of optic neuritis, specifically prompting consideration and testing for MOG antibody disease (MOGAD), an autoimmune condition distinct from MS but within the neuroimmunology spectrum.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q395",
    "question_text": "Which disease-modifying therapy (DMT) requires pre-antiviral agent prophylaxis?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Alemtuzumab\", \"C\": \"Natalizumab\", \"D\": \"Teriflunomide\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Tests knowledge of specific safety protocols (VZV prophylaxis) required before starting certain potent immunosuppressive MS therapies (Alemtuzumab), directly related to the immunological mechanism and risks of the treatment.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q514",
    "question_text": "In a case of primary progressive multiple sclerosis with typical MRI features and normal cerebrospinal fluid, what is known to increase walking speed?",
    "options": "{\"A\": \"4-pyridine derivative (Dalfampridine/4-aminopyridine)\", \"B\": \"Ocrelizumab\", \"C\": \"Baclofen\", \"D\": \"Physical therapy\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Asks about treatments for multiple sclerosis (specifically PPMS), including symptomatic treatment (Dalfampridine/4-AP) for walking speed impairment caused by the underlying neuroimmunological disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q318",
    "question_text": "A patient with optic neuritis has an MRI of the spine that shows long-sequence enhancement and is OGB negative. What is the next step in management?",
    "options": "{\"A\": \"Send for aquaporin-4 antibodies (NMO)\", \"B\": \"Start high-dose steroids\", \"C\": \"Refer for plasma exchange\", \"D\": \"Schedule a follow-up MRI\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the diagnostic workup (specifically testing for NMOSD via AQP4 antibodies) in a patient presenting with symptoms suggestive of a central nervous system demyelinating disorder distinct from typical MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q83",
    "question_text": "Which of the following is a classic presentation of Heerfordt syndrome?",
    "options": "{\"A\": \"Uveoparotid fever\", \"B\": \"Erythema nodosum\", \"C\": \"Hilar adenopathy\", \"D\": \"Polyarthralgia\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of a specific clinical presentation (uveoparotid fever) characteristic of Heerfordt syndrome, a manifestation of neurosarcoidosis, which is an inflammatory condition affecting the nervous system.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q320",
    "question_text": "A young male patient with a known case of relapsing-remitting multiple sclerosis (RRMS) on natalizumab developed lower limb weakness and generalized numbness. Laboratory tests show positive anti-natalizumab antibodies, and MRI shows enhanced lesions. What is the recommended treatment?",
    "options": "{\"A\": \"Plasma exchange\", \"B\": \"IVIG\", \"C\": \"Prednisolone\", \"D\": \"Intravenous steroids\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with the management of a multiple sclerosis relapse, potentially related to treatment failure (development of anti-natalizumab antibodies), requiring consideration of acute relapse treatments.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q97",
    "question_text": "A patient diagnosed with opsoclonus-myoclonus-ataxia syndrome. Which of the following antibodies is most likely to be identified in laboratory workup?",
    "options": "{\"A\": \"Anti-Ri\", \"B\": \"Anti-Hu\", \"C\": \"Anti-Yo\", \"D\": \"Anti-Ma2\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests knowledge of the specific paraneoplastic antibody (Anti-Ri) most commonly associated with Opsoclonus-Myoclonus-Ataxia syndrome, a neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q67",
    "question_text": "A 16-year-old patient presents with confusion, and MRI shows bilateral white matter changes. What is the most likely diagnosis?",
    "options": "{\"A\": \"Acute Disseminated Encephalomyelitis (ADEM)\", \"B\": \"Primary CNS Angiitis\", \"C\": \"Multiple Sclerosis\", \"D\": \"Viral Encephalitis\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the differential diagnosis of acute neurological symptoms with white matter lesions in a young patient, where key considerations are inflammatory/demyelinating conditions like ADEM and MS.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q106",
    "question_text": "What is the best way to prevent progressive multifocal leukoencephalopathy (PML) in patients with MS who will be started on Natalizumab?",
    "options": "{\"A\": \"Annual MRI\", \"B\": \"Pretreatment JC virus titer levels screen\", \"C\": \"Regular liver function tests\", \"D\": \"Use of corticosteroids prior to Natalizumab initiation\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Addresses a critical risk mitigation strategy (JC virus antibody screening) directly related to the use of a specific immunotherapy (Natalizumab) for Multiple Sclerosis to prevent a serious opportunistic infection (PML).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q105",
    "question_text": "A 30-year-old lady presented to the ER with worsening weakness in all four extremities and sensory symptoms. She was diagnosed with multiple sclerosis three months ago after an episode of optic neuritis and was started on Natalizumab due to highly active disease. Which of the following laboratory investigations should be sent based on the suspected differential diagnosis (NMOSD)?",
    "options": "{\"A\": \"JC virus from CSF\", \"B\": \"Serum ACE\", \"C\": \"Serum AQP-4\", \"D\": \"Oligoclonal bands\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on the diagnostic process of differentiating between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder (NMOSD) using specific antibody testing (AQP-4), particularly relevant in a patient with severe symptoms or atypical features.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q81",
    "question_text": "A female patient, known to have relapsing-remitting multiple sclerosis and maintained on disease-modifying therapy (DMT), presented with new limb weakness and numbness. The diagnosis of multiple sclerosis was established. She started on high-dose IV Methylprednisolone but showed no improvement. Which of the following is the next step in management?",
    "options": "{\"A\": \"IV immunoglobulin\", \"B\": \"Plasma exchange\", \"C\": \"ACTH gel\", \"D\": \"Oral steroid\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the management algorithm for acute MS relapses, specifically addressing second-line treatment options (like plasma exchange or IVIG) when initial high-dose steroid therapy fails.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q83",
    "question_text": "A young female patient presents with right leg weakness and incontinence. An MRI report shows two periventricular lesions, and T1 with contrast shows one lesion enhancing. A whole spine MRI shows T2 multiple small lesions. What is the diagnosis?",
    "options": "{\"A\": \"Multiple sclerosis\", \"B\": \"Clinically isolated syndrome (CIS)\", \"C\": \"Radiologically isolated syndrome (RIS)\", \"D\": \"Neuromyelitis optica spectrum disorder (NMOSD)\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Tests the ability to apply the McDonald diagnostic criteria for Multiple Sclerosis, interpreting clinical presentation and MRI findings (demonstrating dissemination in space and time) to reach a specific diagnosis (MS vs. CIS vs. RIS).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q48",
    "question_text": "Which of the following is considered a red flag in multiple sclerosis?",
    "options": "{\"A\": \"Extensive spinal lesion\", \"B\": \"Bilateral Internuclear Ophthalmoplegia (INO)\", \"C\": \"Enhancing lesion present for more than 3 months\", \"D\": \"Severe optic neuritis with poor recovery\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Assesses knowledge of clinical or radiological features (\"red flags\") that are atypical for standard Multiple Sclerosis and may prompt consideration of alternative diagnoses or indicate a more severe disease course.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q125",
    "question_text": "In a patient with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), what is a common finding in the cerebrospinal fluid (CSF)?",
    "options": "{\"A\": \"Normal protein levels\", \"B\": \"Elevated protein levels\", \"C\": \"Presence of oligoclonal bands\", \"D\": \"Increased white blood cell count with neutrophilic predominance\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks about a characteristic laboratory finding (albuminocytologic dissociation, i.e., elevated protein without significant pleocytosis) in CSF analysis for CIDP, an immune-mediated peripheral neuropathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q82",
    "question_text": "A 30-year-old male, known case of type 1 diabetes mellitus, presented 3 months ago with optic neuritis and was started on one of the DMTs as a case of multiple sclerosis. He now presents with a 3-day history of blurred vision. Examination and brain MRI are stable compared with previous documentation. Which DMT is likely responsible for this presentation?",
    "options": "{\"A\": \"Fingolimod\", \"B\": \"Teriflunomide\", \"C\": \"Interferon\", \"D\": \"Natalizumab\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on identifying a specific side effect (macular edema leading to blurred vision) associated with a particular disease-modifying therapy (Fingolimod) used in Multiple Sclerosis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q58",
    "question_text": "Which of the following disease-modifying therapies (DMT) is known to cause paresthesia?",
    "options": "{\"A\": \"Teriflunomide\", \"B\": \"Fingolimod\", \"C\": \"Natalizumab\", \"D\": \"Interferon beta\"}",
    "correct_answer": "A",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Tests knowledge of common side effects associated with specific disease-modifying therapies used for Multiple Sclerosis, linking paresthesia to Teriflunomide.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q84",
    "question_text": "A young female with a previous history of two optic neuritis attacks presents with new symptoms of spinal cord lesions. MRI shows extensive hyperintense T2 lesions from C8-T1, and Aquaporin 4 is negative. What is the most likely diagnosis?",
    "options": "{\"A\": \"Relapsing remitting multiple sclerosis\", \"B\": \"Neuromyelitis optica spectrum disorder\", \"C\": \"Acute disseminated encephalomyelitis\", \"D\": \"Myelin oligodendrocyte glycoprotein antibody-associated disease\"}",
    "correct_answer": "B",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Concerns the differential diagnosis between MS, NMOSD (including AQP4-negative variants like MOGAD, although not explicitly mentioned as an option), and ADEM, based on clinical history (recurrent ON, myelitis) and specific MRI features (longitudinally extensive transverse myelitis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q107",
    "question_text": "A young female patient presents with right leg weakness and incontinence. An MRI report shows two periventricular lesions, and T1 with contrast shows one lesion enhancing. A whole spine MRI shows T2 multiple small lesions. What is the next step in management?",
    "options": "{\"A\": \"Start treatment\", \"B\": \"Repeat MRI in 6 months\", \"C\": \"Perform lumbar puncture for oligoclonal bands\", \"D\": \"Symptomatic management only\"}",
    "correct_answer": "A",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on translating the fulfillment of MS diagnostic criteria (Dissemination in Space and Time, as implied by the scenario matching Q83 Part I 2023) into an immediate management decision, which is typically to initiate treatment.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q88",
    "question_text": "A young female presented with a typical history of optic neuritis. Brain and spine MRI were normal. What is the risk of conversion to multiple sclerosis (MS)?",
    "options": "{\"A\": \"16% risk of conversion to MS\", \"B\": \"25% risk of conversion to MS\", \"C\": \"51% risk of conversion to MS\", \"D\": \"10% risk of conversion to MS\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the prognosis and risk stratification (MS conversion risk) following a clinically isolated syndrome (optic neuritis), a core concept in neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q99",
    "question_text": "What are the characteristic findings in the cerebrospinal fluid (CSF) of a patient with Acute Inflammatory Demyelinating Polyneuropathy (AIDP)?",
    "options": "{\"A\": \"Elevated protein with normal cell count\", \"B\": \"Elevated white blood cell count with lymphocytic predominance\", \"C\": \"Normal protein and elevated cell count\", \"D\": \"Presence of oligoclonal bands\"}",
    "correct_answer": "A",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the classic CSF finding (albuminocytologic dissociation) in AIDP (Guillain-Barr\u00e9 Syndrome), a key neuroimmunological condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q57",
    "question_text": "A patient presents with a triad of areflexia, ophthalmoplegia, and ataxia (Miller Fisher syndrome). What is the recommended treatment?",
    "options": "{\"A\": \"Intravenous immunoglobulin (IVIG)\", \"B\": \"Plasmapheresis (Plex)\", \"C\": \"Corticosteroids\", \"D\": \"Supportive care only\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2021_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2021,
    "explanation": "Classification Reason: Describes Miller Fisher syndrome, a variant of Guillain-Barr\u00e9 syndrome (an autoimmune neuropathy), and asks for its standard immunomodulatory treatments (IVIG/PLEX).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q14",
    "question_text": "In the management of a patient diagnosed with PML, what is the most appropriate step?",
    "options": "{\"A\": \"Start antiviral therapy\", \"B\": \"Stop natalizumab\", \"C\": \"Initiate corticosteroids\", \"D\": \"Refer for neurosurgery\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Addresses the management of Progressive Multifocal Leukoencephalopathy (PML), often occurring as a complication of immunomodulatory therapy (like natalizumab for MS). The crucial step involves altering the immune status (stopping the offending agent).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q13",
    "question_text": "In the same scenario [Implicitly related to an MS/NMO context], what is the most likely diagnosis for her condition?",
    "options": "{\"A\": \"Relapsing remitting multiple sclerosis\", \"B\": \"Primary progressive multiple sclerosis\", \"C\": \"Transverse myelitis\", \"D\": \"Neuromyelitis optica\"}",
    "correct_answer": "D",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the diagnosis of a demyelinating disease (MS or NMO), which falls under the category of neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q43",
    "question_text": "What is the diagnosis for a patient presenting with symptoms consistent with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?",
    "options": "{\"A\": \"AIDP\", \"B\": \"CIDP\", \"C\": \"MMN\", \"D\": \"ALS\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the diagnosis of CIDP, an autoimmune peripheral nerve disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q68",
    "question_text": "A female patient with a long history of multiple sclerosis (MS) on fingolimod presents with spasticity and gait issues, and her MRI shows no active disease. What should be done next for her gait?",
    "options": "{\"A\": \"Start natalizumab\", \"B\": \"Start glatiramer acetate\", \"C\": \"Steroid\", \"D\": \"4-aminopyridine\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Deals with the symptomatic management (gait difficulty using 4-aminopyridine) in a patient with Multiple Sclerosis, a primary neuroimmunological condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q15",
    "question_text": "In a scenario of neuromyelitis optica (NMO) with bilateral optic neuritis and transverse myelitis extending over more than 3 segments, which of the following is most useful for diagnosis?",
    "options": "{\"A\": \"MRI of the brain\", \"B\": \"Serum aquaporin-4 antibody testing\", \"C\": \"Lumbar puncture\", \"D\": \"Visual evoked potentials\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Asks for the key diagnostic test (AQP4 antibody) for Neuromyelitis Optica (NMO), a specific neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q208",
    "question_text": "Trigeminal neuralgia in young age, diagnosis is best made by:",
    "options": "{\"A\": \"MRI\", \"B\": \"CT\", \"C\": \"Clinical Diagnosis\", \"D\": \"LP\"}",
    "correct_answer": "A",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: While TN diagnosis is clinical, the emphasis on *young age* strongly implies the need for MRI to rule out secondary causes, particularly demyelinating disease (like MS), making Neuroimmunology a relevant classification due to this differential.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q312",
    "question_text": "A female patient with jaw claudication and temporal headache, who also has joint pain and diffuse muscle ache, what is the next step?",
    "options": "{\"A\": \"ESR\", \"B\": \"Temporal artery biopsy\", \"C\": \"MRI of the brain\", \"D\": \"Start corticosteroids immediately\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Describes classic symptoms of Giant Cell Arteritis (GCA), an inflammatory vasculitis. Asking for the initial diagnostic test (ESR) places this within the realm of Neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q89",
    "question_text": "Which of the following adverse effects is most commonly associated with the first infusion of a B-cell lysis agent?",
    "options": "{\"A\": \"Anaphylaxis\", \"B\": \"Flushing and throat irritation\", \"C\": \"Upper respiratory infections\", \"D\": \"Hypogammaglobulinemia\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of common side effects (specifically infusion reactions) associated with B-cell depleting therapies used in neuroimmunological disorders like MS or NMOSD.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q34",
    "question_text": "A 55-year-old patient came with left lower limb paresthesia and heaviness that is getting worse, reaching to the upper limb, and intermittent abdominal pain, hyperhidrosis; he received a vaccine 2 weeks ago. What is the diagnosis?",
    "options": "{\"A\": \"Acute Inflammatory Demyelinating Polyneuropathy (AIDP)\", \"B\": \"Acute Intermittent Porphyria (AIP)\", \"C\": \"Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)\", \"D\": \"Multiple Sclerosis (MS)\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: The description of ascending sensory changes and weakness following a vaccine strongly suggests Acute Inflammatory Demyelinating Polyneuropathy (AIDP), a subtype of Guillain-Barr\u00e9 Syndrome (GBS), which is an autoimmune condition. Autonomic features and pain are also common in GBS. AIP is less likely given the temporal association with vaccination and pattern.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q16",
    "question_text": "An elderly patient presents with areflexia (tendon reflex not obtained), ophthalmoplegia, and impaired finger-to-nose test for the past 2 days, with no history of infection or vaccination. What is the likely antibody involved?",
    "options": "{\"A\": \"Anti-GQ1b\", \"B\": \"Anti-GM1\", \"C\": \"Anti-AQP4\", \"D\": \"Anti-MAG\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes the classic triad (ophthalmoplegia, ataxia, areflexia) of Miller Fisher Syndrome, an autoimmune GBS variant, and asks for its characteristic antibody (Anti-GQ1b).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q33",
    "question_text": "An 18-year-old boy presents with vertigo and an exaggerated dermatological reaction during IV insertion. MRI findings are pending. Which condition is most likely associated with these symptoms?",
    "options": "{\"A\": \"Beh\\u00e7et's disease\", \"B\": \"Sj\\u00f6gren's syndrome\", \"C\": \"Susac's syndrome\", \"D\": \"Multiple sclerosis\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Describes symptoms (vertigo, pathergy) suggestive of Beh\u00e7et's disease, a systemic autoimmune vasculitis with neurological manifestations.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q50",
    "question_text": "A lady presents with personality changes and hearing loss. MRI findings are pending. Which condition is most likely associated with these symptoms?",
    "options": "{\"A\": \"Susac's syndrome\", \"B\": \"Multiple sclerosis (MS)\", \"C\": \"Neuromyelitis optica (NMO)\", \"D\": \"Lyme disease\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Presents symptoms (encephalopathy/personality change, hearing loss) characteristic of the triad of Susac's syndrome, an autoimmune microangiopathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q21",
    "question_text": "Which statement is true regarding multiple sclerosis (MS)?",
    "options": "{\"A\": \"Simultaneous bilateral optic neuritis would suggest looking for other diagnoses.\", \"B\": \"Incomplete recovery is typical with MS.\", \"C\": \"MS lesions are typically found only in the spinal cord.\", \"D\": \"MS always presents with a progressive course from onset.\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Tests knowledge of the clinical characteristics and differential diagnosis of Multiple Sclerosis, a primary autoimmune demyelinating disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q38",
    "question_text": "A patient with multiple sclerosis presents with the left eye showing no abduction or adduction, while the right eye has abduction only. What is the likely diagnosis?",
    "options": "{\"A\": \"Bilateral internuclear ophthalmoplegia (BINO)\", \"B\": \"Internuclear ophthalmoplegia (INO)\", \"C\": \"One-and-a-half syndrome\", \"D\": \"Convergence palsy\"}",
    "correct_answer": "C",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Although describing specific eye movement abnormalities (Neuroophthalmology), the context is Multiple Sclerosis, and the question tests recognition of a syndrome commonly caused by MS lesions.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q46",
    "question_text": "A patient with MS on fingolimod has an image showing new activity. What is the next step in management?",
    "options": "{\"A\": \"Natalizumab\", \"B\": \"Glatiramer Acetate\", \"C\": \"Interferon beta\", \"D\": \"Dimethyl fumarate\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Concerns treatment escalation strategy in Multiple Sclerosis, a primary neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q3",
    "question_text": "A 54-year-old male presents with neck pain and tingling sensations in both hands. He has a history of small joint pain and swelling. What is the most likely diagnosis based on the MRI findings?",
    "options": "{\"A\": \"Disc Compression\", \"B\": \"Rheumatoid Pannus\", \"C\": \"Spondylosis\", \"D\": \"Cervical Radiculopathy\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Links neurological symptoms (radiculopathy/myelopathy) to a systemic inflammatory condition (Rheumatoid Arthritis implied by history and pannus option), placing it under Neuroimmunology.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q29",
    "question_text": "In multiple sclerosis (MS), what is the pattern of distribution of lesions?",
    "options": "{\"A\": \"Oligodendrocytes cell body\", \"B\": \"Venules\", \"C\": \"Arterioles\", \"D\": \"Capillaries\"}",
    "correct_answer": "B",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Asks about the specific pathological distribution of lesions in Multiple Sclerosis, relating to its immunopathogenesis (perivenular inflammation).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q103",
    "question_text": "A young patient was found to be unresponsive in bed and sleepy but arousable. Upon examination in the emergency room, no focal neurologic deficits were found. An MRI of the brain showed bilateral hyperintensity of the thalamus and the area around the foramen and right insular. What is the most appropriate next step?",
    "options": "{\"A\": \"Lumbar puncture\", \"B\": \"AQP Antibodies\", \"C\": \"Anti-MAG antibodies\", \"D\": \"Toxicology screen\"}",
    "correct_answer": "A",
    "source_file": "Part 2 Adult Neurology residency 2024 V9_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2024,
    "explanation": "Classification Reason: The MRI findings (bilateral thalamic, periaqueductal) and presentation could suggest autoimmune encephalitis or ADEM/NMOSD spectrum disorders, making antibody testing (like AQP4) relevant alongside CSF analysis.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q196",
    "question_text": "A 15-year-old girl presents to the emergency room with confusion and seizure. Her parents note that she has been more forgetful and irritable, and her behavior has become bizarre. On the morning of presentation, she had a generalized tonic-clonic seizure. IV acyclovir and phenytoin were started. MRI of the brain and EEG are normal. After three days, her clinical status does not improve. CSF PCR is negative for HSV, VZV, EBV. Which of the following autoantibodies is most likely to be responsible for her presentation?",
    "options": "{\"A\": \"Hu antibody\", \"B\": \"NMDA receptor antibody\", \"C\": \"Voltage gated potassium channel antibody\", \"D\": \"GABA-B receptor antibody\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: The core concept is identifying the specific autoantibody associated with a clinical presentation highly suggestive of autoimmune encephalitis (anti-NMDA receptor encephalitis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q188",
    "question_text": "What is the mechanism of action of Ocrelizumab?",
    "options": "{\"A\": \"CD20 (Same as Rituximab)\", \"B\": \"Sphingosine-1-phosphate receptor modulator\", \"C\": \"CD52\", \"D\": \"Interleukin-2 receptor antagonist\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of the mechanism of action of a specific immunomodulatory drug (Ocrelizumab) primarily used in Neuroimmunology (Multiple Sclerosis).",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q187",
    "question_text": "What is the odds ratio for smoking as a risk factor for multiple sclerosis?",
    "options": "{\"A\": \"1.3\", \"B\": \"1.6\", \"C\": \"2.0\", \"D\": \"3.6\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of epidemiological risk factors (smoking) specifically for multiple sclerosis, a primary neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q268",
    "question_text": "A patient with systemic lupus erythematosus (SLE) complicated by nephritis presents with acute behavioral changes and seizures. Cerebrospinal fluid (CSF) analysis shows lymphocytosis and positive oligoclonal bands (OCB). Which of the following conditions is most likely?",
    "options": "{\"A\": \"Herpes simplex virus (HSV) encephalitis\", \"B\": \"SLE cerebritis\", \"C\": \"Posterior reversible encephalopathy syndrome (PRES)\", \"D\": \"Cerebral venous thrombosis (CVT)\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Focuses on diagnosing neurological complications of SLE (SLE cerebritis), differentiating it from mimics based on clinical and CSF findings in a patient with a known autoimmune disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q3",
    "question_text": "A patient with multiple sclerosis presents with optic neuritis (ON). The MRI shows one periventricular lesion. What is the most likely diagnosis?",
    "options": "{\"A\": \"Clinically Isolated Syndrome (CIS)\", \"B\": \"Relapsing-Remitting Multiple Sclerosis (RRMS)\", \"C\": \"Secondary Progressive Multiple Sclerosis\", \"D\": \"Primary Progressive Multiple Sclerosis\"}",
    "correct_answer": "A",
    "source_file": "PART I - 2024 - KSMC Revision_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2024,
    "explanation": "Classification Reason: Assesses understanding of multiple sclerosis diagnostic criteria and classification based on clinical presentation (ON) and MRI findings.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q206",
    "question_text": "Which of the following is a probable risk factor for multiple sclerosis with an odds ratio of 1.4?",
    "options": "{\"A\": \"Low sunlight exposure\", \"B\": \"Shift work\", \"C\": \"Vitamin D deficiency\", \"D\": \"Infectious mononucleosis\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Tests knowledge of epidemiological risk factors associated with the development of Multiple Sclerosis, a primary neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q66",
    "question_text": "A young lady with systemic lupus erythematosus (SLE) complained of seizures and confusion. She has SLE nephritis and is on dialysis. What is your diagnosis?",
    "options": "{\"A\": \"Lupus cerebritis\", \"B\": \"Posterior Reversible Encephalopathy Syndrome (PRES)\", \"C\": \"Cerebral Venous Thrombosis (CVT)\", \"D\": \"Herpes Simplex Virus (HSV) encephalitis\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Requires differential diagnosis of neurological symptoms (seizures, confusion) in a patient with active SLE and renal failure/dialysis. While PRES and CVT are vascular, the core task is distinguishing between various SLE-related CNS complications (including inflammatory cerebritis) and other possibilities, making Neuroimmunology the best fit.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q265",
    "question_text": "What is the best way to diagnose small vessel vasculitis?",
    "options": "{\"A\": \"Respond to corticosteroids\", \"B\": \"Brain biopsy\", \"C\": \"Digital subtraction angiography (DSA)\", \"D\": \"Magnetic resonance imaging (MRI)\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Addresses the definitive diagnostic approach for CNS small vessel vasculitis, emphasizing the role of brain biopsy to confirm inflammation, distinguishing it from other vasculopathies. The focus is on diagnosing the inflammatory condition itself.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q301",
    "question_text": "An 18-year-old woman is referred to your office after branch retinal artery occlusion occurred in each eye several months apart. Her examination reveals moderate hearing loss in the right ear in addition to visual field cuts in each eye. A brain MRI reveals multiple small cortical strokes in the frontal lobes and left parietal lobe. What is the diagnosis?",
    "options": "{\"A\": \"Multiple sclerosis\", \"B\": \"ADEM\", \"C\": \"Susac syndrome\", \"D\": \"Conversion reaction\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2018_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2018,
    "explanation": "Classification Reason: Describes the characteristic clinical triad (encephalopathy/strokes, branch retinal artery occlusions, hearing loss) of Susac syndrome, a rare condition thought to be an immune-mediated endotheliopathy affecting microvessels.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q327",
    "question_text": "Young lady with SLE who has a neurological deficit. What is your diagnosis?",
    "options": "{\"A\": \"Intracerebral hemorrhage\", \"B\": \"Cerebral venous thrombosis\", \"C\": \"PRES\", \"D\": \"Lupus Cerebritis\"}",
    "correct_answer": "D",
    "source_file": "Promotion 2022_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2022,
    "explanation": "Classification Reason: Requires differentiating various potential neurological complications (including vascular ones like ICH, CVT, PRES, and primary inflammatory cerebritis) that can occur in the context of Systemic Lupus Erythematosus (SLE). The overarching theme is neurological manifestations of a systemic autoimmune disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q30",
    "question_text": "Which of the following is a feature of optic neuritis due to multiple sclerosis?",
    "options": "{\"A\": \"Papillitis with papilledema\", \"B\": \"Bilateral optic neuritis\", \"C\": \"Pain with eye movement\", \"D\": \"Sudden painless vision loss\"}",
    "correct_answer": "C",
    "source_file": "Part I 2019_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2019,
    "explanation": "Classification Reason: Asks about a characteristic clinical feature (pain with eye movement) specifically associated with optic neuritis as a manifestation of Multiple Sclerosis (MS), an autoimmune demyelinating disease.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q1",
    "question_text": "Which of the following infections can cause internuclear ophthalmoplegia (INO)?",
    "options": "{\"A\": \"Multiple Sclerosis\", \"B\": \"HIV\", \"C\": \"Cysticercosis\", \"D\": \"Lyme Disease\"}",
    "correct_answer": "B",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Although asking about causes of INO (a neuro-ophth sign), listing Multiple Sclerosis as a primary option shifts the focus to identifying potential etiologies, including this key neuroimmunological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q179",
    "question_text": "Which of the following is the most common presentation of Giant Cell Arteritis (GCA)?",
    "options": "{\"A\": \"Anterior ischemic optic neuropathy (AION)\", \"B\": \"Headache\", \"C\": \"Polymyalgia rheumatica\", \"D\": \"Jaw claudication\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Focuses on the typical clinical presentation of Giant Cell Arteritis (GCA), a systemic vasculitis, rather than the neuro-ophthalmic complication (AION) itself.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q70",
    "question_text": "A case scenario of a patient over 60 years old with a 1-month history of blurry vision and headache. What is the next step in management?",
    "options": "{\"A\": \"Erythrocyte Sedimentation Rate (ESR)\", \"B\": \"Brain MRI\", \"C\": \"Lumbar Puncture\", \"D\": \"Ophthalmology Referral\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: The clinical scenario (age > 60, new headache, visual symptoms) is highly suggestive of Giant Cell Arteritis (GCA). Asking for ESR points towards the diagnostic workup of this specific systemic inflammatory condition.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q404",
    "question_text": "A 78-year-old female presents with bilateral headaches and facial pain when eating, accompanied by decreased vision in one eye. What is the most likely cause of her visual loss?",
    "options": "{\"A\": \"Ischemic optic neuropathy due to short ciliary artery involvement\", \"B\": \"Retinal artery occlusion\", \"C\": \"Central retinal artery occlusion\", \"D\": \"Giant cell arteritis (GCA)\"}",
    "correct_answer": "A",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: The constellation of symptoms (headache, jaw claudication, age, vision loss) strongly points to Giant Cell Arteritis (GCA) as the underlying systemic inflammatory disease causing the optic neuropathy.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q31",
    "question_text": "Which one of the following is a feature of optic neuritis due to multiple sclerosis?",
    "options": "{\"A\": \"Papillitis with papilledema\", \"B\": \"Bilateral optic neuritis\", \"C\": \"Pain with eye movements\", \"D\": \"Sudden painless vision loss\"}",
    "correct_answer": "C",
    "source_file": "Part I 2023_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2023,
    "explanation": "Classification Reason: Duplicate of",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q30",
    "question_text": "A key feature associated with optic neuritis in the context of Multiple Sclerosis (MS) is:",
    "options": "{\"A\": \"Pain with eye movement\", \"B\": \"Sudden painless vision loss\", \"C\": \"Bilateral optic disc swelling\", \"D\": \"Night blindness Classification reason: Pain with eye movement is a classic symptom of optic neuritis, which is commonly associated with MS.\"}",
    "correct_answer": "A",
    "source_file": "Neuropsychiatry",
    "exam_type": null,
    "exam_year": null,
    "explanation": "",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q338",
    "question_text": "A young female patient was admitted to the psychiatric ward with non-specific abnormal movements, agitation, and other psychiatric issues. An MRI showed a normal temporal lobe. What is the most likely diagnosis?",
    "options": "{\"A\": \"Paraneoplastic encephalitis\", \"B\": \"Psychogenic movement disorder\", \"C\": \"Wilson's disease\", \"D\": \"Huntington's disease\"}",
    "correct_answer": "A",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Presents a scenario where prominent psychiatric symptoms might mask an underlying autoimmune/paraneoplastic encephalitis, making this a key differential diagnosis in the Neuroimmunology field, despite the initial psychiatric presentation.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q69",
    "question_text": "A young lady presents with persistent nausea and vomiting. Brain MRI is unremarkable. Based on the suspected diagnosis, which criteria is core?",
    "options": "{\"A\": \"Optic neuritis\", \"B\": \"Cerebellitis\", \"C\": \"Diencephalitis\", \"D\": \"Narcolepsy\"}",
    "correct_answer": "A",
    "source_file": "Part I 2022_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2022,
    "explanation": "Classification Reason: Persistent nausea/vomiting with normal MRI suggests Area Postrema Syndrome, often seen in Neuromyelitis Optica Spectrum Disorder (NMOSD). The question asks for another core criterion for NMOSD diagnosis, with Optic Neuritis being a key one. The underlying concept relates to diagnosing an autoimmune neurological disorder.",
    "subspecialty": "Neuroimmunology"
  },
  {
    "question_number": "Q45",
    "question_text": "Typical JME on topiramate and well controlled; he wants to stop the medication. What is the recommendation?",
    "options": "{\"A\": \"Lifelong treatment\", \"B\": \"Gradual tapering off after 2 years seizure-free\", \"C\": \"Immediate discontinuation of medication\", \"D\": \"Switch to another antiepileptic drug before stopping\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Focuses on the long-term management strategy (medication duration) for a specific epilepsy syndrome (Juvenile Myoclonic Epilepsy - JME).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q63",
    "question_text": "Patient with MTS seizure on Topamax 200mg BID and carbamazepine 400mg BID; his seizures are still not controlled. What will you do?",
    "options": "{\"A\": \"Increase Carbamazepine dose\", \"B\": \"Refer to surgery\", \"C\": \"Add a benzodiazepine\", \"D\": \"Switch Topamax to levetiracetam\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Deals with refractory epilepsy (specifically Mesial Temporal Sclerosis related) and the decision between adjusting medication and considering epilepsy surgery.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q37",
    "question_text": "What is the 2-year recurrence rate of seizures after the first seizure attack?",
    "options": "{\"A\": \"30%\", \"B\": \"10%\", \"C\": \"50%\", \"D\": \"70%\"}",
    "correct_answer": "A",
    "source_file": "Part 1 2021_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2021,
    "explanation": "Classification Reason: Asks about the prognosis and natural history specifically related to seizure recurrence after a first event.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q9",
    "question_text": "In a case of catamenial seizures, what is the recommended treatment?",
    "options": "{\"A\": \"Acetazolamide\", \"B\": \"Clobazam\", \"C\": \"Acetazolamide with hormonal therapy\", \"D\": \"Perimenstrual progesterone supplementation\"}",
    "correct_answer": "D",
    "source_file": "Part 1 2020_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2020,
    "explanation": "Classification Reason: Concerns the specific treatment strategy for seizures related to the menstrual cycle (catamenial epilepsy).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q250",
    "question_text": "Hypsarrhythmia with tuberous sclerosis (TS), what is the treatment?",
    "options": "{\"A\": \"ACTH\", \"B\": \"Corticosteroid\", \"C\": \"Vigabatrin\", \"D\": \"Valproic acid\"}",
    "correct_answer": "C",
    "source_file": "Promotion 2019_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2019,
    "explanation": "Classification Reason: Focuses on the treatment of infantile spasms (indicated by hypsarrhythmia) in the context of Tuberous Sclerosis, a condition strongly associated with epilepsy. While TS is genetic, the question is about seizure management.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q225",
    "question_text": "An 18-year-old female patient with seizures is found dead in bed after taking only one AED. What is the risk of sudden unexpected death in epilepsy (SUDEP)?",
    "options": "{\"A\": \"SUDEP risk is negligible in patients on monotherapy\", \"B\": \"SUDEP risk is highest in patients with uncontrolled generalized tonic-clonic seizures\", \"C\": \"SUDEP risk is only increased in patients with refractory epilepsy on polytherapy\", \"D\": \"SUDEP risk is unrelated to seizure frequency or control\"}",
    "correct_answer": "B",
    "source_file": "Part II 2022_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2022,
    "explanation": "Classification Reason: Directly addresses the concept and risk factors associated with SUDEP, a specific mortality concern in epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q215",
    "question_text": "What is the effect of adding a third antiepileptic drug (AED) on seizure control?",
    "options": "{\"A\": \"60%\", \"B\": \"50%\", \"C\": \"11%\", \"D\": \"5%\"}",
    "correct_answer": "D",
    "source_file": "Part II 2019_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2019,
    "explanation": "Classification Reason: Questions the efficacy of polytherapy (adding a third AED) in managing refractory epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q156",
    "question_text": "Which of the following treatments is commonly used for Landau-Kleffner syndrome?",
    "options": "{\"A\": \"Carbamazepine\", \"B\": \"Valproic acid\", \"C\": \"Phenytoin\", \"D\": \"Lamotrigine\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Asks about the pharmacological management of Landau-Kleffner syndrome, an epileptic encephalopathy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q161",
    "question_text": "Patient with MTS seizure; EEG showed left temporal discharges. What symptoms does he have?",
    "options": "{\"A\": \"Left automatism\", \"B\": \"Right hand dystonia\", \"C\": \"Aphasia\", \"D\": \"Right head version\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Tests knowledge of seizure semiology (automatisms) and its lateralization based on EEG findings in Mesial Temporal Sclerosis (MTS) epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q114",
    "question_text": "In a scenario of dyscognitive auras (Temporal lobe epilepsy), what imaging is typically used for diagnosis?",
    "options": "{\"A\": \"CT scan\", \"B\": \"MRI\", \"C\": \"PET scan\", \"D\": \"EEG\"}",
    "correct_answer": "B",
    "source_file": "Part II 2018_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2018,
    "explanation": "Classification Reason: Focuses on the appropriate diagnostic workup (specifically imaging) for suspected temporal lobe epilepsy based on seizure semiology (dyscognitive auras).",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q259",
    "question_text": "A patient presents with an aura of fear and seizure localization. Which area of the brain is most likely involved?",
    "options": "{\"A\": \"Cingulate gyrus\", \"B\": \"Temporal lobe\", \"C\": \"Insular lobe\", \"D\": \"Occipital lobe\"}",
    "correct_answer": "B",
    "source_file": "Promotion 2023_mcqs.txt",
    "exam_type": "Promotion",
    "exam_year": 2023,
    "explanation": "Classification Reason: Deals with seizure semiology (aura of fear) and its correlation with anatomical localization within the brain, specifically related to epilepsy.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q77",
    "question_text": "A known case of epilepsy, a female on lamotrigine, wants to start on OCB. What will you tell her?",
    "options": "{\"A\": \"Double the lamotrigine dose\", \"B\": \"Stop lamotrigine before starting OCB\", \"C\": \"No change in lamotrigine dose is needed\", \"D\": \"Switch to valproate before starting OCB\"}",
    "correct_answer": "A",
    "source_file": "Part 2 2021_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2021,
    "explanation": "Classification Reason: Concerns the drug-drug interaction between an AED (lamotrigine) and oral contraceptive pills (OCP), a common management issue in epilepsy patients.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q189",
    "question_text": "A patient with a first-time seizure, normal physical examination, and normal EEG, regarding his risk of seizure recurrence?",
    "options": "{\"A\": \"He has a 25% risk of seizure recurrence in 2 years\", \"B\": \"He has the highest risk of recurrence in the following 4 years\", \"C\": \"EEG findings have nothing to do with his risk of seizure recurrence\", \"D\": \"The risk of recurrence is negligible if MRI is normal\"}",
    "correct_answer": "A",
    "source_file": "Part I 2018_mcqs.txt",
    "exam_type": "Part I",
    "exam_year": 2018,
    "explanation": "Classification Reason: Assesses understanding of seizure recurrence risk factors (specifically the impact of normal workup) after a first seizure.",
    "subspecialty": "Epilepsy"
  },
  {
    "question_number": "Q145",
    "question_text": "A 3-year-old boy presented with developmental delay and seizures consisting of tonic seizures, drop attacks, and other types of seizures. What do you expect to find on his EEG (Lennox-Gastaut syndrome)?",
    "options": "{\"A\": \"3 Hz spike and wave\", \"B\": \"Epileptiform discharges less than 2 Hz\", \"C\": \"Generalized polyspike and wave discharges\", \"D\": \"Focal temporal spikes\"}",
    "correct_answer": "B",
    "source_file": "Part 2 2020 copy_mcqs.txt",
    "exam_type": "Part II",
    "exam_year": 2020,
    "explanation": "Classification Reason: Tests knowledge of the characteristic EEG findings associated with a specific severe childhood epilepsy syndrome (Lennox-Gastaut).",
    "subspecialty": "Epilepsy"
  }
]